EP1379511B1 - DIHYDRO-BENZO (b) (1, 4) DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II - Google Patents
DIHYDRO-BENZO (b) (1, 4) DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II Download PDFInfo
- Publication number
- EP1379511B1 EP1379511B1 EP02737911A EP02737911A EP1379511B1 EP 1379511 B1 EP1379511 B1 EP 1379511B1 EP 02737911 A EP02737911 A EP 02737911A EP 02737911 A EP02737911 A EP 02737911A EP 1379511 B1 EP1379511 B1 EP 1379511B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- phenyl
- methyl
- amino
- butyl ester
- acid tert
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102100036837 Metabotropic glutamate receptor 2 Human genes 0.000 title description 6
- 101150016175 Grm2 gene Proteins 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract description 658
- 150000001875 compounds Chemical class 0.000 claims abstract description 599
- 239000003814 drug Substances 0.000 claims abstract description 13
- 230000001154 acute effect Effects 0.000 claims abstract description 7
- 230000001684 chronic effect Effects 0.000 claims abstract description 7
- 230000002265 prevention Effects 0.000 claims abstract description 7
- 208000012902 Nervous system disease Diseases 0.000 claims abstract description 6
- 208000025966 Neurological disease Diseases 0.000 claims abstract description 6
- 230000008569 process Effects 0.000 claims abstract description 5
- -1 3-oxo-piperazin-1-yl Chemical group 0.000 claims description 35
- 125000000217 alkyl group Chemical group 0.000 claims description 30
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 25
- 150000003839 salts Chemical class 0.000 claims description 21
- 229910052736 halogen Inorganic materials 0.000 claims description 15
- 239000002253 acid Substances 0.000 claims description 12
- 150000002367 halogens Chemical class 0.000 claims description 12
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 11
- 125000001153 fluoro group Chemical group F* 0.000 claims description 10
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 9
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 125000001424 substituent group Chemical group 0.000 claims description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- 208000028017 Psychotic disease Diseases 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- 238000007363 ring formation reaction Methods 0.000 claims description 5
- 125000001462 1-pyrrolyl group Chemical group [*]N1C([H])=C([H])C([H])=C1[H] 0.000 claims description 4
- DJMZLSQXQSZBAN-UHFFFAOYSA-N 4-[2-oxo-7-(2,2,2-trifluoroethoxy)-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-4-yl]pyridine-2-carbonitrile Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(OCC(F)(F)F)=CC=2N=C1C1=CC=NC(C#N)=C1 DJMZLSQXQSZBAN-UHFFFAOYSA-N 0.000 claims description 4
- KGBAJRRLCNCMNT-UHFFFAOYSA-N 4-[3-[5-(hydroxymethyl)-1,3,4-thiadiazol-2-yl]phenyl]-7-[methyl(propyl)amino]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)CCC)=CC=2N=C1C(C=1)=CC=CC=1C1=NN=C(CO)S1 KGBAJRRLCNCMNT-UHFFFAOYSA-N 0.000 claims description 4
- CZLWEHDNIPKFTN-UHFFFAOYSA-N 4-[7-[cyclopropylmethyl(methyl)amino]-2-oxo-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-4-yl]pyridine-2-carbonitrile Chemical compound C=1C=2N=C(C=3C=C(N=CC=3)C#N)CC(=O)NC=2C=C(C(F)(F)F)C=1N(C)CC1CC1 CZLWEHDNIPKFTN-UHFFFAOYSA-N 0.000 claims description 4
- VYNUPTPNOCSSBJ-UHFFFAOYSA-N 7-(diethylamino)-4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-2-oxo-1,3-dihydro-1,5-benzodiazepine-8-carbonitrile Chemical compound C1C(=O)NC=2C=C(C#N)C(N(CC)CC)=CC=2N=C1C(C=1)=CC=CC=1C1=CC(C)=NO1 VYNUPTPNOCSSBJ-UHFFFAOYSA-N 0.000 claims description 4
- JXWKOMRRAURYHF-UHFFFAOYSA-N 8-chloro-4-[3-[4-(hydroxymethyl)-1,3-thiazol-2-yl]phenyl]-7-[methyl(2-methylpropyl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=NC(CO)=CS1 JXWKOMRRAURYHF-UHFFFAOYSA-N 0.000 claims description 4
- 208000024827 Alzheimer disease Diseases 0.000 claims description 4
- 208000026139 Memory disease Diseases 0.000 claims description 4
- 125000003277 amino group Chemical group 0.000 claims description 4
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 4
- 208000010877 cognitive disease Diseases 0.000 claims description 4
- 201000000980 schizophrenia Diseases 0.000 claims description 4
- SLZWQLBLGIMSRX-UHFFFAOYSA-N 4-(3-imidazol-1-ylphenyl)-7-(2-methylpropylamino)-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(NCC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1C=CN=C1 SLZWQLBLGIMSRX-UHFFFAOYSA-N 0.000 claims description 3
- GBRPDPUYJNPHFW-UHFFFAOYSA-N 4-[2-oxo-7-pyrrolidin-1-yl-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-4-yl]pyridine-2-carbonitrile Chemical compound FC(F)(F)C1=CC=2NC(=O)CC(C=3C=C(N=CC=3)C#N)=NC=2C=C1N1CCCC1 GBRPDPUYJNPHFW-UHFFFAOYSA-N 0.000 claims description 3
- ASXHDONHHPHYRD-UHFFFAOYSA-N 4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-2-oxo-7-piperidin-1-yl-1,3-dihydro-1,5-benzodiazepine-8-carbonitrile Chemical compound O1N=C(C)C=C1C1=CC=CC(C=2CC(=O)NC3=CC(=C(N4CCCCC4)C=C3N=2)C#N)=C1 ASXHDONHHPHYRD-UHFFFAOYSA-N 0.000 claims description 3
- LGGCNWMQSRYKEK-UHFFFAOYSA-N 4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-7-[methyl(propan-2-yl)amino]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=CC(C)=NO1 LGGCNWMQSRYKEK-UHFFFAOYSA-N 0.000 claims description 3
- OWPXWLMWINGIJA-UHFFFAOYSA-N 4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-7-[methyl(propyl)amino]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)CCC)=CC=2N=C1C(C=1)=CC=CC=1C1=CC(C)=NO1 OWPXWLMWINGIJA-UHFFFAOYSA-N 0.000 claims description 3
- QVWATQZHVALIAI-UHFFFAOYSA-N 4-[3-[4-(hydroxymethyl)-1,3-thiazol-2-yl]phenyl]-7-[methyl(propyl)amino]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)CCC)=CC=2N=C1C(C=1)=CC=CC=1C1=NC(CO)=CS1 QVWATQZHVALIAI-UHFFFAOYSA-N 0.000 claims description 3
- MOZPRFSXXYUWQA-UHFFFAOYSA-N 4-[3-[5-(azetidin-1-ylmethyl)triazol-1-yl]phenyl]-8-chloro-7-[methyl(2-methylpropyl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CN1CCC1 MOZPRFSXXYUWQA-UHFFFAOYSA-N 0.000 claims description 3
- AKNWSIBZOBQZRO-UHFFFAOYSA-N 4-[3-[5-(azetidin-1-ylmethyl)triazol-1-yl]phenyl]-8-chloro-7-[methyl(propan-2-yl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CN1CCC1 AKNWSIBZOBQZRO-UHFFFAOYSA-N 0.000 claims description 3
- RMBIAVCOZGNTCG-UHFFFAOYSA-N 4-[3-[5-[(cyclopropylmethylamino)methyl]triazol-1-yl]phenyl]-8-methyl-7-[methyl(2-methylpropyl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CNCC1CC1 RMBIAVCOZGNTCG-UHFFFAOYSA-N 0.000 claims description 3
- QPHLWEQWHSMTNX-UHFFFAOYSA-N 4-[7-[cyclopropyl(methyl)amino]-2-oxo-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-4-yl]pyridine-2-carbonitrile Chemical compound C=1C=2N=C(C=3C=C(N=CC=3)C#N)CC(=O)NC=2C=C(C(F)(F)F)C=1N(C)C1CC1 QPHLWEQWHSMTNX-UHFFFAOYSA-N 0.000 claims description 3
- MMFHASXGTDQSPH-UHFFFAOYSA-N 4-[7-[methyl(propan-2-yl)amino]-2-oxo-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-4-yl]pyridine-2-carbonitrile Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C(C)C)=CC=2N=C1C1=CC=NC(C#N)=C1 MMFHASXGTDQSPH-UHFFFAOYSA-N 0.000 claims description 3
- DDDRVKGHRFVCSK-UHFFFAOYSA-N 7-(dimethylamino)-4-(3-imidazol-1-ylphenyl)-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1C=CN=C1 DDDRVKGHRFVCSK-UHFFFAOYSA-N 0.000 claims description 3
- UYLWLBKJGHXHEJ-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-(2-methylpyrazol-3-yl)phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=CC=NN1C UYLWLBKJGHXHEJ-UHFFFAOYSA-N 0.000 claims description 3
- ZZVIUNYEAUAGMT-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=CC(C)=NO1 ZZVIUNYEAUAGMT-UHFFFAOYSA-N 0.000 claims description 3
- VAQIGIYSLWNPSM-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-[4-(hydroxymethyl)-1,3-oxazol-2-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=NC(CO)=CO1 VAQIGIYSLWNPSM-UHFFFAOYSA-N 0.000 claims description 3
- UXWOBRYNOZWNRK-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-[4-(hydroxymethyl)-1,3-thiazol-2-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=NC(CO)=CS1 UXWOBRYNOZWNRK-UHFFFAOYSA-N 0.000 claims description 3
- AKHVLIYLESRYKL-UHFFFAOYSA-N 7-(dimethylamino)-8-(2-phenylethynyl)-4-[3-(triazol-1-yl)phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound CN(C)C1=CC=2N=C(C=3C=C(C=CC=3)N3N=NC=C3)CC(=O)NC=2C=C1C#CC1=CC=CC=C1 AKHVLIYLESRYKL-UHFFFAOYSA-N 0.000 claims description 3
- OHWFEQKMVFNWLV-UHFFFAOYSA-N 7-(dimethylamino)-8-methyl-4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=CC(C)=NO1 OHWFEQKMVFNWLV-UHFFFAOYSA-N 0.000 claims description 3
- NXJBMLLXZBHSHA-UHFFFAOYSA-N 7-[methyl(2-methylpropyl)amino]-4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=CC(C)=NO1 NXJBMLLXZBHSHA-UHFFFAOYSA-N 0.000 claims description 3
- GKGGRNXTYYJBPH-UHFFFAOYSA-N 7-[methyl(2-methylpropyl)amino]-4-[3-(triazol-1-yl)phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1C=CN=N1 GKGGRNXTYYJBPH-UHFFFAOYSA-N 0.000 claims description 3
- HWPJVWXJTPQBEF-UHFFFAOYSA-N 7-[methyl(2-methylpropyl)amino]-4-[3-[5-[[methyl(propan-2-yl)amino]methyl]triazol-1-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CN(C)C(C)C HWPJVWXJTPQBEF-UHFFFAOYSA-N 0.000 claims description 3
- JHMOJYCUDSVXIH-UHFFFAOYSA-N 7-[methyl(propyl)amino]-4-[3-(triazol-1-yl)phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)CCC)=CC=2N=C1C(C=1)=CC=CC=1N1C=CN=N1 JHMOJYCUDSVXIH-UHFFFAOYSA-N 0.000 claims description 3
- OGFPVPFGOGJHSX-UHFFFAOYSA-N 8-(2-fluorophenyl)-4-[3-(triazol-1-yl)phenyl]-7-(2,2,2-trifluoroethoxy)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound FC1=CC=CC=C1C(C(=C1)OCC(F)(F)F)=CC2=C1N=C(C=1C=C(C=CC=1)N1N=NC=C1)CC(=O)N2 OGFPVPFGOGJHSX-UHFFFAOYSA-N 0.000 claims description 3
- PKAGRYFXAAQOOC-UHFFFAOYSA-N 8-chloro-4-(3-imidazol-1-ylphenyl)-7-(2-methylpropylamino)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(NCC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1C=CN=C1 PKAGRYFXAAQOOC-UHFFFAOYSA-N 0.000 claims description 3
- PFXSUPYIBPKVQN-UHFFFAOYSA-N 8-chloro-4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-7-(2-methylpropylamino)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(NCC(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=CC(C)=NO1 PFXSUPYIBPKVQN-UHFFFAOYSA-N 0.000 claims description 3
- BMMSJPYGKWFQKH-UHFFFAOYSA-N 8-chloro-4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-7-(propan-2-ylamino)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(NC(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=CC(C)=NO1 BMMSJPYGKWFQKH-UHFFFAOYSA-N 0.000 claims description 3
- NGCNTLZHOWWZPG-UHFFFAOYSA-N 8-chloro-4-[3-[4-(hydroxymethyl)-1,3-oxazol-2-yl]phenyl]-7-[methyl(2-methylpropyl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=NC(CO)=CO1 NGCNTLZHOWWZPG-UHFFFAOYSA-N 0.000 claims description 3
- FNVVDXIMWWBIRY-UHFFFAOYSA-N 8-chloro-4-[3-[4-(hydroxymethyl)-1,3-oxazol-2-yl]phenyl]-7-[methyl(propyl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CCC)=CC=2N=C1C(C=1)=CC=CC=1C1=NC(CO)=CO1 FNVVDXIMWWBIRY-UHFFFAOYSA-N 0.000 claims description 3
- WHTNPSQCYHTFRC-UHFFFAOYSA-N 8-chloro-4-[3-[4-(hydroxymethyl)-1,3-thiazol-2-yl]phenyl]-7-[methyl(propan-2-yl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=NC(CO)=CS1 WHTNPSQCYHTFRC-UHFFFAOYSA-N 0.000 claims description 3
- ADOSEGKIEQRXKL-UHFFFAOYSA-N 8-chloro-4-[3-[4-(hydroxymethyl)-1,3-thiazol-2-yl]phenyl]-7-[methyl(propyl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CCC)=CC=2N=C1C(C=1)=CC=CC=1C1=NC(CO)=CS1 ADOSEGKIEQRXKL-UHFFFAOYSA-N 0.000 claims description 3
- VGCFBGKWKFNEIC-UHFFFAOYSA-N 8-chloro-4-[3-[5-[(dimethylamino)methyl]triazol-1-yl]phenyl]-7-[methyl(2-methylpropyl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CN(C)C VGCFBGKWKFNEIC-UHFFFAOYSA-N 0.000 claims description 3
- GZPCGGQMFQCOJG-UHFFFAOYSA-N 8-chloro-4-[3-[5-[[methyl(2-methylpropyl)amino]methyl]triazol-1-yl]phenyl]-7-[methyl(propan-2-yl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound CC(C)CN(C)CC1=CN=NN1C1=CC=CC(C=2CC(=O)NC3=CC(Cl)=C(N(C)C(C)C)C=C3N=2)=C1 GZPCGGQMFQCOJG-UHFFFAOYSA-N 0.000 claims description 3
- JPOWMXAAAODWDG-UHFFFAOYSA-N 8-chloro-7-[ethyl(methyl)amino]-4-[3-[4-(hydroxymethyl)-1,3-oxazol-2-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CC)=CC=2N=C1C(C=1)=CC=CC=1C1=NC(CO)=CO1 JPOWMXAAAODWDG-UHFFFAOYSA-N 0.000 claims description 3
- MDZRWNNRILAEHU-UHFFFAOYSA-N 8-chloro-7-[ethyl(methyl)amino]-4-[3-[4-(hydroxymethyl)-1,3-thiazol-2-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CC)=CC=2N=C1C(C=1)=CC=CC=1C1=NC(CO)=CS1 MDZRWNNRILAEHU-UHFFFAOYSA-N 0.000 claims description 3
- KMRCILAGDOXKQR-UHFFFAOYSA-N 8-chloro-7-[methyl(2-methylpropyl)amino]-4-[3-(triazol-1-yl)phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1C=CN=N1 KMRCILAGDOXKQR-UHFFFAOYSA-N 0.000 claims description 3
- SOYNHYRIQYZWGC-UHFFFAOYSA-N 8-chloro-7-[methyl(2-methylpropyl)amino]-4-[3-[5-(piperidin-1-ylmethyl)triazol-1-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CN1CCCCC1 SOYNHYRIQYZWGC-UHFFFAOYSA-N 0.000 claims description 3
- DHDNESILTRMMAB-UHFFFAOYSA-N 8-chloro-7-[methyl(2-methylpropyl)amino]-4-[3-[5-(pyrrolidin-1-ylmethyl)triazol-1-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CN1CCCC1 DHDNESILTRMMAB-UHFFFAOYSA-N 0.000 claims description 3
- SAVDHCKDKXITDB-UHFFFAOYSA-N 8-chloro-7-[methyl(propan-2-yl)amino]-4-[3-[5-(pyrrolidin-1-ylmethyl)triazol-1-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CN1CCCC1 SAVDHCKDKXITDB-UHFFFAOYSA-N 0.000 claims description 3
- VHBNDJVFQOPHQL-UHFFFAOYSA-N 8-chloro-7-[methyl(propan-2-yl)amino]-4-[3-[5-[[methyl(propan-2-yl)amino]methyl]triazol-1-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound CC(C)N(C)CC1=CN=NN1C1=CC=CC(C=2CC(=O)NC3=CC(Cl)=C(N(C)C(C)C)C=C3N=2)=C1 VHBNDJVFQOPHQL-UHFFFAOYSA-N 0.000 claims description 3
- YTKAPOCJJREWCQ-UHFFFAOYSA-N 8-chloro-7-[methyl(propyl)amino]-4-[3-[5-(pyrrolidin-1-ylmethyl)triazol-1-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CCC)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CN1CCCC1 YTKAPOCJJREWCQ-UHFFFAOYSA-N 0.000 claims description 3
- QBSNFNKYIAYAHP-UHFFFAOYSA-N 8-methyl-7-[methyl(2-methylpropyl)amino]-4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=CC(C)=NO1 QBSNFNKYIAYAHP-UHFFFAOYSA-N 0.000 claims description 3
- PUMGQYZLUWHXDO-UHFFFAOYSA-N 8-methyl-7-[methyl(2-methylpropyl)amino]-4-[3-[5-(pyrrolidin-1-ylmethyl)triazol-1-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CN1CCCC1 PUMGQYZLUWHXDO-UHFFFAOYSA-N 0.000 claims description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 3
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 2
- HAAZRBAMJKYOAA-UHFFFAOYSA-N 7-[ethyl(methyl)amino]-8-methyl-4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C)C(N(C)CC)=CC=2N=C1C(C=1)=CC=CC=1C1=CC(C)=NO1 HAAZRBAMJKYOAA-UHFFFAOYSA-N 0.000 claims description 2
- GGCLCUPVAHZUHM-UHFFFAOYSA-N 7-[methyl(propan-2-yl)amino]-4-[3-[5-(pyrrolidin-1-ylmethyl)triazol-1-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CN1CCCC1 GGCLCUPVAHZUHM-UHFFFAOYSA-N 0.000 claims description 2
- CWRWLBCLNIXFEP-UHFFFAOYSA-N 8-chloro-4-[3-[4-(hydroxymethyl)-1,3-oxazol-2-yl]phenyl]-7-[methyl(propan-2-yl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=NC(CO)=CO1 CWRWLBCLNIXFEP-UHFFFAOYSA-N 0.000 claims description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 238000010511 deprotection reaction Methods 0.000 claims description 2
- 125000002883 imidazolyl group Chemical group 0.000 claims description 2
- 125000000842 isoxazolyl group Chemical group 0.000 claims description 2
- 125000002971 oxazolyl group Chemical group 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 2
- 125000000335 thiazolyl group Chemical group 0.000 claims description 2
- 125000006701 (C1-C7) alkyl group Chemical group 0.000 claims 10
- 125000005843 halogen group Chemical group 0.000 claims 3
- 230000006806 disease prevention Effects 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 21
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 561
- 239000007787 solid Substances 0.000 description 376
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 366
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 198
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 148
- 239000000203 mixture Substances 0.000 description 130
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 126
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 116
- 239000003921 oil Substances 0.000 description 108
- 235000019198 oils Nutrition 0.000 description 108
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 107
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 106
- 239000000243 solution Substances 0.000 description 93
- MEGIEGFVRNXYSU-UHFFFAOYSA-N tert-butyl n-[2-amino-5-(dimethylamino)-4-(trifluoromethyl)phenyl]carbamate Chemical compound CN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C(F)(F)F MEGIEGFVRNXYSU-UHFFFAOYSA-N 0.000 description 80
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 78
- 238000006243 chemical reaction Methods 0.000 description 74
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 73
- JTBNUOXTNBABIE-UHFFFAOYSA-N tert-butyl 3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(N2C(=CN=N2)COC2OCCCC2)=C1 JTBNUOXTNBABIE-UHFFFAOYSA-N 0.000 description 67
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 65
- 239000012267 brine Substances 0.000 description 64
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 64
- 239000006260 foam Substances 0.000 description 63
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 57
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 56
- BSPODPDIDGXFDC-UHFFFAOYSA-N tert-butyl 3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoate Chemical compound O1N=C(C)C=C1C1=CC=CC(C(=O)CC(=O)OC(C)(C)C)=C1 BSPODPDIDGXFDC-UHFFFAOYSA-N 0.000 description 54
- 239000000463 material Substances 0.000 description 51
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 50
- 235000019439 ethyl acetate Nutrition 0.000 description 46
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 44
- ZTCGGBIFOFASKI-UHFFFAOYSA-N tert-butyl acetate;lithium Chemical compound [Li].CC(=O)OC(C)(C)C ZTCGGBIFOFASKI-UHFFFAOYSA-N 0.000 description 43
- PVCLQUXXFKCAPM-UHFFFAOYSA-N tert-butyl n-[2-amino-4-chloro-5-(dimethylamino)phenyl]carbamate Chemical compound CN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1Cl PVCLQUXXFKCAPM-UHFFFAOYSA-N 0.000 description 43
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 36
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 35
- 239000000741 silica gel Substances 0.000 description 35
- 229910002027 silica gel Inorganic materials 0.000 description 35
- 239000012044 organic layer Substances 0.000 description 33
- 239000003480 eluent Substances 0.000 description 32
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 31
- 230000009467 reduction Effects 0.000 description 30
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 28
- 239000002904 solvent Substances 0.000 description 28
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 27
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 26
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 26
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 26
- 239000000126 substance Substances 0.000 description 26
- 125000003545 alkoxy group Chemical group 0.000 description 25
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 25
- ZOKRGURYDNRVFP-UHFFFAOYSA-N 8-chloro-4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-7-[methyl(propan-2-yl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CO ZOKRGURYDNRVFP-UHFFFAOYSA-N 0.000 description 24
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 24
- QQJNABOVYNTCRV-UHFFFAOYSA-N tert-butyl 3-(2-cyanopyridin-4-yl)-3-oxopropanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=NC(C#N)=C1 QQJNABOVYNTCRV-UHFFFAOYSA-N 0.000 description 24
- AXZWODMDQAVCJE-UHFFFAOYSA-L tin(II) chloride (anhydrous) Chemical compound [Cl-].[Cl-].[Sn+2] AXZWODMDQAVCJE-UHFFFAOYSA-L 0.000 description 24
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 23
- 238000003756 stirring Methods 0.000 description 22
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 22
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 21
- 238000004587 chromatography analysis Methods 0.000 description 21
- SWEAKJSASQXXAU-UHFFFAOYSA-N tert-butyl n-[2-amino-4-chloro-5-[methyl(2-methylpropyl)amino]phenyl]carbamate Chemical compound CC(C)CN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1Cl SWEAKJSASQXXAU-UHFFFAOYSA-N 0.000 description 21
- 239000000047 product Substances 0.000 description 19
- ZCGIEZPJGKROLT-UHFFFAOYSA-N tert-butyl n-[2-amino-5-[methyl(2-methylpropyl)amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound CC(C)CN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C(F)(F)F ZCGIEZPJGKROLT-UHFFFAOYSA-N 0.000 description 19
- 238000005984 hydrogenation reaction Methods 0.000 description 18
- BUDAECSKCNVXAI-UHFFFAOYSA-N tert-butyl 3-[3-[4-(oxan-2-yloxymethyl)-1,3-thiazol-2-yl]phenyl]-3-oxopropanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(C=2SC=C(COC3OCCCC3)N=2)=C1 BUDAECSKCNVXAI-UHFFFAOYSA-N 0.000 description 18
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 17
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 17
- 238000010898 silica gel chromatography Methods 0.000 description 17
- HXZFITILXOESLM-UHFFFAOYSA-N tert-butyl n-[5-chloro-2-nitro-4-(trifluoromethyl)phenyl]carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC(Cl)=C(C(F)(F)F)C=C1[N+]([O-])=O HXZFITILXOESLM-UHFFFAOYSA-N 0.000 description 17
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 16
- 229940093499 ethyl acetate Drugs 0.000 description 16
- 239000008279 sol Substances 0.000 description 16
- GMAMRGUSLZPGRI-UHFFFAOYSA-N tert-butyl 3-[3-[4-(oxan-2-yloxymethyl)-1,3-oxazol-2-yl]phenyl]-3-oxopropanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(C=2OC=C(COC3OCCCC3)N=2)=C1 GMAMRGUSLZPGRI-UHFFFAOYSA-N 0.000 description 16
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 16
- 238000010992 reflux Methods 0.000 description 15
- UZERPUAWQOHXES-UHFFFAOYSA-N tert-butyl n-(4-cyano-5-fluoro-2-nitrophenyl)carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC(F)=C(C#N)C=C1[N+]([O-])=O UZERPUAWQOHXES-UHFFFAOYSA-N 0.000 description 15
- KPASUWYIMLKUGR-UHFFFAOYSA-N 4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-7-[methyl(propan-2-yl)amino]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CO KPASUWYIMLKUGR-UHFFFAOYSA-N 0.000 description 14
- QJRUGCDPBLUQTE-UHFFFAOYSA-N tert-butyl 3-oxo-3-[3-(1,2,4-triazol-1-yl)phenyl]propanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(N2N=CN=C2)=C1 QJRUGCDPBLUQTE-UHFFFAOYSA-N 0.000 description 14
- CXXUSSYNGZCIJB-UHFFFAOYSA-N tert-butyl 3-oxo-3-[3-(triazol-1-yl)phenyl]propanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(N2N=NC=C2)=C1 CXXUSSYNGZCIJB-UHFFFAOYSA-N 0.000 description 14
- IIZCUVHOPYPQGS-UHFFFAOYSA-N (4,5-dichloro-2-nitrophenyl)carbamic acid Chemical compound OC(=O)NC1=CC(Cl)=C(Cl)C=C1[N+]([O-])=O IIZCUVHOPYPQGS-UHFFFAOYSA-N 0.000 description 13
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 13
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 13
- 238000001914 filtration Methods 0.000 description 13
- 229910052938 sodium sulfate Inorganic materials 0.000 description 13
- HBMYBFUHFGSHSZ-UHFFFAOYSA-N tert-butyl n-[2-amino-5-[methyl(propyl)amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound CCCN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C(F)(F)F HBMYBFUHFGSHSZ-UHFFFAOYSA-N 0.000 description 13
- FXAGRCKETPSFSX-UHFFFAOYSA-N 8-chloro-4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-7-[methyl(propyl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CCC)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CO FXAGRCKETPSFSX-UHFFFAOYSA-N 0.000 description 12
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 12
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 12
- 229910006124 SOCl2 Inorganic materials 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 12
- KUHMJDSOPHMSDX-UHFFFAOYSA-N ethyl 3-oxo-3-[3-(triazol-1-yl)phenyl]propanoate Chemical compound CCOC(=O)CC(=O)C1=CC=CC(N2N=NC=C2)=C1 KUHMJDSOPHMSDX-UHFFFAOYSA-N 0.000 description 12
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 12
- WDKOTVLVDWHHLW-UHFFFAOYSA-N tert-butyl n-(5-chloro-4-methyl-2-nitrophenyl)carbamate Chemical compound CC1=CC([N+]([O-])=O)=C(NC(=O)OC(C)(C)C)C=C1Cl WDKOTVLVDWHHLW-UHFFFAOYSA-N 0.000 description 12
- KRWKPWWLGUDSOV-UHFFFAOYSA-N tert-butyl n-[2-amino-4-chloro-5-(2-methylpropylamino)phenyl]carbamate Chemical compound CC(C)CNC1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1Cl KRWKPWWLGUDSOV-UHFFFAOYSA-N 0.000 description 12
- JYFRKZBBSNUAKO-UHFFFAOYSA-N tert-butyl n-[2-amino-4-chloro-5-[methyl(propyl)amino]phenyl]carbamate Chemical compound CCCN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1Cl JYFRKZBBSNUAKO-UHFFFAOYSA-N 0.000 description 12
- UCPKVTBSSTWLHN-UHFFFAOYSA-N 8-chloro-4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-7-[methyl(2-methylpropyl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CO UCPKVTBSSTWLHN-UHFFFAOYSA-N 0.000 description 11
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 10
- DPJCXCZTLWNFOH-UHFFFAOYSA-N 2-nitroaniline Chemical class NC1=CC=CC=C1[N+]([O-])=O DPJCXCZTLWNFOH-UHFFFAOYSA-N 0.000 description 10
- YHKHGQRGQRHDRS-UHFFFAOYSA-N 4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-8-methyl-7-[methyl(2-methylpropyl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CO YHKHGQRGQRHDRS-UHFFFAOYSA-N 0.000 description 10
- 239000011541 reaction mixture Substances 0.000 description 10
- 238000003786 synthesis reaction Methods 0.000 description 10
- AVXDDDSVQMREIQ-UHFFFAOYSA-N tert-butyl n-[2-amino-4-chloro-5-[2-methoxyethyl(methyl)amino]phenyl]carbamate Chemical compound COCCN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1Cl AVXDDDSVQMREIQ-UHFFFAOYSA-N 0.000 description 10
- ISKUUZNVPWUNTC-UHFFFAOYSA-N tert-butyl n-[2-amino-5-(dimethylamino)-4-fluorophenyl]carbamate Chemical compound CN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1F ISKUUZNVPWUNTC-UHFFFAOYSA-N 0.000 description 10
- 150000002148 esters Chemical class 0.000 description 9
- BSQWYELDCUXPSJ-UHFFFAOYSA-N methyl 3-azidobenzoate Chemical compound COC(=O)C1=CC=CC(N=[N+]=[N-])=C1 BSQWYELDCUXPSJ-UHFFFAOYSA-N 0.000 description 9
- 239000002244 precipitate Substances 0.000 description 9
- FAJRXWKLPIBEDN-UHFFFAOYSA-N tert-butyl n-[2-amino-4-(2-fluorophenyl)-5-(2,2,2-trifluoroethoxy)phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OC(C)(C)C)=CC(OCC(F)(F)F)=C1C1=CC=CC=C1F FAJRXWKLPIBEDN-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- SUNMBRGCANLOEG-UHFFFAOYSA-N 1,3-dichloroacetone Chemical compound ClCC(=O)CCl SUNMBRGCANLOEG-UHFFFAOYSA-N 0.000 description 8
- RAVMZWQUVKTGBS-UHFFFAOYSA-N 3-(2,2-dimethyl-6-oxo-1,3-dioxin-4-yl)benzonitrile Chemical compound O1C(C)(C)OC(=O)C=C1C1=CC=CC(C#N)=C1 RAVMZWQUVKTGBS-UHFFFAOYSA-N 0.000 description 8
- ARKUSYJPKDWWKW-UHFFFAOYSA-N 4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-7-[methyl(2-methylpropyl)amino]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CO ARKUSYJPKDWWKW-UHFFFAOYSA-N 0.000 description 8
- RRRQXQWTDIKCBC-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-[3-(hydroxymethyl)-1,2-oxazol-5-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=CC(CO)=NO1 RRRQXQWTDIKCBC-UHFFFAOYSA-N 0.000 description 8
- VUZQOAXTGJJJJI-UHFFFAOYSA-N 8-chloro-4-[3-[5-(hydroxymethyl)-1,2,4-triazol-1-yl]phenyl]-7-[methyl(propyl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CCC)=CC=2N=C1C(C=1)=CC=CC=1N1N=CN=C1CO VUZQOAXTGJJJJI-UHFFFAOYSA-N 0.000 description 8
- 239000007832 Na2SO4 Substances 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 8
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 8
- GVWISOJSERXQBM-UHFFFAOYSA-N n-methylpropan-1-amine Chemical compound CCCNC GVWISOJSERXQBM-UHFFFAOYSA-N 0.000 description 8
- XHFGWHUWQXTGAT-UHFFFAOYSA-N n-methylpropan-2-amine Chemical compound CNC(C)C XHFGWHUWQXTGAT-UHFFFAOYSA-N 0.000 description 8
- NJGOKCQKYUXLSX-UHFFFAOYSA-N tert-butyl 3-(3-cyanophenyl)-3-oxopropanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(C#N)=C1 NJGOKCQKYUXLSX-UHFFFAOYSA-N 0.000 description 8
- AUDSAJIZWLBHRN-UHFFFAOYSA-N tert-butyl 3-[3-[3-(oxan-2-yloxymethyl)-1,2-oxazol-5-yl]phenyl]-3-oxopropanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(C=2ON=C(COC3OCCCC3)C=2)=C1 AUDSAJIZWLBHRN-UHFFFAOYSA-N 0.000 description 8
- JJGNFUCMTKEOQN-UHFFFAOYSA-N tert-butyl 3-[3-[5-(oxan-2-yloxymethyl)-1,2,4-triazol-1-yl]phenyl]-3-oxopropanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(N2C(=NC=N2)COC2OCCCC2)=C1 JJGNFUCMTKEOQN-UHFFFAOYSA-N 0.000 description 8
- WXSHWXSHDJJFMX-UHFFFAOYSA-N tert-butyl 3-[3-[5-(oxan-2-yloxymethyl)-1,2-oxazol-3-yl]phenyl]-3-oxopropanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(C2=NOC(COC3OCCCC3)=C2)=C1 WXSHWXSHDJJFMX-UHFFFAOYSA-N 0.000 description 8
- MMUFWRNJOBPGMV-UHFFFAOYSA-N tert-butyl 3-[3-[5-[(dimethylamino)methyl]triazol-1-yl]phenyl]-3-oxopropanoate Chemical compound CN(C)CC1=CN=NN1C1=CC=CC(C(=O)CC(=O)OC(C)(C)C)=C1 MMUFWRNJOBPGMV-UHFFFAOYSA-N 0.000 description 8
- UJFGZNBJAVEEGG-UHFFFAOYSA-N tert-butyl 3-oxo-3-(3-pyrazol-1-ylphenyl)propanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(N2N=CC=C2)=C1 UJFGZNBJAVEEGG-UHFFFAOYSA-N 0.000 description 8
- NNVBILVWKLMHPC-UHFFFAOYSA-N tert-butyl n-(2-amino-4-fluoro-5-pyrrolidin-1-ylphenyl)carbamate Chemical compound C1=C(N)C(NC(=O)OC(C)(C)C)=CC(N2CCCC2)=C1F NNVBILVWKLMHPC-UHFFFAOYSA-N 0.000 description 8
- CHCLFKQUCNAXTK-UHFFFAOYSA-N tert-butyl n-[2-amino-4-(2,3-difluorophenyl)-5-(dimethylamino)phenyl]carbamate Chemical compound CN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C1=CC=CC(F)=C1F CHCLFKQUCNAXTK-UHFFFAOYSA-N 0.000 description 8
- MDTHMKQMDZHFHK-UHFFFAOYSA-N tert-butyl n-[2-amino-4-chloro-5-[ethyl(methyl)amino]phenyl]carbamate Chemical compound CCN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1Cl MDTHMKQMDZHFHK-UHFFFAOYSA-N 0.000 description 8
- IZYKHDOWPOKDDY-UHFFFAOYSA-N tert-butyl n-[2-amino-4-methyl-5-[methyl(2-methylpropyl)amino]phenyl]carbamate Chemical compound CC(C)CN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C IZYKHDOWPOKDDY-UHFFFAOYSA-N 0.000 description 8
- FIRRBISFFRMYNX-UHFFFAOYSA-N tert-butyl n-[2-amino-5-(azetidin-1-yl)-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OC(C)(C)C)=CC(N2CCC2)=C1C(F)(F)F FIRRBISFFRMYNX-UHFFFAOYSA-N 0.000 description 8
- FBTJEKMDVKZHDX-UHFFFAOYSA-N tert-butyl n-[2-amino-5-(dimethylamino)-4-methylphenyl]carbamate Chemical compound CN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C FBTJEKMDVKZHDX-UHFFFAOYSA-N 0.000 description 8
- XMWVNQVJVMIVMK-UHFFFAOYSA-N tert-butyl n-[2-amino-5-[methyl(propan-2-yl)amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound CC(C)N(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C(F)(F)F XMWVNQVJVMIVMK-UHFFFAOYSA-N 0.000 description 8
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 8
- ILVLBKPSGQKXNP-UHFFFAOYSA-N 4-[3-(2-bromoacetyl)phenyl]-8-chloro-7-(dimethylamino)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C)=CC=2N=C1C1=CC=CC(C(=O)CBr)=C1 ILVLBKPSGQKXNP-UHFFFAOYSA-N 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 7
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 7
- HTJDQJBWANPRPF-UHFFFAOYSA-N Cyclopropylamine Chemical compound NC1CC1 HTJDQJBWANPRPF-UHFFFAOYSA-N 0.000 description 7
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 7
- 239000000969 carrier Substances 0.000 description 7
- 239000000543 intermediate Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- VZQQUUOWRMHQPG-UHFFFAOYSA-N tert-butyl n-[2-amino-4-chloro-5-[methyl(propan-2-yl)amino]phenyl]carbamate Chemical compound CC(C)N(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1Cl VZQQUUOWRMHQPG-UHFFFAOYSA-N 0.000 description 7
- UBXMQARTMWZVEP-UHFFFAOYSA-N tert-butyl n-[2-amino-4-cyano-5-(dimethylamino)phenyl]carbamate Chemical compound CN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C#N UBXMQARTMWZVEP-UHFFFAOYSA-N 0.000 description 7
- VTVFCTSEAINUQK-UHFFFAOYSA-N tert-butyl n-[2-amino-5-pyrrolidin-1-yl-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OC(C)(C)C)=CC(N2CCCC2)=C1C(F)(F)F VTVFCTSEAINUQK-UHFFFAOYSA-N 0.000 description 7
- BZVZBKJBMILRFM-UHFFFAOYSA-N 2,2-dimethyl-6-[3-(triazol-1-yl)phenyl]-1,3-dioxin-4-one Chemical compound O1C(C)(C)OC(=O)C=C1C1=CC=CC(N2N=NC=C2)=C1 BZVZBKJBMILRFM-UHFFFAOYSA-N 0.000 description 6
- KDSNLYIMUZNERS-UHFFFAOYSA-N 2-methylpropanamine Chemical compound CC(C)CN KDSNLYIMUZNERS-UHFFFAOYSA-N 0.000 description 6
- QKEFOVJZNPELQH-UHFFFAOYSA-N 3-(2-bromoacetyl)benzoic acid Chemical compound OC(=O)C1=CC=CC(C(=O)CBr)=C1 QKEFOVJZNPELQH-UHFFFAOYSA-N 0.000 description 6
- FLCGMVBKTAMPQY-UHFFFAOYSA-N 3-[8-chloro-7-(dimethylamino)-2-oxo-1,3-dihydro-1,5-benzodiazepin-4-yl]benzonitrile Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C)=CC=2N=C1C1=CC=CC(C#N)=C1 FLCGMVBKTAMPQY-UHFFFAOYSA-N 0.000 description 6
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 6
- MVPLCCRWNXQSML-UHFFFAOYSA-N 4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-7-[methyl(2-methylpropyl)amino]-2-oxo-1,3-dihydro-1,5-benzodiazepine-8-carbonitrile Chemical compound C1C(=O)NC=2C=C(C#N)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CO MVPLCCRWNXQSML-UHFFFAOYSA-N 0.000 description 6
- OABSXOMYUDYCAN-UHFFFAOYSA-N 6-(3-imidazol-1-ylphenyl)-2,2-dimethyl-1,3-dioxin-4-one Chemical compound O1C(C)(C)OC(=O)C=C1C1=CC=CC(N2C=NC=C2)=C1 OABSXOMYUDYCAN-UHFFFAOYSA-N 0.000 description 6
- HJDOCXLVWHFJJZ-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CO HJDOCXLVWHFJJZ-UHFFFAOYSA-N 0.000 description 6
- OPTWSLJVKZLSTK-UHFFFAOYSA-N 8-chloro-7-(dimethylamino)-4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CO OPTWSLJVKZLSTK-UHFFFAOYSA-N 0.000 description 6
- 108010010914 Metabotropic glutamate receptors Proteins 0.000 description 6
- 102000016193 Metabotropic glutamate receptors Human genes 0.000 description 6
- 235000019502 Orange oil Nutrition 0.000 description 6
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 6
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 229910001629 magnesium chloride Inorganic materials 0.000 description 6
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
- LVRJAFUTXDBMCM-UHFFFAOYSA-N methyl 3-(2-bromopropanoyl)benzoate Chemical compound COC(=O)C1=CC=CC(C(=O)C(C)Br)=C1 LVRJAFUTXDBMCM-UHFFFAOYSA-N 0.000 description 6
- KYEBGXQJMRBXGX-UHFFFAOYSA-N methyl 3-[2-(hydroxymethyl)-5-methyl-1,3-thiazol-4-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C2=C(SC(CO)=N2)C)=C1 KYEBGXQJMRBXGX-UHFFFAOYSA-N 0.000 description 6
- GLJBAIOKEWBTLH-UHFFFAOYSA-N methyl 3-[5-(oxan-2-yloxymethyl)-1,3,4-thiadiazol-2-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C=2SC(COC3OCCCC3)=NN=2)=C1 GLJBAIOKEWBTLH-UHFFFAOYSA-N 0.000 description 6
- FQFGNAOZWRLIEO-UHFFFAOYSA-N methyl 3-[5-[2-(oxan-2-yloxy)ethyl]-1,3,4-thiadiazol-2-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C=2SC(CCOC3OCCCC3)=NN=2)=C1 FQFGNAOZWRLIEO-UHFFFAOYSA-N 0.000 description 6
- QKYWADPCTHTJHQ-UHFFFAOYSA-N n,2-dimethylpropan-1-amine Chemical compound CNCC(C)C QKYWADPCTHTJHQ-UHFFFAOYSA-N 0.000 description 6
- 239000010502 orange oil Substances 0.000 description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 description 6
- FEPASYFSULWDNV-UHFFFAOYSA-N tert-butyl 3-(3-imidazol-1-ylphenyl)-3-oxopropanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(N2C=NC=C2)=C1 FEPASYFSULWDNV-UHFFFAOYSA-N 0.000 description 6
- QKUXMIVMLPOOQJ-UHFFFAOYSA-N tert-butyl 3-[2-(3-methyl-1,2-oxazol-5-yl)pyridin-4-yl]-3-oxopropanoate Chemical compound O1N=C(C)C=C1C1=CC(C(=O)CC(=O)OC(C)(C)C)=CC=N1 QKUXMIVMLPOOQJ-UHFFFAOYSA-N 0.000 description 6
- JUZXQJPXPXGYEY-UHFFFAOYSA-N tert-butyl 3-[3-(2-methylpyrazol-3-yl)phenyl]-3-oxopropanoate Chemical compound CN1N=CC=C1C1=CC=CC(C(=O)CC(=O)OC(C)(C)C)=C1 JUZXQJPXPXGYEY-UHFFFAOYSA-N 0.000 description 6
- OUIJQUXVADJPRM-UHFFFAOYSA-N tert-butyl 3-[3-[3-methyl-4-(oxan-2-yloxymethyl)-1,2-oxazol-5-yl]phenyl]-3-oxopropanoate Chemical compound CC1=NOC(C=2C=C(C=CC=2)C(=O)CC(=O)OC(C)(C)C)=C1COC1CCCCO1 OUIJQUXVADJPRM-UHFFFAOYSA-N 0.000 description 6
- GUJBVLUYJDMBKB-UHFFFAOYSA-N tert-butyl 3-[3-[4-(oxan-2-yloxymethyl)pyrazol-1-yl]phenyl]-3-oxopropanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(N2N=CC(COC3OCCCC3)=C2)=C1 GUJBVLUYJDMBKB-UHFFFAOYSA-N 0.000 description 6
- RAFPNQXZTPWERJ-UHFFFAOYSA-N tert-butyl n-(2-amino-4-cyano-5-pyrrolidin-1-ylphenyl)carbamate Chemical compound C1=C(N)C(NC(=O)OC(C)(C)C)=CC(N2CCCC2)=C1C#N RAFPNQXZTPWERJ-UHFFFAOYSA-N 0.000 description 6
- DBFFOSHTRIHRAO-UHFFFAOYSA-N tert-butyl n-(2-amino-4-methyl-5-pyrrolidin-1-ylphenyl)carbamate Chemical compound CC1=CC(N)=C(NC(=O)OC(C)(C)C)C=C1N1CCCC1 DBFFOSHTRIHRAO-UHFFFAOYSA-N 0.000 description 6
- NKQCIXSPRUQCPK-UHFFFAOYSA-N tert-butyl n-[2-amino-4-cyano-5-[methyl(2-methylpropyl)amino]phenyl]carbamate Chemical compound CC(C)CN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C#N NKQCIXSPRUQCPK-UHFFFAOYSA-N 0.000 description 6
- FOTWLZJLVZRDQS-UHFFFAOYSA-N tert-butyl n-[2-amino-4-cyano-5-[methyl(propan-2-yl)amino]phenyl]carbamate Chemical compound CC(C)N(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C#N FOTWLZJLVZRDQS-UHFFFAOYSA-N 0.000 description 6
- ZADFCGJNPDZVLX-UHFFFAOYSA-N tert-butyl n-[2-amino-4-cyano-5-[methyl(propyl)amino]phenyl]carbamate Chemical compound CCCN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C#N ZADFCGJNPDZVLX-UHFFFAOYSA-N 0.000 description 6
- GMPJOZLBWVFYPE-UHFFFAOYSA-N tert-butyl n-[2-amino-4-methyl-5-[methyl(propyl)amino]phenyl]carbamate Chemical compound CCCN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C GMPJOZLBWVFYPE-UHFFFAOYSA-N 0.000 description 6
- VVESNTLWXXMRBT-UHFFFAOYSA-N tert-butyl n-[2-amino-5-[cyclopropylmethyl(methyl)amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C=1C(NC(=O)OC(C)(C)C)=C(N)C=C(C(F)(F)F)C=1N(C)CC1CC1 VVESNTLWXXMRBT-UHFFFAOYSA-N 0.000 description 6
- BIWDUNBAIDXQII-UHFFFAOYSA-N tert-butyl n-[2-amino-5-[ethyl(methyl)amino]-4-methylphenyl]carbamate Chemical compound CCN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C BIWDUNBAIDXQII-UHFFFAOYSA-N 0.000 description 6
- XETDEUBKAJMXJS-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-4-iodo-2-nitrophenyl]carbamate Chemical compound CN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1I XETDEUBKAJMXJS-UHFFFAOYSA-N 0.000 description 6
- RNEVREZJAWDXDT-UHFFFAOYSA-N (4-iodo-2-nitrophenyl)carbamic acid Chemical compound OC(=O)NC1=CC=C(I)C=C1[N+]([O-])=O RNEVREZJAWDXDT-UHFFFAOYSA-N 0.000 description 5
- GFISDBXSWQMOND-UHFFFAOYSA-N 2,5-dimethoxyoxolane Chemical class COC1CCC(OC)O1 GFISDBXSWQMOND-UHFFFAOYSA-N 0.000 description 5
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 5
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 5
- 229910004373 HOAc Inorganic materials 0.000 description 5
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 5
- 235000011152 sodium sulphate Nutrition 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- DZSOJGQNGBMGRO-UHFFFAOYSA-N tert-butyl 3-[3-(2-bromo-1,1-dimethoxyethyl)phenyl]-3-oxopropanoate Chemical compound COC(CBr)(OC)C1=CC=CC(C(=O)CC(=O)OC(C)(C)C)=C1 DZSOJGQNGBMGRO-UHFFFAOYSA-N 0.000 description 5
- QXKXGQLNZMEQNY-UHFFFAOYSA-N tert-butyl 3-[3-(2-methyl-1,3-oxazol-4-yl)phenyl]-3-oxopropanoate Chemical compound O1C(C)=NC(C=2C=C(C=CC=2)C(=O)CC(=O)OC(C)(C)C)=C1 QXKXGQLNZMEQNY-UHFFFAOYSA-N 0.000 description 5
- XMXRCKFQUWNONR-UHFFFAOYSA-N tert-butyl 3-[3-[5-(oxan-2-yloxymethyl)-1,3,4-thiadiazol-2-yl]phenyl]-3-oxopropanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(C=2SC(COC3OCCCC3)=NN=2)=C1 XMXRCKFQUWNONR-UHFFFAOYSA-N 0.000 description 5
- AHWNNHUULLZMNZ-UHFFFAOYSA-N tert-butyl n-[2-[[3-(2-cyanopyridin-4-yl)-3-oxopropanoyl]amino]-5-[cyclopropyl(methyl)amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C=1C(NC(=O)OC(C)(C)C)=C(NC(=O)CC(=O)C=2C=C(N=CC=2)C#N)C=C(C(F)(F)F)C=1N(C)C1CC1 AHWNNHUULLZMNZ-UHFFFAOYSA-N 0.000 description 5
- CSVKISHLQVPEQV-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-(dimethylamino)-2-[[3-[2-(3-methyl-1,2-oxazol-5-yl)pyridin-4-yl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=NC(C=2ON=C(C)C=2)=C1 CSVKISHLQVPEQV-UHFFFAOYSA-N 0.000 description 5
- XRHYZWTWMLLKBA-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-2-[[3-[3-[4-(oxan-2-yloxymethyl)pyrazol-1-yl]phenyl]-3-oxopropanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2N=CC(COC3OCCCC3)=C2)=C1 XRHYZWTWMLLKBA-UHFFFAOYSA-N 0.000 description 5
- VYDAKJJKBICISY-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-4-fluoro-2-[[3-[3-[3-(oxan-2-yloxymethyl)-1,2-oxazol-5-yl]phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(F)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C=2ON=C(COC3OCCCC3)C=2)=C1 VYDAKJJKBICISY-UHFFFAOYSA-N 0.000 description 5
- COULAOZTCJTHOX-UHFFFAOYSA-N (2-amino-2-sulfanylideneethyl) 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OCC(N)=S COULAOZTCJTHOX-UHFFFAOYSA-N 0.000 description 4
- DPZNOMCNRMUKPS-UHFFFAOYSA-N 1,3-Dimethoxybenzene Chemical compound COC1=CC=CC(OC)=C1 DPZNOMCNRMUKPS-UHFFFAOYSA-N 0.000 description 4
- AZIZBYRGIGKTLW-UHFFFAOYSA-N 1,4-diazepin-2-one Chemical compound O=C1C=NC=CC=N1 AZIZBYRGIGKTLW-UHFFFAOYSA-N 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 4
- IUVCFHHAEHNCFT-INIZCTEOSA-N 2-[(1s)-1-[4-amino-3-(3-fluoro-4-propan-2-yloxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-6-fluoro-3-(3-fluorophenyl)chromen-4-one Chemical compound C1=C(F)C(OC(C)C)=CC=C1C(C1=C(N)N=CN=C11)=NN1[C@@H](C)C1=C(C=2C=C(F)C=CC=2)C(=O)C2=CC(F)=CC=C2O1 IUVCFHHAEHNCFT-INIZCTEOSA-N 0.000 description 4
- VUNAQOGRLGNALG-UHFFFAOYSA-N 2-chloro-5-nitrobenzene-1,4-diamine Chemical compound NC1=CC([N+]([O-])=O)=C(N)C=C1Cl VUNAQOGRLGNALG-UHFFFAOYSA-N 0.000 description 4
- WXHAKCASYYCJED-UHFFFAOYSA-N 3-imidazol-1-ylbenzoic acid Chemical compound OC(=O)C1=CC=CC(N2C=NC=C2)=C1 WXHAKCASYYCJED-UHFFFAOYSA-N 0.000 description 4
- KWHURWOGZQWLTK-UHFFFAOYSA-N 5-chloro-4-iodo-2-nitroaniline Chemical compound NC1=CC(Cl)=C(I)C=C1[N+]([O-])=O KWHURWOGZQWLTK-UHFFFAOYSA-N 0.000 description 4
- SVBXTOXJMCTOGK-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-[4-(hydroxymethyl)pyrazol-1-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1C=C(CO)C=N1 SVBXTOXJMCTOGK-UHFFFAOYSA-N 0.000 description 4
- UKWXUAIGXSIJFV-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-[5-(hydroxymethyl)-1,3-thiazol-4-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C=1N=CSC=1CO UKWXUAIGXSIJFV-UHFFFAOYSA-N 0.000 description 4
- IHISLAGMARCMIL-UHFFFAOYSA-N 7-[cyclopropylmethyl(methyl)amino]-4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C=1C=2N=C(C=3C=C(C=CC=3)N3C(=CN=N3)CO)CC(=O)NC=2C=C(C(F)(F)F)C=1N(C)CC1CC1 IHISLAGMARCMIL-UHFFFAOYSA-N 0.000 description 4
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
- 239000001828 Gelatine Substances 0.000 description 4
- 101001071429 Homo sapiens Metabotropic glutamate receptor 2 Proteins 0.000 description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
- 229910010084 LiAlH4 Inorganic materials 0.000 description 4
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 208000027089 Parkinsonian disease Diseases 0.000 description 4
- 206010034010 Parkinsonism Diseases 0.000 description 4
- YNHIGQDRGKUECZ-UHFFFAOYSA-L PdCl2(PPh3)2 Substances [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 4
- OEFGUXQAZIAYFK-UHFFFAOYSA-N [2-amino-4-chloro-5-(cyclopropylmethylamino)phenyl]carbamic acid Chemical compound C1=C(NC(O)=O)C(N)=CC(Cl)=C1NCC1CC1 OEFGUXQAZIAYFK-UHFFFAOYSA-N 0.000 description 4
- 125000004414 alkyl thio group Chemical group 0.000 description 4
- 239000000010 aprotic solvent Substances 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- 150000001805 chlorine compounds Chemical group 0.000 description 4
- QTMDXZNDVAMKGV-UHFFFAOYSA-L copper(ii) bromide Chemical compound [Cu+2].[Br-].[Br-] QTMDXZNDVAMKGV-UHFFFAOYSA-L 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- DXPCGDSYMCLBBG-UHFFFAOYSA-N ethyl 3-[3-[5-(oxan-2-yloxymethyl)pyrazol-1-yl]phenyl]-3-oxopropanoate Chemical compound CCOC(=O)CC(=O)C1=CC=CC(N2C(=CC=N2)COC2OCCCC2)=C1 DXPCGDSYMCLBBG-UHFFFAOYSA-N 0.000 description 4
- DIZFWJVCPSJKGW-UHFFFAOYSA-N ethyl 3-ethynylbenzoate Chemical compound CCOC(=O)C1=CC=CC(C#C)=C1 DIZFWJVCPSJKGW-UHFFFAOYSA-N 0.000 description 4
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 239000005457 ice water Substances 0.000 description 4
- 230000026045 iodination Effects 0.000 description 4
- 238000006192 iodination reaction Methods 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 239000012280 lithium aluminium hydride Substances 0.000 description 4
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 4
- NKGYSGGAEUCELQ-UHFFFAOYSA-N methyl 3-(1,2,4-triazol-1-yl)benzoate Chemical compound COC(=O)C1=CC=CC(N2N=CN=C2)=C1 NKGYSGGAEUCELQ-UHFFFAOYSA-N 0.000 description 4
- ULHKMSVNVCQHHX-UHFFFAOYSA-N methyl 3-(2,5-dimethyl-1,3-thiazol-4-yl)benzoate Chemical compound COC(=O)C1=CC=CC(C2=C(SC(C)=N2)C)=C1 ULHKMSVNVCQHHX-UHFFFAOYSA-N 0.000 description 4
- ZKRMSRDPBCGOLE-UHFFFAOYSA-N methyl 3-(2-bromopentanoyl)benzoate Chemical compound CCCC(Br)C(=O)C1=CC=CC(C(=O)OC)=C1 ZKRMSRDPBCGOLE-UHFFFAOYSA-N 0.000 description 4
- MCUGUUDHGRYPAG-UHFFFAOYSA-N methyl 3-(5-methyl-1,3-thiazol-4-yl)benzoate Chemical compound COC(=O)C1=CC=CC(C2=C(SC=N2)C)=C1 MCUGUUDHGRYPAG-UHFFFAOYSA-N 0.000 description 4
- SNVAHEGEZKMZMQ-UHFFFAOYSA-N methyl 3-(aminocarbamothioyl)benzoate;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.COC(=O)C1=CC=CC(C(=S)NN)=C1 SNVAHEGEZKMZMQ-UHFFFAOYSA-N 0.000 description 4
- GGRYEDQOBPIMKX-UHFFFAOYSA-N methyl 3-[4-(oxan-2-yloxymethyl)-1,3-thiazol-2-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C=2SC=C(COC3OCCCC3)N=2)=C1 GGRYEDQOBPIMKX-UHFFFAOYSA-N 0.000 description 4
- 239000000825 pharmaceutical preparation Substances 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- SLYIMFAKJLSEKV-UHFFFAOYSA-N tert-butyl 3-[2-[5-(oxan-2-yloxymethyl)-1,3-thiazol-4-yl]phenyl]-3-oxopropanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC=C1C1=C(COC2OCCCC2)SC=N1 SLYIMFAKJLSEKV-UHFFFAOYSA-N 0.000 description 4
- JCSBFYHNRCDUSC-UHFFFAOYSA-N tert-butyl 3-[3-(1,3-oxazol-4-yl)phenyl]-3-oxopropanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(C=2N=COC=2)=C1 JCSBFYHNRCDUSC-UHFFFAOYSA-N 0.000 description 4
- OIWFSEYKZPVODW-UHFFFAOYSA-N tert-butyl 3-[3-(2-methyl-5-propyl-1,3-oxazol-4-yl)phenyl]-3-oxopropanoate Chemical compound O1C(C)=NC(C=2C=C(C=CC=2)C(=O)CC(=O)OC(C)(C)C)=C1CCC OIWFSEYKZPVODW-UHFFFAOYSA-N 0.000 description 4
- WKONNHBSKSNOFO-UHFFFAOYSA-N tert-butyl 3-[3-(5-methyl-1,3-oxazol-4-yl)phenyl]-3-oxopropanoate Chemical compound O1C=NC(C=2C=C(C=CC=2)C(=O)CC(=O)OC(C)(C)C)=C1C WKONNHBSKSNOFO-UHFFFAOYSA-N 0.000 description 4
- XZDVPSLFTODFHJ-UHFFFAOYSA-N tert-butyl 3-[3-(5-methyl-1,3-thiazol-4-yl)phenyl]-3-oxopropanoate Chemical compound S1C=NC(C=2C=C(C=CC=2)C(=O)CC(=O)OC(C)(C)C)=C1C XZDVPSLFTODFHJ-UHFFFAOYSA-N 0.000 description 4
- KRAAHLBYOAAUSR-UHFFFAOYSA-N tert-butyl 3-[3-[2-methyl-4-(oxan-2-yloxymethyl)pyrazol-3-yl]phenyl]-3-oxopropanoate Chemical compound C=1C=CC(C(=O)CC(=O)OC(C)(C)C)=CC=1C=1N(C)N=CC=1COC1CCCCO1 KRAAHLBYOAAUSR-UHFFFAOYSA-N 0.000 description 4
- SASYMJHCCVZGQC-UHFFFAOYSA-N tert-butyl 3-[3-[2-methyl-5-(oxan-2-yloxymethyl)pyrazol-3-yl]phenyl]-3-oxopropanoate Chemical compound C1=C(C=2C=C(C=CC=2)C(=O)CC(=O)OC(C)(C)C)N(C)N=C1COC1CCCCO1 SASYMJHCCVZGQC-UHFFFAOYSA-N 0.000 description 4
- IEIAOGRUQMUPSY-UHFFFAOYSA-N tert-butyl 3-[3-[3-(methoxymethyl)-1,2-oxazol-5-yl]phenyl]-3-oxopropanoate Chemical compound O1N=C(COC)C=C1C1=CC=CC(C(=O)CC(=O)OC(C)(C)C)=C1 IEIAOGRUQMUPSY-UHFFFAOYSA-N 0.000 description 4
- CBKISQSXNFTNAL-UHFFFAOYSA-N tert-butyl 3-[3-[4-(oxan-2-yloxymethyl)-1,2-oxazol-3-yl]phenyl]-3-oxopropanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(C=2C(=CON=2)COC2OCCCC2)=C1 CBKISQSXNFTNAL-UHFFFAOYSA-N 0.000 description 4
- TWQZIGVARAPZQH-UHFFFAOYSA-N tert-butyl 3-[3-[5-(oxan-2-yloxymethyl)-1,3,4-oxadiazol-2-yl]phenyl]-3-oxopropanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(C=2OC(COC3OCCCC3)=NN=2)=C1 TWQZIGVARAPZQH-UHFFFAOYSA-N 0.000 description 4
- LIRVTIRHQMDFOD-UHFFFAOYSA-N tert-butyl 3-[3-[5-[2-(oxan-2-yloxy)ethyl]-1,3,4-oxadiazol-2-yl]phenyl]-3-oxopropanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(C=2OC(CCOC3OCCCC3)=NN=2)=C1 LIRVTIRHQMDFOD-UHFFFAOYSA-N 0.000 description 4
- RIMOABNKOCSPHV-UHFFFAOYSA-N tert-butyl 3-[3-[5-[2-(oxan-2-yloxy)ethyl]-1,3,4-thiadiazol-2-yl]phenyl]-3-oxopropanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(C=2SC(CCOC3OCCCC3)=NN=2)=C1 RIMOABNKOCSPHV-UHFFFAOYSA-N 0.000 description 4
- VQUJLQDYVXMACA-UHFFFAOYSA-N tert-butyl 3-oxo-3-[3-(1,3-thiazol-4-yl)phenyl]propanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(C=2N=CSC=2)=C1 VQUJLQDYVXMACA-UHFFFAOYSA-N 0.000 description 4
- ZZBJYHQQJIGQQG-UHFFFAOYSA-N tert-butyl 3-oxo-3-[3-(2-propan-2-yl-1h-imidazol-5-yl)phenyl]propanoate Chemical compound N1C(C(C)C)=NC=C1C1=CC=CC(C(=O)CC(=O)OC(C)(C)C)=C1 ZZBJYHQQJIGQQG-UHFFFAOYSA-N 0.000 description 4
- KHTMLENFPRFJLG-UHFFFAOYSA-N tert-butyl n-(2-amino-4-chloro-5-piperidin-1-ylphenyl)carbamate Chemical compound C1=C(N)C(NC(=O)OC(C)(C)C)=CC(N2CCCCC2)=C1Cl KHTMLENFPRFJLG-UHFFFAOYSA-N 0.000 description 4
- XTEQSICTSBNARJ-UHFFFAOYSA-N tert-butyl n-(2-amino-4-chloro-5-pyrrolidin-1-ylphenyl)carbamate Chemical compound C1=C(N)C(NC(=O)OC(C)(C)C)=CC(N2CCCC2)=C1Cl XTEQSICTSBNARJ-UHFFFAOYSA-N 0.000 description 4
- IRCHZEIDHNOTSR-UHFFFAOYSA-N tert-butyl n-(2-amino-4-cyano-5-piperidin-1-ylphenyl)carbamate Chemical compound C1=C(N)C(NC(=O)OC(C)(C)C)=CC(N2CCCCC2)=C1C#N IRCHZEIDHNOTSR-UHFFFAOYSA-N 0.000 description 4
- JTJFEWDXNKYBOE-UHFFFAOYSA-N tert-butyl n-(2-nitrophenyl)carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC=CC=C1[N+]([O-])=O JTJFEWDXNKYBOE-UHFFFAOYSA-N 0.000 description 4
- AMALPKAIGCFWJR-UHFFFAOYSA-N tert-butyl n-(4-chloro-2-nitro-5-piperidin-1-ylphenyl)carbamate Chemical compound C1=C([N+]([O-])=O)C(NC(=O)OC(C)(C)C)=CC(N2CCCCC2)=C1Cl AMALPKAIGCFWJR-UHFFFAOYSA-N 0.000 description 4
- GECGLUPYXZBNDZ-UHFFFAOYSA-N tert-butyl n-(4-chloro-2-nitro-5-pyrrolidin-1-ylphenyl)carbamate Chemical compound C1=C([N+]([O-])=O)C(NC(=O)OC(C)(C)C)=CC(N2CCCC2)=C1Cl GECGLUPYXZBNDZ-UHFFFAOYSA-N 0.000 description 4
- WTJQXKQMFSDKEF-UHFFFAOYSA-N tert-butyl n-(4-cyano-2-nitro-5-piperidin-1-ylphenyl)carbamate Chemical compound C1=C([N+]([O-])=O)C(NC(=O)OC(C)(C)C)=CC(N2CCCCC2)=C1C#N WTJQXKQMFSDKEF-UHFFFAOYSA-N 0.000 description 4
- BRBCVTCJIFNRSM-UHFFFAOYSA-N tert-butyl n-(4-cyano-2-nitro-5-pyrrolidin-1-ylphenyl)carbamate Chemical compound C1=C([N+]([O-])=O)C(NC(=O)OC(C)(C)C)=CC(N2CCCC2)=C1C#N BRBCVTCJIFNRSM-UHFFFAOYSA-N 0.000 description 4
- UYZHRUJEJDICNT-UHFFFAOYSA-N tert-butyl n-(4-methyl-2-nitro-5-pyrrolidin-1-ylphenyl)carbamate Chemical compound CC1=CC([N+]([O-])=O)=C(NC(=O)OC(C)(C)C)C=C1N1CCCC1 UYZHRUJEJDICNT-UHFFFAOYSA-N 0.000 description 4
- TURPHPRFINIZKQ-UHFFFAOYSA-N tert-butyl n-[2-[[3-(2-cyanopyridin-4-yl)-3-oxopropanoyl]amino]-4-fluoro-5-pyrrolidin-1-ylphenyl]carbamate Chemical compound FC=1C=C(NC(=O)CC(=O)C=2C=C(N=CC=2)C#N)C(NC(=O)OC(C)(C)C)=CC=1N1CCCC1 TURPHPRFINIZKQ-UHFFFAOYSA-N 0.000 description 4
- GZLUSEMSWUKDFF-UHFFFAOYSA-N tert-butyl n-[2-[[3-(2-cyanopyridin-4-yl)-3-oxopropanoyl]amino]-5-(2,2,2-trifluoroethoxy)-4-(trifluoromethyl)phenyl]carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC(OCC(F)(F)F)=C(C(F)(F)F)C=C1NC(=O)CC(=O)C1=CC=NC(C#N)=C1 GZLUSEMSWUKDFF-UHFFFAOYSA-N 0.000 description 4
- RFOPIOHIUPCDPV-UHFFFAOYSA-N tert-butyl n-[2-[[3-(2-cyanopyridin-4-yl)-3-oxopropanoyl]amino]-5-(dimethylamino)-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=NC(C#N)=C1 RFOPIOHIUPCDPV-UHFFFAOYSA-N 0.000 description 4
- WHDYGVAGQYOHSV-UHFFFAOYSA-N tert-butyl n-[2-[[3-(2-cyanopyridin-4-yl)-3-oxopropanoyl]amino]-5-[cyclopropylmethyl(methyl)amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C=1C(NC(=O)OC(C)(C)C)=C(NC(=O)CC(=O)C=2C=C(N=CC=2)C#N)C=C(C(F)(F)F)C=1N(C)CC1CC1 WHDYGVAGQYOHSV-UHFFFAOYSA-N 0.000 description 4
- ZAAPBVPUTMYLCV-UHFFFAOYSA-N tert-butyl n-[2-[[3-(2-cyanopyridin-4-yl)-3-oxopropanoyl]amino]-5-pyrrolidin-1-yl-4-(trifluoromethyl)phenyl]carbamate Chemical compound FC(F)(F)C=1C=C(NC(=O)CC(=O)C=2C=C(N=CC=2)C#N)C(NC(=O)OC(C)(C)C)=CC=1N1CCCC1 ZAAPBVPUTMYLCV-UHFFFAOYSA-N 0.000 description 4
- ZBJKSZQKXWZHQR-UHFFFAOYSA-N tert-butyl n-[2-[[3-(3-cyanophenyl)-3-oxopropanoyl]amino]-4-(2,3-difluorophenyl)-5-(dimethylamino)phenyl]carbamate Chemical compound C1=C(C=2C(=C(F)C=CC=2)F)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C#N)=C1 ZBJKSZQKXWZHQR-UHFFFAOYSA-N 0.000 description 4
- UCZYSGNJQBSQEP-UHFFFAOYSA-N tert-butyl n-[2-[[3-(3-cyanophenyl)-3-oxopropanoyl]amino]-4-(dimethylamino)-5-methylphenyl]carbamate Chemical compound C1=C(C)C(N(C)C)=CC(NC(=O)CC(=O)C=2C=C(C=CC=2)C#N)=C1NC(=O)OC(C)(C)C UCZYSGNJQBSQEP-UHFFFAOYSA-N 0.000 description 4
- ZWQDTLNBNQMAOE-UHFFFAOYSA-N tert-butyl n-[2-[[3-(3-cyanophenyl)-3-oxopropanoyl]amino]-5-(dimethylamino)-4-(2-phenylethynyl)phenyl]carbamate Chemical compound C1=C(C#CC=2C=CC=CC=2)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C#N)=C1 ZWQDTLNBNQMAOE-UHFFFAOYSA-N 0.000 description 4
- JYTVKBWKBHSTMD-UHFFFAOYSA-N tert-butyl n-[2-[[3-(3-cyanophenyl)-3-oxopropanoyl]amino]-5-(dimethylamino)-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C#N)=C1 JYTVKBWKBHSTMD-UHFFFAOYSA-N 0.000 description 4
- JEGRAECHZKDVPC-UHFFFAOYSA-N tert-butyl n-[2-[[3-[3-[5-(oxan-2-yloxymethyl)-1,2-oxazol-3-yl]phenyl]-3-oxopropanoyl]amino]-5-pyrrolidin-1-yl-4-(trifluoromethyl)phenyl]carbamate Chemical compound FC(F)(F)C=1C=C(NC(=O)CC(=O)C=2C=C(C=CC=2)C2=NOC(COC3OCCCC3)=C2)C(NC(=O)OC(C)(C)C)=CC=1N1CCCC1 JEGRAECHZKDVPC-UHFFFAOYSA-N 0.000 description 4
- ULUYFMFUKZHDMF-UHFFFAOYSA-N tert-butyl n-[2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]-5-pyrrolidin-1-yl-4-(trifluoromethyl)phenyl]carbamate Chemical compound FC(F)(F)C=1C=C(NC(=O)CC(=O)C=2C=C(C=CC=2)N2C(=CN=N2)COC2OCCCC2)C(NC(=O)OC(C)(C)C)=CC=1N1CCCC1 ULUYFMFUKZHDMF-UHFFFAOYSA-N 0.000 description 4
- ZLINMNGRQYBXPF-UHFFFAOYSA-N tert-butyl n-[2-amino-4-chloro-5-(diethylamino)phenyl]carbamate Chemical compound CCN(CC)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1Cl ZLINMNGRQYBXPF-UHFFFAOYSA-N 0.000 description 4
- NBCGQUAUBRFHRC-UHFFFAOYSA-N tert-butyl n-[2-amino-4-cyano-5-(diethylamino)phenyl]carbamate Chemical compound CCN(CC)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C#N NBCGQUAUBRFHRC-UHFFFAOYSA-N 0.000 description 4
- VTSJYKYERZLMEK-UHFFFAOYSA-N tert-butyl n-[2-amino-5-(2,2,2-trifluoroethoxy)-4-(trifluoromethyl)phenyl]carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC(OCC(F)(F)F)=C(C(F)(F)F)C=C1N VTSJYKYERZLMEK-UHFFFAOYSA-N 0.000 description 4
- XTFQHQUHVPJOCG-UHFFFAOYSA-N tert-butyl n-[2-amino-5-(2-methylpropylamino)-4-(trifluoromethyl)phenyl]carbamate Chemical compound CC(C)CNC1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C(F)(F)F XTFQHQUHVPJOCG-UHFFFAOYSA-N 0.000 description 4
- LSAWKBSICVVJIY-UHFFFAOYSA-N tert-butyl n-[2-amino-5-(azetidin-1-yl)-4-chlorophenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OC(C)(C)C)=CC(N2CCC2)=C1Cl LSAWKBSICVVJIY-UHFFFAOYSA-N 0.000 description 4
- WIJJMYDKODJPIW-UHFFFAOYSA-N tert-butyl n-[2-amino-5-(dimethylamino)-4-(2-fluorophenyl)phenyl]carbamate Chemical compound CN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C1=CC=CC=C1F WIJJMYDKODJPIW-UHFFFAOYSA-N 0.000 description 4
- IBSWABSPOIPRBR-UHFFFAOYSA-N tert-butyl n-[2-amino-5-[cyclopropyl(methyl)amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C=1C(NC(=O)OC(C)(C)C)=C(N)C=C(C(F)(F)F)C=1N(C)C1CC1 IBSWABSPOIPRBR-UHFFFAOYSA-N 0.000 description 4
- OWDYVWOBISSUIH-UHFFFAOYSA-N tert-butyl n-[2-nitro-5-(2,2,2-trifluoroethoxy)-4-(trifluoromethyl)phenyl]carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC(OCC(F)(F)F)=C(C(F)(F)F)C=C1[N+]([O-])=O OWDYVWOBISSUIH-UHFFFAOYSA-N 0.000 description 4
- GEGYSTYXJJPRBT-UHFFFAOYSA-N tert-butyl n-[2-nitro-5-pyrrolidin-1-yl-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C([N+]([O-])=O)C(NC(=O)OC(C)(C)C)=CC(N2CCCC2)=C1C(F)(F)F GEGYSTYXJJPRBT-UHFFFAOYSA-N 0.000 description 4
- NRNBENKRHSPQIS-UHFFFAOYSA-N tert-butyl n-[4-(2,3-difluorophenyl)-5-(dimethylamino)-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(C=2C(=C(F)C=CC=2)F)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C(C=1)=CC=CC=1N1N=NC=C1COC1CCCCO1 NRNBENKRHSPQIS-UHFFFAOYSA-N 0.000 description 4
- QBYAXVIGWOCXOG-UHFFFAOYSA-N tert-butyl n-[4-(2,3-difluorophenyl)-5-(dimethylamino)-2-[[3-oxo-3-[3-(triazol-1-yl)phenyl]propanoyl]amino]phenyl]carbamate Chemical compound C1=C(C=2C(=C(F)C=CC=2)F)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C(C=1)=CC=CC=1N1C=CN=N1 QBYAXVIGWOCXOG-UHFFFAOYSA-N 0.000 description 4
- YQBNEQDCUXQJLE-UHFFFAOYSA-N tert-butyl n-[4-(2,3-difluorophenyl)-5-(dimethylamino)-2-nitrophenyl]carbamate Chemical compound CN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1C1=CC=CC(F)=C1F YQBNEQDCUXQJLE-UHFFFAOYSA-N 0.000 description 4
- NKIZEINYJRNYHN-UHFFFAOYSA-N tert-butyl n-[4-(2-fluorophenyl)-2-[[3-(3-imidazol-1-ylphenyl)-3-oxopropanoyl]amino]-5-(2,2,2-trifluoroethoxy)phenyl]carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC(OCC(F)(F)F)=C(C=2C(=CC=CC=2)F)C=C1NC(=O)CC(=O)C(C=1)=CC=CC=1N1C=CN=C1 NKIZEINYJRNYHN-UHFFFAOYSA-N 0.000 description 4
- LBSHGZQIUGOUJG-UHFFFAOYSA-N tert-butyl n-[4-(2-fluorophenyl)-2-[[3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoyl]amino]-5-(2,2,2-trifluoroethoxy)phenyl]carbamate Chemical compound O1N=C(C)C=C1C1=CC=CC(C(=O)CC(=O)NC=2C(=CC(OCC(F)(F)F)=C(C=2)C=2C(=CC=CC=2)F)NC(=O)OC(C)(C)C)=C1 LBSHGZQIUGOUJG-UHFFFAOYSA-N 0.000 description 4
- YMZFZFSLKFDAMI-UHFFFAOYSA-N tert-butyl n-[4-(2-fluorophenyl)-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]-5-(2,2,2-trifluoroethoxy)phenyl]carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC(OCC(F)(F)F)=C(C=2C(=CC=CC=2)F)C=C1NC(=O)CC(=O)C(C=1)=CC=CC=1N1N=NC=C1COC1CCCCO1 YMZFZFSLKFDAMI-UHFFFAOYSA-N 0.000 description 4
- ICGROOYTDLQPRH-UHFFFAOYSA-N tert-butyl n-[4-(2-fluorophenyl)-2-[[3-oxo-3-[3-(triazol-1-yl)phenyl]propanoyl]amino]-5-(2,2,2-trifluoroethoxy)phenyl]carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC(OCC(F)(F)F)=C(C=2C(=CC=CC=2)F)C=C1NC(=O)CC(=O)C(C=1)=CC=CC=1N1C=CN=N1 ICGROOYTDLQPRH-UHFFFAOYSA-N 0.000 description 4
- NZQOBOKJRZMNRO-UHFFFAOYSA-N tert-butyl n-[4-(2-fluorophenyl)-2-nitro-5-(2,2,2-trifluoroethoxy)phenyl]carbamate Chemical compound C1=C([N+]([O-])=O)C(NC(=O)OC(C)(C)C)=CC(OCC(F)(F)F)=C1C1=CC=CC=C1F NZQOBOKJRZMNRO-UHFFFAOYSA-N 0.000 description 4
- UERWCIWQQPVALG-UHFFFAOYSA-N tert-butyl n-[4-chloro-2-[[3-(2-cyanopyridin-4-yl)-3-oxopropanoyl]amino]-5-(dimethylamino)phenyl]carbamate Chemical compound C1=C(Cl)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=NC(C#N)=C1 UERWCIWQQPVALG-UHFFFAOYSA-N 0.000 description 4
- PCIUUFCHBGXPMZ-UHFFFAOYSA-N tert-butyl n-[4-chloro-2-[[3-(3-cyanophenyl)-3-oxopropanoyl]amino]-5-(dimethylamino)phenyl]carbamate Chemical compound C1=C(Cl)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C#N)=C1 PCIUUFCHBGXPMZ-UHFFFAOYSA-N 0.000 description 4
- SPGMZWVIGQEBIG-UHFFFAOYSA-N tert-butyl n-[4-chloro-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]-5-piperidin-1-ylphenyl]carbamate Chemical compound ClC=1C=C(NC(=O)CC(=O)C=2C=C(C=CC=2)N2C(=CN=N2)COC2OCCCC2)C(NC(=O)OC(C)(C)C)=CC=1N1CCCCC1 SPGMZWVIGQEBIG-UHFFFAOYSA-N 0.000 description 4
- WQTQSDRHEYJIQU-UHFFFAOYSA-N tert-butyl n-[4-chloro-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]-5-pyrrolidin-1-ylphenyl]carbamate Chemical compound ClC=1C=C(NC(=O)CC(=O)C=2C=C(C=CC=2)N2C(=CN=N2)COC2OCCCC2)C(NC(=O)OC(C)(C)C)=CC=1N1CCCC1 WQTQSDRHEYJIQU-UHFFFAOYSA-N 0.000 description 4
- HIOXCNFOHNCNCZ-UHFFFAOYSA-N tert-butyl n-[4-chloro-2-nitro-5-(propan-2-ylamino)phenyl]carbamate Chemical compound CC(C)NC1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1Cl HIOXCNFOHNCNCZ-UHFFFAOYSA-N 0.000 description 4
- NKQMESHTYIOCPN-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-(2-methylpropylamino)-2-nitrophenyl]carbamate Chemical compound CC(C)CNC1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1Cl NKQMESHTYIOCPN-UHFFFAOYSA-N 0.000 description 4
- SHPXBSYDECMULC-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-(diethylamino)-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(N(CC)CC)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C(=CN=N2)COC2OCCCC2)=C1 SHPXBSYDECMULC-UHFFFAOYSA-N 0.000 description 4
- JZCNNNYFVZOLTG-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-(dimethylamino)-2-[[3-[3-(2-methylpyrazol-3-yl)phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C=2N(N=CC=2)C)=C1 JZCNNNYFVZOLTG-UHFFFAOYSA-N 0.000 description 4
- MVSWCQHVXOUUKD-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-(dimethylamino)-2-[[3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C=2ON=C(C)C=2)=C1 MVSWCQHVXOUUKD-UHFFFAOYSA-N 0.000 description 4
- HNDNCQAAOTXLMR-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-(dimethylamino)-2-[[3-[3-[2-methyl-5-(oxan-2-yloxymethyl)pyrazol-3-yl]phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C=2N(N=C(COC3OCCCC3)C=2)C)=C1 HNDNCQAAOTXLMR-UHFFFAOYSA-N 0.000 description 4
- UUNGXIMMXUMPFX-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-(dimethylamino)-2-[[3-[3-[3-(methoxymethyl)-1,2-oxazol-5-yl]phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound O1N=C(COC)C=C1C1=CC=CC(C(=O)CC(=O)NC=2C(=CC(=C(Cl)C=2)N(C)C)NC(=O)OC(C)(C)C)=C1 UUNGXIMMXUMPFX-UHFFFAOYSA-N 0.000 description 4
- OUJKSEHVYMLUOW-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-(dimethylamino)-2-[[3-[3-[3-(oxan-2-yloxymethyl)-1,2-oxazol-5-yl]phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C=2ON=C(COC3OCCCC3)C=2)=C1 OUJKSEHVYMLUOW-UHFFFAOYSA-N 0.000 description 4
- OLKXVHOJPVPZKZ-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-(dimethylamino)-2-[[3-[3-[3-methyl-4-(oxan-2-yloxymethyl)-1,2-oxazol-5-yl]phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C2=C(C(C)=NO2)COC2OCCCC2)=C1 OLKXVHOJPVPZKZ-UHFFFAOYSA-N 0.000 description 4
- XEFKUPHBRXEWPV-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-(dimethylamino)-2-[[3-[3-[5-(oxan-2-yloxymethyl)-1,2-oxazol-3-yl]phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C2=NOC(COC3OCCCC3)=C2)=C1 XEFKUPHBRXEWPV-UHFFFAOYSA-N 0.000 description 4
- OZEOGLIDYADNMJ-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-(dimethylamino)-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C(=CN=N2)COC2OCCCC2)=C1 OZEOGLIDYADNMJ-UHFFFAOYSA-N 0.000 description 4
- AQROUWCYMOVTSA-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-(dimethylamino)-2-[[3-[3-[5-[(dimethylamino)methyl]triazol-1-yl]phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound CN(C)CC1=CN=NN1C1=CC=CC(C(=O)CC(=O)NC=2C(=CC(=C(Cl)C=2)N(C)C)NC(=O)OC(C)(C)C)=C1 AQROUWCYMOVTSA-UHFFFAOYSA-N 0.000 description 4
- CBUAHVOVJDYBSP-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-(dimethylamino)-2-[[3-oxo-3-(3-pyrazol-1-ylphenyl)propanoyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2N=CC=C2)=C1 CBUAHVOVJDYBSP-UHFFFAOYSA-N 0.000 description 4
- VQHDTNKXJNFGJP-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-(dimethylamino)-2-[[3-oxo-3-[3-(triazol-1-yl)phenyl]propanoyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2N=NC=C2)=C1 VQHDTNKXJNFGJP-UHFFFAOYSA-N 0.000 description 4
- JPYFQJABINHNNT-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-[2-methoxyethyl(methyl)amino]-2-[[3-[2-(3-methyl-1,2-oxazol-5-yl)pyridin-4-yl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(N(C)CCOC)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=NC(C=2ON=C(C)C=2)=C1 JPYFQJABINHNNT-UHFFFAOYSA-N 0.000 description 4
- JBTDJESCAAHTTD-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-[2-methoxyethyl(methyl)amino]-2-[[3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(N(C)CCOC)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C=2ON=C(C)C=2)=C1 JBTDJESCAAHTTD-UHFFFAOYSA-N 0.000 description 4
- INOWWRDVLIPDPA-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-[2-methoxyethyl(methyl)amino]-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(N(C)CCOC)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C(=CN=N2)COC2OCCCC2)=C1 INOWWRDVLIPDPA-UHFFFAOYSA-N 0.000 description 4
- IJQUHDMJIROQJV-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-[2-methoxyethyl(methyl)amino]-2-[[3-oxo-3-[3-(triazol-1-yl)phenyl]propanoyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(N(C)CCOC)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2N=NC=C2)=C1 IJQUHDMJIROQJV-UHFFFAOYSA-N 0.000 description 4
- UWIPDKGOVLNYQV-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-[2-methoxyethyl(methyl)amino]-2-nitrophenyl]carbamate Chemical compound COCCN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1Cl UWIPDKGOVLNYQV-UHFFFAOYSA-N 0.000 description 4
- LOQXDUNKYQJUEN-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-[cyclopropyl(methyl)amino]-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C=1C(NC(=O)OC(C)(C)C)=C(NC(=O)CC(=O)C=2C=C(C=CC=2)N2C(=CN=N2)COC2OCCCC2)C=C(Cl)C=1N(C)C1CC1 LOQXDUNKYQJUEN-UHFFFAOYSA-N 0.000 description 4
- GREMHAKJXOHFIX-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-[cyclopropyl(methyl)amino]-2-nitrophenyl]carbamate Chemical compound C=1C(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C(Cl)C=1N(C)C1CC1 GREMHAKJXOHFIX-UHFFFAOYSA-N 0.000 description 4
- MWKSTVVTZNUPEO-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-[ethyl(methyl)amino]-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(N(C)CC)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C(=CN=N2)COC2OCCCC2)=C1 MWKSTVVTZNUPEO-UHFFFAOYSA-N 0.000 description 4
- NITHKDSYOYKAOK-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-[ethyl(methyl)amino]-2-nitrophenyl]carbamate Chemical compound CCN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1Cl NITHKDSYOYKAOK-UHFFFAOYSA-N 0.000 description 4
- DBZNTQPMPNGVEZ-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-[methyl(2-methylpropyl)amino]-2-[[3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(N(C)CC(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C=2ON=C(C)C=2)=C1 DBZNTQPMPNGVEZ-UHFFFAOYSA-N 0.000 description 4
- BUFOPBSPNWMZPX-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-[methyl(2-methylpropyl)amino]-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(N(C)CC(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C(=CN=N2)COC2OCCCC2)=C1 BUFOPBSPNWMZPX-UHFFFAOYSA-N 0.000 description 4
- HIJGGUTUMXRNPR-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-[methyl(2-methylpropyl)amino]-2-nitrophenyl]carbamate Chemical compound CC(C)CN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1Cl HIJGGUTUMXRNPR-UHFFFAOYSA-N 0.000 description 4
- IVJACFAMWQJOPA-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-[methyl(propan-2-yl)amino]-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(N(C)C(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C(=CN=N2)COC2OCCCC2)=C1 IVJACFAMWQJOPA-UHFFFAOYSA-N 0.000 description 4
- CRWZRJODVOQKTK-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-[methyl(propan-2-yl)amino]-2-nitrophenyl]carbamate Chemical compound CC(C)N(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1Cl CRWZRJODVOQKTK-UHFFFAOYSA-N 0.000 description 4
- GJIPDAASAQDVET-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-[methyl(propyl)amino]-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(N(C)CCC)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C(=CN=N2)COC2OCCCC2)=C1 GJIPDAASAQDVET-UHFFFAOYSA-N 0.000 description 4
- BDNOCXZROUUIRP-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-[methyl(propyl)amino]-2-nitrophenyl]carbamate Chemical compound CCCN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1Cl BDNOCXZROUUIRP-UHFFFAOYSA-N 0.000 description 4
- OTPDUTIFZJMZFA-UHFFFAOYSA-N tert-butyl n-[4-cyano-2-[[3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoyl]amino]-5-[methyl(propan-2-yl)amino]phenyl]carbamate Chemical compound C1=C(C#N)C(N(C)C(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C=2ON=C(C)C=2)=C1 OTPDUTIFZJMZFA-UHFFFAOYSA-N 0.000 description 4
- IXAVVXPIXSKWNQ-UHFFFAOYSA-N tert-butyl n-[4-cyano-2-[[3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoyl]amino]-5-[methyl(propyl)amino]phenyl]carbamate Chemical compound C1=C(C#N)C(N(C)CCC)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C=2ON=C(C)C=2)=C1 IXAVVXPIXSKWNQ-UHFFFAOYSA-N 0.000 description 4
- RFIMLXZGEGMUGZ-UHFFFAOYSA-N tert-butyl n-[4-cyano-2-[[3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoyl]amino]-5-piperidin-1-ylphenyl]carbamate Chemical compound O1N=C(C)C=C1C1=CC=CC(C(=O)CC(=O)NC=2C(=CC(=C(C#N)C=2)N2CCCCC2)NC(=O)OC(C)(C)C)=C1 RFIMLXZGEGMUGZ-UHFFFAOYSA-N 0.000 description 4
- PPAXQSWZYUGWEU-UHFFFAOYSA-N tert-butyl n-[4-cyano-2-[[3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoyl]amino]-5-pyrrolidin-1-ylphenyl]carbamate Chemical compound O1N=C(C)C=C1C1=CC=CC(C(=O)CC(=O)NC=2C(=CC(=C(C#N)C=2)N2CCCC2)NC(=O)OC(C)(C)C)=C1 PPAXQSWZYUGWEU-UHFFFAOYSA-N 0.000 description 4
- QWGVTPGKULHZQC-UHFFFAOYSA-N tert-butyl n-[4-cyano-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]-5-pyrrolidin-1-ylphenyl]carbamate Chemical compound N#CC=1C=C(NC(=O)CC(=O)C=2C=C(C=CC=2)N2C(=CN=N2)COC2OCCCC2)C(NC(=O)OC(C)(C)C)=CC=1N1CCCC1 QWGVTPGKULHZQC-UHFFFAOYSA-N 0.000 description 4
- OUFGSYZXZNLCCI-UHFFFAOYSA-N tert-butyl n-[4-cyano-5-(diethylamino)-2-[[3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(C#N)C(N(CC)CC)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C=2ON=C(C)C=2)=C1 OUFGSYZXZNLCCI-UHFFFAOYSA-N 0.000 description 4
- KOODUFBMIZYITK-UHFFFAOYSA-N tert-butyl n-[4-cyano-5-(diethylamino)-2-nitrophenyl]carbamate Chemical compound CCN(CC)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1C#N KOODUFBMIZYITK-UHFFFAOYSA-N 0.000 description 4
- CHIFOKQNKYQYOX-UHFFFAOYSA-N tert-butyl n-[4-cyano-5-(dimethylamino)-2-[[3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(C#N)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C=2ON=C(C)C=2)=C1 CHIFOKQNKYQYOX-UHFFFAOYSA-N 0.000 description 4
- FXDNMUMFUMSQCI-UHFFFAOYSA-N tert-butyl n-[4-cyano-5-(dimethylamino)-2-nitrophenyl]carbamate Chemical compound CN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1C#N FXDNMUMFUMSQCI-UHFFFAOYSA-N 0.000 description 4
- FNADLUIWKSSEIJ-UHFFFAOYSA-N tert-butyl n-[4-cyano-5-[methyl(2-methylpropyl)amino]-2-[[3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(C#N)C(N(C)CC(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C=2ON=C(C)C=2)=C1 FNADLUIWKSSEIJ-UHFFFAOYSA-N 0.000 description 4
- ZJFCYDZAECYZAG-UHFFFAOYSA-N tert-butyl n-[4-cyano-5-[methyl(2-methylpropyl)amino]-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(C#N)C(N(C)CC(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C(=CN=N2)COC2OCCCC2)=C1 ZJFCYDZAECYZAG-UHFFFAOYSA-N 0.000 description 4
- GMCOTEWHWHJOPG-UHFFFAOYSA-N tert-butyl n-[4-cyano-5-[methyl(2-methylpropyl)amino]-2-nitrophenyl]carbamate Chemical compound CC(C)CN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1C#N GMCOTEWHWHJOPG-UHFFFAOYSA-N 0.000 description 4
- XQMIWOOAWWNFPH-UHFFFAOYSA-N tert-butyl n-[4-cyano-5-[methyl(propan-2-yl)amino]-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(C#N)C(N(C)C(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C(=CN=N2)COC2OCCCC2)=C1 XQMIWOOAWWNFPH-UHFFFAOYSA-N 0.000 description 4
- NKLRTCKKMBMRNF-UHFFFAOYSA-N tert-butyl n-[4-cyano-5-[methyl(propan-2-yl)amino]-2-nitrophenyl]carbamate Chemical compound CC(C)N(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1C#N NKLRTCKKMBMRNF-UHFFFAOYSA-N 0.000 description 4
- FLGVVOUCPMJFNS-UHFFFAOYSA-N tert-butyl n-[4-cyano-5-[methyl(propyl)amino]-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(C#N)C(N(C)CCC)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C(=CN=N2)COC2OCCCC2)=C1 FLGVVOUCPMJFNS-UHFFFAOYSA-N 0.000 description 4
- OBKIDMHLEQETGJ-UHFFFAOYSA-N tert-butyl n-[4-cyano-5-[methyl(propyl)amino]-2-nitrophenyl]carbamate Chemical compound CCCN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1C#N OBKIDMHLEQETGJ-UHFFFAOYSA-N 0.000 description 4
- BQLCXJJIMBWCEI-UHFFFAOYSA-N tert-butyl n-[4-fluoro-2-[[3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoyl]amino]-5-pyrrolidin-1-ylphenyl]carbamate Chemical compound O1N=C(C)C=C1C1=CC=CC(C(=O)CC(=O)NC=2C(=CC(=C(F)C=2)N2CCCC2)NC(=O)OC(C)(C)C)=C1 BQLCXJJIMBWCEI-UHFFFAOYSA-N 0.000 description 4
- HRPLKZWZVAYNHR-UHFFFAOYSA-N tert-butyl n-[4-fluoro-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]-5-pyrrolidin-1-ylphenyl]carbamate Chemical compound FC=1C=C(NC(=O)CC(=O)C=2C=C(C=CC=2)N2C(=CN=N2)COC2OCCCC2)C(NC(=O)OC(C)(C)C)=CC=1N1CCCC1 HRPLKZWZVAYNHR-UHFFFAOYSA-N 0.000 description 4
- SOMRGHTXBFUCKG-UHFFFAOYSA-N tert-butyl n-[4-methyl-2-[[3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoyl]amino]-5-[methyl(propyl)amino]phenyl]carbamate Chemical compound C1=C(C)C(N(C)CCC)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C=2ON=C(C)C=2)=C1 SOMRGHTXBFUCKG-UHFFFAOYSA-N 0.000 description 4
- FHLVGANBKJIMMN-UHFFFAOYSA-N tert-butyl n-[4-methyl-5-[methyl(2-methylpropyl)amino]-2-nitrophenyl]carbamate Chemical compound CC(C)CN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1C FHLVGANBKJIMMN-UHFFFAOYSA-N 0.000 description 4
- KNUSVONKWWMFAS-UHFFFAOYSA-N tert-butyl n-[4-methyl-5-[methyl(propyl)amino]-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(C)C(N(C)CCC)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C(=CN=N2)COC2OCCCC2)=C1 KNUSVONKWWMFAS-UHFFFAOYSA-N 0.000 description 4
- QRUDPZAAJNYWAD-UHFFFAOYSA-N tert-butyl n-[4-methyl-5-[methyl(propyl)amino]-2-nitrophenyl]carbamate Chemical compound CCCN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1C QRUDPZAAJNYWAD-UHFFFAOYSA-N 0.000 description 4
- XBYNEZWMJVZREW-UHFFFAOYSA-N tert-butyl n-[5-(2-methylpropylamino)-2-nitro-4-(trifluoromethyl)phenyl]carbamate Chemical compound CC(C)CNC1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1C(F)(F)F XBYNEZWMJVZREW-UHFFFAOYSA-N 0.000 description 4
- DAJXIWKXTKDKEW-UHFFFAOYSA-N tert-butyl n-[5-(azetidin-1-yl)-2-[[3-(2-cyanopyridin-4-yl)-3-oxopropanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound FC(F)(F)C=1C=C(NC(=O)CC(=O)C=2C=C(N=CC=2)C#N)C(NC(=O)OC(C)(C)C)=CC=1N1CCC1 DAJXIWKXTKDKEW-UHFFFAOYSA-N 0.000 description 4
- HSPBTXINJQHKRZ-UHFFFAOYSA-N tert-butyl n-[5-(azetidin-1-yl)-2-[[3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound O1N=C(C)C=C1C1=CC=CC(C(=O)CC(=O)NC=2C(=CC(=C(C=2)C(F)(F)F)N2CCC2)NC(=O)OC(C)(C)C)=C1 HSPBTXINJQHKRZ-UHFFFAOYSA-N 0.000 description 4
- NKOIWYRJCJPDQV-UHFFFAOYSA-N tert-butyl n-[5-(azetidin-1-yl)-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound FC(F)(F)C=1C=C(NC(=O)CC(=O)C=2C=C(C=CC=2)N2C(=CN=N2)COC2OCCCC2)C(NC(=O)OC(C)(C)C)=CC=1N1CCC1 NKOIWYRJCJPDQV-UHFFFAOYSA-N 0.000 description 4
- CEDKDQPPTSSGFR-UHFFFAOYSA-N tert-butyl n-[5-(azetidin-1-yl)-2-nitro-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C([N+]([O-])=O)C(NC(=O)OC(C)(C)C)=CC(N2CCC2)=C1C(F)(F)F CEDKDQPPTSSGFR-UHFFFAOYSA-N 0.000 description 4
- ZSAHBWVCBUULTF-UHFFFAOYSA-N tert-butyl n-[5-(azetidin-1-yl)-4-chloro-2-[[3-(2-cyanopyridin-4-yl)-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound ClC=1C=C(NC(=O)CC(=O)C=2C=C(N=CC=2)C#N)C(NC(=O)OC(C)(C)C)=CC=1N1CCC1 ZSAHBWVCBUULTF-UHFFFAOYSA-N 0.000 description 4
- BDMOQVUUWATQJS-UHFFFAOYSA-N tert-butyl n-[5-(azetidin-1-yl)-4-chloro-2-nitrophenyl]carbamate Chemical compound C1=C([N+]([O-])=O)C(NC(=O)OC(C)(C)C)=CC(N2CCC2)=C1Cl BDMOQVUUWATQJS-UHFFFAOYSA-N 0.000 description 4
- TVUNRMQOWSMGLN-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-2-[[3-[3-[2-[2-(oxan-2-yloxy)ethyl]pyrazol-3-yl]phenyl]-3-oxopropanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C=2N(N=CC=2)CCOC2OCCCC2)=C1 TVUNRMQOWSMGLN-UHFFFAOYSA-N 0.000 description 4
- WBECFPZKBQMDNU-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-2-[[3-[3-[2-methyl-4-(oxan-2-yloxymethyl)pyrazol-3-yl]phenyl]-3-oxopropanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C=2N(N=CC=2COC2OCCCC2)C)=C1 WBECFPZKBQMDNU-UHFFFAOYSA-N 0.000 description 4
- RTHALQQUESYJKD-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-2-[[3-[3-[3-(oxan-2-yloxymethyl)-1,2-oxazol-5-yl]phenyl]-3-oxopropanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C=2ON=C(COC3OCCCC3)C=2)=C1 RTHALQQUESYJKD-UHFFFAOYSA-N 0.000 description 4
- HVLVVPXTMOYBSA-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-2-[[3-[3-[3-methyl-4-(oxan-2-yloxymethyl)-1,2-oxazol-5-yl]phenyl]-3-oxopropanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C2=C(C(C)=NO2)COC2OCCCC2)=C1 HVLVVPXTMOYBSA-UHFFFAOYSA-N 0.000 description 4
- FYACULANNSGUHH-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-2-[[3-[3-[4-(oxan-2-yloxymethyl)-1,2-oxazol-3-yl]phenyl]-3-oxopropanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C=2C(=CON=2)COC2OCCCC2)=C1 FYACULANNSGUHH-UHFFFAOYSA-N 0.000 description 4
- LWAOGCAGGVVLOY-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-2-[[3-[3-[5-(oxan-2-yloxymethyl)pyrazol-1-yl]phenyl]-3-oxopropanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C(=CC=N2)COC2OCCCC2)=C1 LWAOGCAGGVVLOY-UHFFFAOYSA-N 0.000 description 4
- KXCMXHJMINRCJT-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C(=CN=N2)COC2OCCCC2)=C1 KXCMXHJMINRCJT-UHFFFAOYSA-N 0.000 description 4
- SEXDMEZJQIRSQI-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-2-[[3-[3-[5-[(dimethylamino)methyl]triazol-1-yl]phenyl]-3-oxopropanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound CN(C)CC1=CN=NN1C1=CC=CC(C(=O)CC(=O)NC=2C(=CC(=C(C=2)C(F)(F)F)N(C)C)NC(=O)OC(C)(C)C)=C1 SEXDMEZJQIRSQI-UHFFFAOYSA-N 0.000 description 4
- JNSXCMSWXPFDRY-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-2-[[3-[3-[5-[(dimethylamino)methyl]triazol-1-yl]phenyl]-3-oxopropanoyl]amino]-4-fluorophenyl]carbamate Chemical compound CN(C)CC1=CN=NN1C1=CC=CC(C(=O)CC(=O)NC=2C(=CC(=C(F)C=2)N(C)C)NC(=O)OC(C)(C)C)=C1 JNSXCMSWXPFDRY-UHFFFAOYSA-N 0.000 description 4
- XRYKHXQBPDJAED-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-2-[[3-[3-[5-[2-(oxan-2-yloxy)ethyl]triazol-1-yl]phenyl]-3-oxopropanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C(=CN=N2)CCOC2OCCCC2)=C1 XRYKHXQBPDJAED-UHFFFAOYSA-N 0.000 description 4
- VSSKZVZRHASLJE-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-2-[[3-oxo-3-(3-pyrazol-1-ylphenyl)propanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2N=CC=C2)=C1 VSSKZVZRHASLJE-UHFFFAOYSA-N 0.000 description 4
- TUWYUPFKTNBXFX-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-2-[[3-oxo-3-[3-(1,2,4-triazol-1-yl)phenyl]propanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2N=CN=C2)=C1 TUWYUPFKTNBXFX-UHFFFAOYSA-N 0.000 description 4
- FBLVKWULSZQOPE-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-2-[[3-oxo-3-[3-(1,2,4-triazol-4-yl)phenyl]propanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C=NN=C2)=C1 FBLVKWULSZQOPE-UHFFFAOYSA-N 0.000 description 4
- HPFHUXWRNWPFDC-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-2-[[3-oxo-3-[3-(triazol-1-yl)phenyl]propanoyl]amino]-4-(2-phenylethynyl)phenyl]carbamate Chemical compound C1=C(C#CC=2C=CC=CC=2)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C(C=1)=CC=CC=1N1C=CN=N1 HPFHUXWRNWPFDC-UHFFFAOYSA-N 0.000 description 4
- ZAUJSZSKPPUOAZ-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-2-[[3-oxo-3-[3-(triazol-1-yl)phenyl]propanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2N=NC=C2)=C1 ZAUJSZSKPPUOAZ-UHFFFAOYSA-N 0.000 description 4
- QSOKYLAWCXMFLQ-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-2-nitro-4-(trifluoromethyl)phenyl]carbamate Chemical compound CN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1C(F)(F)F QSOKYLAWCXMFLQ-UHFFFAOYSA-N 0.000 description 4
- TUVPLYLIYXHUOQ-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-4-(2-fluorophenyl)-2-nitrophenyl]carbamate Chemical compound CN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1C1=CC=CC=C1F TUVPLYLIYXHUOQ-UHFFFAOYSA-N 0.000 description 4
- FVTRAULPOJIHMN-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-4-fluoro-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(F)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C(=CN=N2)COC2OCCCC2)=C1 FVTRAULPOJIHMN-UHFFFAOYSA-N 0.000 description 4
- NDYUIOKHGZXUOJ-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-4-fluoro-2-nitrophenyl]carbamate Chemical compound CN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1F NDYUIOKHGZXUOJ-UHFFFAOYSA-N 0.000 description 4
- ZIDZUINSTNGQLE-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-4-methyl-2-[[3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(C)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C=2ON=C(C)C=2)=C1 ZIDZUINSTNGQLE-UHFFFAOYSA-N 0.000 description 4
- OZZQSOLBMVOECU-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-4-methyl-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(C)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C(=CN=N2)COC2OCCCC2)=C1 OZZQSOLBMVOECU-UHFFFAOYSA-N 0.000 description 4
- IEEXIRDZRIEEFO-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-4-methyl-2-nitrophenyl]carbamate Chemical compound CN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1C IEEXIRDZRIEEFO-UHFFFAOYSA-N 0.000 description 4
- PLLUXTVCAFEEFQ-UHFFFAOYSA-N tert-butyl n-[5-[cyclopropyl(methyl)amino]-2-nitro-4-(trifluoromethyl)phenyl]carbamate Chemical compound C=1C(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C(C(F)(F)F)C=1N(C)C1CC1 PLLUXTVCAFEEFQ-UHFFFAOYSA-N 0.000 description 4
- GDLSOIWBYALHCK-UHFFFAOYSA-N tert-butyl n-[5-[cyclopropylmethyl(methyl)amino]-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C=1C(NC(=O)OC(C)(C)C)=C(NC(=O)CC(=O)C=2C=C(C=CC=2)N2C(=CN=N2)COC2OCCCC2)C=C(C(F)(F)F)C=1N(C)CC1CC1 GDLSOIWBYALHCK-UHFFFAOYSA-N 0.000 description 4
- ASXWDOLBWMGZQS-UHFFFAOYSA-N tert-butyl n-[5-[cyclopropylmethyl(methyl)amino]-2-nitro-4-(trifluoromethyl)phenyl]carbamate Chemical compound C=1C(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C(C(F)(F)F)C=1N(C)CC1CC1 ASXWDOLBWMGZQS-UHFFFAOYSA-N 0.000 description 4
- FDTZNLTZLYEUPF-UHFFFAOYSA-N tert-butyl n-[5-[ethyl(methyl)amino]-4-methyl-2-[[3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(C)C(N(C)CC)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C=2ON=C(C)C=2)=C1 FDTZNLTZLYEUPF-UHFFFAOYSA-N 0.000 description 4
- IXRKWQLNNPFANV-UHFFFAOYSA-N tert-butyl n-[5-[ethyl(methyl)amino]-4-methyl-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(C)C(N(C)CC)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C(=CN=N2)COC2OCCCC2)=C1 IXRKWQLNNPFANV-UHFFFAOYSA-N 0.000 description 4
- HMYYSHIZRSMCCS-UHFFFAOYSA-N tert-butyl n-[5-[ethyl(methyl)amino]-4-methyl-2-nitrophenyl]carbamate Chemical compound CCN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1C HMYYSHIZRSMCCS-UHFFFAOYSA-N 0.000 description 4
- HWGMPADHNJRBSZ-UHFFFAOYSA-N tert-butyl n-[5-[methyl(2-methylpropyl)amino]-2-nitro-4-(trifluoromethyl)phenyl]carbamate Chemical compound CC(C)CN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1C(F)(F)F HWGMPADHNJRBSZ-UHFFFAOYSA-N 0.000 description 4
- NRYOCASQKQZBJI-UHFFFAOYSA-N tert-butyl n-[5-[methyl(propan-2-yl)amino]-2-nitro-4-(trifluoromethyl)phenyl]carbamate Chemical compound CC(C)N(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1C(F)(F)F NRYOCASQKQZBJI-UHFFFAOYSA-N 0.000 description 4
- KVLYBUAHJPTZFY-UHFFFAOYSA-N tert-butyl n-[5-[methyl(propyl)amino]-2-nitro-4-(trifluoromethyl)phenyl]carbamate Chemical compound CCCN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1C(F)(F)F KVLYBUAHJPTZFY-UHFFFAOYSA-N 0.000 description 4
- UHEVPEPVQWAYOH-UHFFFAOYSA-N tert-butyl n-[5-chloro-4-(2-fluorophenyl)-2-nitrophenyl]carbamate Chemical compound C1=C([N+]([O-])=O)C(NC(=O)OC(C)(C)C)=CC(Cl)=C1C1=CC=CC=C1F UHEVPEPVQWAYOH-UHFFFAOYSA-N 0.000 description 4
- KNJCEKKBFIVAGS-UHFFFAOYSA-N tert-butyl n-[5-cyano-2-[[3-(3-cyanophenyl)-3-oxopropanoyl]amino]-4-(dimethylamino)phenyl]carbamate Chemical compound C1=C(C#N)C(N(C)C)=CC(NC(=O)CC(=O)C=2C=C(C=CC=2)C#N)=C1NC(=O)OC(C)(C)C KNJCEKKBFIVAGS-UHFFFAOYSA-N 0.000 description 4
- HIHLPWFEZHZXPD-UHFFFAOYSA-N tert-butyl n-[5-fluoro-2-nitro-4-(trifluoromethyl)phenyl]carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC(F)=C(C(F)(F)F)C=C1[N+]([O-])=O HIHLPWFEZHZXPD-UHFFFAOYSA-N 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- CWMFRHBXRUITQE-UHFFFAOYSA-N trimethylsilylacetylene Chemical group C[Si](C)(C)C#C CWMFRHBXRUITQE-UHFFFAOYSA-N 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- 238000010626 work up procedure Methods 0.000 description 4
- GORVDCBAQYYSLF-UHFFFAOYSA-N (2-aminophenyl)carbamic acid Chemical compound NC1=CC=CC=C1NC(O)=O GORVDCBAQYYSLF-UHFFFAOYSA-N 0.000 description 3
- MFQOHSPLPDWOCF-UHFFFAOYSA-N (5-chloro-4-fluoro-2-nitrophenyl)carbamic acid Chemical compound OC(=O)NC1=CC(Cl)=C(F)C=C1[N+]([O-])=O MFQOHSPLPDWOCF-UHFFFAOYSA-N 0.000 description 3
- LLPVQGDNKWRPQT-UHFFFAOYSA-N (5-chloro-4-iodo-2-nitrophenyl)carbamic acid Chemical compound OC(=O)NC1=CC(Cl)=C(I)C=C1[N+]([O-])=O LLPVQGDNKWRPQT-UHFFFAOYSA-N 0.000 description 3
- QIYREYQYKITJFD-UHFFFAOYSA-N 3-(2-methyl-1,3-oxazol-4-yl)benzoic acid Chemical compound O1C(C)=NC(C=2C=C(C=CC=2)C(O)=O)=C1 QIYREYQYKITJFD-UHFFFAOYSA-N 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 3
- HWEMWQQJAUMBMT-UHFFFAOYSA-N 4-[3-(2-bromoacetyl)phenyl]-7-(dimethylamino)-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C1=CC=CC(C(=O)CBr)=C1 HWEMWQQJAUMBMT-UHFFFAOYSA-N 0.000 description 3
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 3
- BOFVWSCCFHBHOW-UHFFFAOYSA-N 8-chloro-4-[3-[4-(chloromethyl)-1,3-thiazol-2-yl]phenyl]-7-(dimethylamino)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=NC(CCl)=CS1 BOFVWSCCFHBHOW-UHFFFAOYSA-N 0.000 description 3
- GHDNDBMWSDRACU-UHFFFAOYSA-N 8-chloro-4-[3-[5-(hydroxymethyl)-1,2,4-triazol-1-yl]phenyl]-7-[methyl(2-methylpropyl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=CN=C1CO GHDNDBMWSDRACU-UHFFFAOYSA-N 0.000 description 3
- IVXVSHZYRIYCGO-UHFFFAOYSA-N 8-chloro-7-(dimethylamino)-4-[3-[4-(hydroxymethyl)-1,3-thiazol-2-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=NC(CO)=CS1 IVXVSHZYRIYCGO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- QZRGKCOWNLSUDK-UHFFFAOYSA-N Iodochlorine Chemical compound ICl QZRGKCOWNLSUDK-UHFFFAOYSA-N 0.000 description 3
- HETCEOQFVDFGSY-UHFFFAOYSA-N Isopropenyl acetate Chemical compound CC(=C)OC(C)=O HETCEOQFVDFGSY-UHFFFAOYSA-N 0.000 description 3
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 3
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 3
- 239000012300 argon atmosphere Substances 0.000 description 3
- 150000001502 aryl halides Chemical class 0.000 description 3
- ATCKJLDGNXGLAO-UHFFFAOYSA-N bis(trimethylsilyl) propanedioate Chemical compound C[Si](C)(C)OC(=O)CC(=O)O[Si](C)(C)C ATCKJLDGNXGLAO-UHFFFAOYSA-N 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 210000003169 central nervous system Anatomy 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- IGSKHXTUVXSOMB-UHFFFAOYSA-N cyclopropylmethanamine Chemical compound NCC1CC1 IGSKHXTUVXSOMB-UHFFFAOYSA-N 0.000 description 3
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 3
- HCUYBXPSSCRKRF-UHFFFAOYSA-N diphosgene Chemical compound ClC(=O)OC(Cl)(Cl)Cl HCUYBXPSSCRKRF-UHFFFAOYSA-N 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 3
- 239000012948 isocyanate Substances 0.000 description 3
- 150000002513 isocyanates Chemical class 0.000 description 3
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 3
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 3
- XFVLSRIDRSWWBW-UHFFFAOYSA-N methyl 3-(1,3-thiazol-4-yl)benzoate Chemical compound COC(=O)C1=CC=CC(C=2N=CSC=2)=C1 XFVLSRIDRSWWBW-UHFFFAOYSA-N 0.000 description 3
- BCONYJHGQGUUPJ-UHFFFAOYSA-N methyl 3-(2,2-dihydroxyacetyl)benzoate Chemical compound COC(=O)C1=CC=CC(C(=O)C(O)O)=C1 BCONYJHGQGUUPJ-UHFFFAOYSA-N 0.000 description 3
- QZEHZZXUVLRWFG-UHFFFAOYSA-N methyl 3-(2-bromo-1,1-dimethoxyethyl)benzoate Chemical compound COC(=O)C1=CC=CC(C(CBr)(OC)OC)=C1 QZEHZZXUVLRWFG-UHFFFAOYSA-N 0.000 description 3
- JEQKIZSBVJVZGD-UHFFFAOYSA-N methyl 3-(2-methyl-1,3-oxazol-4-yl)benzoate Chemical compound COC(=O)C1=CC=CC(C=2N=C(C)OC=2)=C1 JEQKIZSBVJVZGD-UHFFFAOYSA-N 0.000 description 3
- GQGMWTKOWVKNPF-UHFFFAOYSA-N methyl 3-(2-methyl-5-propyl-1,3-oxazol-4-yl)benzoate Chemical compound O1C(C)=NC(C=2C=C(C=CC=2)C(=O)OC)=C1CCC GQGMWTKOWVKNPF-UHFFFAOYSA-N 0.000 description 3
- MUNULOKWRWVZEA-UHFFFAOYSA-N methyl 3-(2-propan-2-yl-1h-imidazol-5-yl)benzoate Chemical compound COC(=O)C1=CC=CC(C=2NC(=NC=2)C(C)C)=C1 MUNULOKWRWVZEA-UHFFFAOYSA-N 0.000 description 3
- XFYPJAPDFKSOIC-UHFFFAOYSA-N methyl 3-(5-methyl-1,3-oxazol-4-yl)benzoate Chemical compound COC(=O)C1=CC=CC(C2=C(OC=N2)C)=C1 XFYPJAPDFKSOIC-UHFFFAOYSA-N 0.000 description 3
- NSUKZHPOWCPFRY-UHFFFAOYSA-N methyl 3-[2-methyl-5-(oxan-2-yloxymethyl)-1,3-thiazol-4-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C2=C(SC(C)=N2)COC2OCCCC2)=C1 NSUKZHPOWCPFRY-UHFFFAOYSA-N 0.000 description 3
- WDFCGZDPFZYSLM-UHFFFAOYSA-N methyl 3-[3-[(2-methylpropan-2-yl)oxy]-3-oxopropanoyl]benzoate Chemical compound COC(=O)C1=CC=CC(C(=O)CC(=O)OC(C)(C)C)=C1 WDFCGZDPFZYSLM-UHFFFAOYSA-N 0.000 description 3
- GCRVOUCLHCAJSR-UHFFFAOYSA-N methyl 3-[4-(hydroxymethyl)-1,3-thiazol-2-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C=2SC=C(CO)N=2)=C1 GCRVOUCLHCAJSR-UHFFFAOYSA-N 0.000 description 3
- BZCDVQIEADVFMX-UHFFFAOYSA-N methyl 3-[4-(oxan-2-yloxymethyl)-5-propyl-1,3-thiazol-2-yl]benzoate Chemical compound CCCC=1SC(C=2C=C(C=CC=2)C(=O)OC)=NC=1COC1CCCCO1 BZCDVQIEADVFMX-UHFFFAOYSA-N 0.000 description 3
- NQKXNYZEOCIKRN-UHFFFAOYSA-N methyl 3-[5-(2-hydroxyethyl)-1,3,4-oxadiazol-2-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C=2OC(CCO)=NN=2)=C1 NQKXNYZEOCIKRN-UHFFFAOYSA-N 0.000 description 3
- CORSWMXIQKGKEC-UHFFFAOYSA-N methyl 3-[5-(2-hydroxyethyl)-1,3,4-thiadiazol-2-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C=2SC(CCO)=NN=2)=C1 CORSWMXIQKGKEC-UHFFFAOYSA-N 0.000 description 3
- GRJKSWGQVPXVKL-UHFFFAOYSA-N methyl 3-[5-(bromomethyl)-1,3-thiazol-4-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C2=C(SC=N2)CBr)=C1 GRJKSWGQVPXVKL-UHFFFAOYSA-N 0.000 description 3
- FBHMSRURHJEWJJ-UHFFFAOYSA-N methyl 3-[5-(bromomethyl)-2-methyl-1,3-thiazol-4-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C2=C(SC(C)=N2)CBr)=C1 FBHMSRURHJEWJJ-UHFFFAOYSA-N 0.000 description 3
- ZOTCIZYLAPBDOU-UHFFFAOYSA-N methyl 3-[5-(hydroxymethyl)-1,3,4-oxadiazol-2-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C=2OC(CO)=NN=2)=C1 ZOTCIZYLAPBDOU-UHFFFAOYSA-N 0.000 description 3
- FGXFYSRYGACCIU-UHFFFAOYSA-N methyl 3-[5-(hydroxymethyl)-1,3,4-thiadiazol-2-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C=2SC(CO)=NN=2)=C1 FGXFYSRYGACCIU-UHFFFAOYSA-N 0.000 description 3
- UHVAXAIDJRUUTK-UHFFFAOYSA-N methyl 3-[5-(hydroxymethyl)-1,3-thiazol-4-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C2=C(SC=N2)CO)=C1 UHVAXAIDJRUUTK-UHFFFAOYSA-N 0.000 description 3
- OFJCRJNYJRXVHP-UHFFFAOYSA-N methyl 3-[5-(hydroxymethyl)-2-methyl-1,3-thiazol-4-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C2=C(SC(C)=N2)CO)=C1 OFJCRJNYJRXVHP-UHFFFAOYSA-N 0.000 description 3
- AUGFTAYXXLVEEC-UHFFFAOYSA-N methyl 3-[5-(oxan-2-yloxymethyl)-1,3-thiazol-4-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C2=C(SC=N2)COC2OCCCC2)=C1 AUGFTAYXXLVEEC-UHFFFAOYSA-N 0.000 description 3
- RDEKSPBPFHLJBK-UHFFFAOYSA-N methyl 3-[5-methyl-4-(oxan-2-yloxymethyl)-5h-1,3-thiazol-4-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C2(COC3OCCCC3)C(SC=N2)C)=C1 RDEKSPBPFHLJBK-UHFFFAOYSA-N 0.000 description 3
- MIBLEENMGJLIOC-UHFFFAOYSA-N methyl 3-[[(2-methylpropan-2-yl)oxycarbonylamino]carbamothioyl]benzoate Chemical compound COC(=O)C1=CC=CC(C(=S)NNC(=O)OC(C)(C)C)=C1 MIBLEENMGJLIOC-UHFFFAOYSA-N 0.000 description 3
- MBBRSLODSVCTGY-UHFFFAOYSA-N methyl 3-carbamothioylbenzoate Chemical compound COC(=O)C1=CC=CC(C(N)=S)=C1 MBBRSLODSVCTGY-UHFFFAOYSA-N 0.000 description 3
- HXCUTXDIOYMIJT-UHFFFAOYSA-N methyl 3-pent-4-enoylbenzoate Chemical compound COC(=O)C1=CC=CC(C(=O)CCC=C)=C1 HXCUTXDIOYMIJT-UHFFFAOYSA-N 0.000 description 3
- GAKCQFDXNPITFA-UHFFFAOYSA-N methyl 3-propanoylbenzoate Chemical compound CCC(=O)C1=CC=CC(C(=O)OC)=C1 GAKCQFDXNPITFA-UHFFFAOYSA-N 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- HDZGCSFEDULWCS-UHFFFAOYSA-N monomethylhydrazine Chemical compound CNN HDZGCSFEDULWCS-UHFFFAOYSA-N 0.000 description 3
- 150000002828 nitro derivatives Chemical class 0.000 description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 3
- QVBPZZKELHNMDZ-UHFFFAOYSA-M potassium;3-[(2-methylpropan-2-yl)oxy]-3-oxopropanoate Chemical compound [K+].CC(C)(C)OC(=O)CC([O-])=O QVBPZZKELHNMDZ-UHFFFAOYSA-M 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 239000012264 purified product Substances 0.000 description 3
- 238000007127 saponification reaction Methods 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- VHPYGHWGDNXWOS-UHFFFAOYSA-N tert-butyl 3-[3-(2,5-dimethyl-1,3-thiazol-4-yl)phenyl]-3-oxopropanoate Chemical compound S1C(C)=NC(C=2C=C(C=CC=2)C(=O)CC(=O)OC(C)(C)C)=C1C VHPYGHWGDNXWOS-UHFFFAOYSA-N 0.000 description 3
- KRGHFSYYRLWBES-UHFFFAOYSA-N tert-butyl 3-[3-[2-methyl-5-(oxan-2-yloxymethyl)-1,3-thiazol-4-yl]phenyl]-3-oxopropanoate Chemical compound S1C(C)=NC(C=2C=C(C=CC=2)C(=O)CC(=O)OC(C)(C)C)=C1COC1CCCCO1 KRGHFSYYRLWBES-UHFFFAOYSA-N 0.000 description 3
- UVVAELUZKZNGPT-UHFFFAOYSA-N tert-butyl 3-[3-[4-(oxan-2-yloxymethyl)-5-propyl-1,3-thiazol-2-yl]phenyl]-3-oxopropanoate Chemical compound CCCC=1SC(C=2C=C(C=CC=2)C(=O)CC(=O)OC(C)(C)C)=NC=1COC1CCCCO1 UVVAELUZKZNGPT-UHFFFAOYSA-N 0.000 description 3
- OLIUAHMMRPTIAG-UHFFFAOYSA-N tert-butyl n-(4-fluoro-2-nitro-5-pyrrolidin-1-ylphenyl)carbamate Chemical compound C1=C([N+]([O-])=O)C(NC(=O)OC(C)(C)C)=CC(N2CCCC2)=C1F OLIUAHMMRPTIAG-UHFFFAOYSA-N 0.000 description 3
- NBGGIMGIDJFPDI-UHFFFAOYSA-N tert-butyl n-[2-amino-4-chloro-5-(propan-2-ylamino)phenyl]carbamate Chemical compound CC(C)NC1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1Cl NBGGIMGIDJFPDI-UHFFFAOYSA-N 0.000 description 3
- XBBZBAQPFLQFBQ-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-(diethylamino)-2-nitrophenyl]carbamate Chemical compound CCN(CC)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1Cl XBBZBAQPFLQFBQ-UHFFFAOYSA-N 0.000 description 3
- VOLMDAFAGHTTKQ-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-(dimethylamino)-2-nitrophenyl]carbamate Chemical compound CN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1Cl VOLMDAFAGHTTKQ-UHFFFAOYSA-N 0.000 description 3
- GNSCRQCDBOWMBM-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-2-[[3-(3-imidazol-1-ylphenyl)-3-oxopropanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C=NC=C2)=C1 GNSCRQCDBOWMBM-UHFFFAOYSA-N 0.000 description 3
- VIMUEBPPVHTZRI-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-2-[[3-[3-(2-methylsulfanylimidazol-1-yl)phenyl]-3-oxopropanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound CSC1=NC=CN1C1=CC=CC(C(=O)CC(=O)NC=2C(=CC(=C(C=2)C(F)(F)F)N(C)C)NC(=O)OC(C)(C)C)=C1 VIMUEBPPVHTZRI-UHFFFAOYSA-N 0.000 description 3
- OZMQJDUAEZYSHE-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-2-[[3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C=2ON=C(C)C=2)=C1 OZMQJDUAEZYSHE-UHFFFAOYSA-N 0.000 description 3
- IWHHIPIHMUKMED-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-2-nitro-4-(2-phenylethynyl)phenyl]carbamate Chemical compound CN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1C#CC1=CC=CC=C1 IWHHIPIHMUKMED-UHFFFAOYSA-N 0.000 description 3
- IOJPNIMLSSTLFK-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-4-fluoro-2-[[3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(F)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C=2ON=C(C)C=2)=C1 IOJPNIMLSSTLFK-UHFFFAOYSA-N 0.000 description 3
- QCSLIRFWJPOENV-UHFFFAOYSA-N (2-fluorophenyl)boronic acid Chemical compound OB(O)C1=CC=CC=C1F QCSLIRFWJPOENV-UHFFFAOYSA-N 0.000 description 2
- XDDFMQJPLRZESJ-UHFFFAOYSA-N (2-nitrophenyl)carbamic acid Chemical compound OC(=O)NC1=CC=CC=C1[N+]([O-])=O XDDFMQJPLRZESJ-UHFFFAOYSA-N 0.000 description 2
- FZENGILVLUJGJX-NSCUHMNNSA-N (E)-acetaldehyde oxime Chemical compound C\C=N\O FZENGILVLUJGJX-NSCUHMNNSA-N 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 description 2
- DYOSAFQUIFEGSK-UHFFFAOYSA-N 2,5-dimethoxy-2,3-dihydrofuran Chemical compound COC1CC=C(OC)O1 DYOSAFQUIFEGSK-UHFFFAOYSA-N 0.000 description 2
- MFYSUUPKMDJYPF-UHFFFAOYSA-N 2-[(4-methyl-2-nitrophenyl)diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC1=CC=C(C)C=C1[N+]([O-])=O MFYSUUPKMDJYPF-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- KOHBEDRJXKOYHL-UHFFFAOYSA-N 2-methoxy-n-methylethanamine Chemical compound CNCCOC KOHBEDRJXKOYHL-UHFFFAOYSA-N 0.000 description 2
- SDTMFDGELKWGFT-UHFFFAOYSA-N 2-methylpropan-2-olate Chemical compound CC(C)(C)[O-] SDTMFDGELKWGFT-UHFFFAOYSA-N 0.000 description 2
- JFPJVTNYCURRAB-UHFFFAOYSA-N 2-nitro-n-phenylacetamide Chemical class [O-][N+](=O)CC(=O)NC1=CC=CC=C1 JFPJVTNYCURRAB-UHFFFAOYSA-N 0.000 description 2
- STSDOUMXZZFNET-UHFFFAOYSA-N 3-(3-methoxycarbonylphenyl)-1,2-oxazole-4-carboxylic acid Chemical compound COC(=O)C1=CC=CC(C=2C(=CON=2)C(O)=O)=C1 STSDOUMXZZFNET-UHFFFAOYSA-N 0.000 description 2
- QPUVFEMYORGPAE-UHFFFAOYSA-N 3-(hydrazinecarbonyl)benzoic acid Chemical compound NNC(=O)C1=CC=CC(C(O)=O)=C1 QPUVFEMYORGPAE-UHFFFAOYSA-N 0.000 description 2
- NDILQXVACSSLIV-UHFFFAOYSA-N 3-(triazol-1-yl)benzoic acid Chemical compound OC(=O)C1=CC=CC(N2N=NC=C2)=C1 NDILQXVACSSLIV-UHFFFAOYSA-N 0.000 description 2
- MDHLBQACNPMHBI-UHFFFAOYSA-N 3-[3-[2-[2-(oxan-2-yloxy)ethyl]pyrazol-3-yl]phenyl]-3-oxopropanoic acid Chemical compound OC(=O)CC(=O)C1=CC=CC(C=2N(N=CC=2)CCOC2OCCCC2)=C1 MDHLBQACNPMHBI-UHFFFAOYSA-N 0.000 description 2
- GFWYZLBZGCKMAU-UHFFFAOYSA-N 3-[3-[5-[2-(oxan-2-yloxy)ethyl]triazol-1-yl]phenyl]-3-oxopropanoic acid Chemical compound OC(=O)CC(=O)C1=CC=CC(N2C(=CN=N2)CCOC2OCCCC2)=C1 GFWYZLBZGCKMAU-UHFFFAOYSA-N 0.000 description 2
- JFHSXTVRMLNYBV-UHFFFAOYSA-N 3-[7-(dimethylamino)-2-oxo-8-(2-phenylethynyl)-1,3-dihydro-1,5-benzodiazepin-4-yl]benzonitrile Chemical compound CN(C)C1=CC=2N=C(C=3C=C(C=CC=3)C#N)CC(=O)NC=2C=C1C#CC1=CC=CC=C1 JFHSXTVRMLNYBV-UHFFFAOYSA-N 0.000 description 2
- JIZVYNKTURNYEM-UHFFFAOYSA-N 3-[8-chloro-7-(dimethylamino)-2-oxo-1,3-dihydro-1,5-benzodiazepin-4-yl]benzenecarbothioamide Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C)=CC=2N=C1C1=CC=CC(C(N)=S)=C1 JIZVYNKTURNYEM-UHFFFAOYSA-N 0.000 description 2
- SCURQRUCMAQTDQ-UHFFFAOYSA-N 3-[8-methyl-7-[methyl(propyl)amino]-2-oxo-1,3-dihydro-1,5-benzodiazepin-4-yl]benzonitrile Chemical compound C1C(=O)NC=2C=C(C)C(N(C)CCC)=CC=2N=C1C1=CC=CC(C#N)=C1 SCURQRUCMAQTDQ-UHFFFAOYSA-N 0.000 description 2
- VBYDSMBICNUTKN-UHFFFAOYSA-N 3-hydrazinylbenzoic acid Chemical compound NNC1=CC=CC(C(O)=O)=C1 VBYDSMBICNUTKN-UHFFFAOYSA-N 0.000 description 2
- HUIHVQSQBUJFHU-UHFFFAOYSA-N 4-[3-[5-(azetidin-1-ylmethyl)triazol-1-yl]phenyl]-8-chloro-7-[methyl(propyl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CCC)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CN1CCC1 HUIHVQSQBUJFHU-UHFFFAOYSA-N 0.000 description 2
- WSSGGBADVBMTQB-UHFFFAOYSA-N 4-[3-[5-[(cyclopropylamino)methyl]triazol-1-yl]phenyl]-7-(dimethylamino)-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CNC1CC1 WSSGGBADVBMTQB-UHFFFAOYSA-N 0.000 description 2
- QHHWCDNRPHPYQQ-UHFFFAOYSA-N 4-iodo-2-nitro-5-(2,2,2-trifluoroethoxy)aniline Chemical compound NC1=CC(OCC(F)(F)F)=C(I)C=C1[N+]([O-])=O QHHWCDNRPHPYQQ-UHFFFAOYSA-N 0.000 description 2
- AAMCWLIPRMIPBN-UHFFFAOYSA-N 5-chloro-2-nitro-4-(trifluoromethyl)aniline Chemical compound NC1=CC(Cl)=C(C(F)(F)F)C=C1[N+]([O-])=O AAMCWLIPRMIPBN-UHFFFAOYSA-N 0.000 description 2
- ZCWXYZBQDNFULS-UHFFFAOYSA-N 5-chloro-2-nitroaniline Chemical compound NC1=CC(Cl)=CC=C1[N+]([O-])=O ZCWXYZBQDNFULS-UHFFFAOYSA-N 0.000 description 2
- AZYQBJATLAZUGA-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-(2-methyl-5-propyl-1,3-oxazol-4-yl)phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound O1C(C)=NC(C=2C=C(C=CC=2)C=2CC(=O)NC3=CC(=C(N(C)C)C=C3N=2)C(F)(F)F)=C1CCC AZYQBJATLAZUGA-UHFFFAOYSA-N 0.000 description 2
- NHRBQYACWKMFEG-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-(2-methylsulfanylimidazol-1-yl)phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound CSC1=NC=CN1C1=CC=CC(C=2CC(=O)NC3=CC(=C(N(C)C)C=C3N=2)C(F)(F)F)=C1 NHRBQYACWKMFEG-UHFFFAOYSA-N 0.000 description 2
- CSNDNDHKYZGUMO-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-[2-(hydroxymethyl)-1,3-thiazol-4-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=CSC(CO)=N1 CSNDNDHKYZGUMO-UHFFFAOYSA-N 0.000 description 2
- CWISYQWCACPLOS-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-[3-(morpholin-4-ylmethyl)-1,2-oxazol-5-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C(ON=1)=CC=1CN1CCOCC1 CWISYQWCACPLOS-UHFFFAOYSA-N 0.000 description 2
- DHRMKLJEMNFEJH-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-[5-(hydroxymethyl)-1,3,4-thiadiazol-2-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=NN=C(CO)S1 DHRMKLJEMNFEJH-UHFFFAOYSA-N 0.000 description 2
- GJIDIDKLKBUSBF-UHFFFAOYSA-N 7-[methyl(2-methylpropyl)amino]-4-[3-(1,2,4-triazol-1-yl)phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1C=NC=N1 GJIDIDKLKBUSBF-UHFFFAOYSA-N 0.000 description 2
- LICLEBJBXWNZFH-UHFFFAOYSA-N 7-[methyl(propyl)amino]-4-[3-(1,2,4-triazol-1-yl)phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)CCC)=CC=2N=C1C(C=1)=CC=CC=1N1C=NC=N1 LICLEBJBXWNZFH-UHFFFAOYSA-N 0.000 description 2
- OUCUIVCOJAAQTO-UHFFFAOYSA-N 8-(2,3-difluorophenyl)-7-(dimethylamino)-4-[3-(triazol-1-yl)phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound CN(C)C1=CC=2N=C(C=3C=C(C=CC=3)N3N=NC=C3)CC(=O)NC=2C=C1C1=CC=CC(F)=C1F OUCUIVCOJAAQTO-UHFFFAOYSA-N 0.000 description 2
- UZLHXQRDAAICFP-UHFFFAOYSA-N 8-(2-fluorophenyl)-4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-7-(2,2,2-trifluoroethoxy)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound O1N=C(C)C=C1C1=CC=CC(C=2CC(=O)NC3=CC(=C(OCC(F)(F)F)C=C3N=2)C=2C(=CC=CC=2)F)=C1 UZLHXQRDAAICFP-UHFFFAOYSA-N 0.000 description 2
- GUASMZIPYPYKSA-UHFFFAOYSA-N 8-chloro-4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-7-pyrrolidin-1-yl-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound OCC1=CN=NN1C1=CC=CC(C=2CC(=O)NC3=CC(Cl)=C(N4CCCC4)C=C3N=2)=C1 GUASMZIPYPYKSA-UHFFFAOYSA-N 0.000 description 2
- QNTLDKMHNIHKFL-UHFFFAOYSA-N 8-chloro-7-(diethylamino)-4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(CC)CC)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CO QNTLDKMHNIHKFL-UHFFFAOYSA-N 0.000 description 2
- HKRIKRFHPVJZIY-UHFFFAOYSA-N 8-chloro-7-(dimethylamino)-4-(3-pyrazol-1-ylphenyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1C=CC=N1 HKRIKRFHPVJZIY-UHFFFAOYSA-N 0.000 description 2
- SWAWMSXUDXHPOS-UHFFFAOYSA-N 8-chloro-7-(dimethylamino)-4-[3-(2-methylpyrazol-3-yl)phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=CC=NN1C SWAWMSXUDXHPOS-UHFFFAOYSA-N 0.000 description 2
- NSZWOFVHJQPIFX-UHFFFAOYSA-N 8-chloro-7-(dimethylamino)-4-[3-[2-(ethylamino)-1,3-thiazol-4-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound S1C(NCC)=NC(C=2C=C(C=CC=2)C=2CC(=O)NC3=CC(Cl)=C(N(C)C)C=C3N=2)=C1 NSZWOFVHJQPIFX-UHFFFAOYSA-N 0.000 description 2
- ZTYQGUGTODENSI-UHFFFAOYSA-N 8-chloro-7-(dimethylamino)-4-[3-[2-(hydroxymethyl)-1,3-thiazol-4-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=CSC(CO)=N1 ZTYQGUGTODENSI-UHFFFAOYSA-N 0.000 description 2
- BREUBDMZWPWXRF-UHFFFAOYSA-N 8-chloro-7-(dimethylamino)-4-[3-[4-(hydroxymethyl)-1,3-oxazol-2-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=NC(CO)=CO1 BREUBDMZWPWXRF-UHFFFAOYSA-N 0.000 description 2
- NDZRYLINSNNBHE-UHFFFAOYSA-N 8-chloro-7-(dimethylamino)-4-[3-[4-(methylaminomethyl)-1,3-thiazol-2-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound CNCC1=CSC(C=2C=C(C=CC=2)C=2CC(=O)NC3=CC(Cl)=C(N(C)C)C=C3N=2)=N1 NDZRYLINSNNBHE-UHFFFAOYSA-N 0.000 description 2
- SGBSHYMKIPQJED-UHFFFAOYSA-N 8-chloro-7-[2-methoxyethyl(methyl)amino]-4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CCOC)=CC=2N=C1C(C=1)=CC=CC=1C1=CC(C)=NO1 SGBSHYMKIPQJED-UHFFFAOYSA-N 0.000 description 2
- LPPGUWFASDRCNV-UHFFFAOYSA-N 8-chloro-7-[cyclopropyl(methyl)amino]-4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C=1C=2N=C(C=3C=C(C=CC=3)N3C(=CN=N3)CO)CC(=O)NC=2C=C(Cl)C=1N(C)C1CC1 LPPGUWFASDRCNV-UHFFFAOYSA-N 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 239000007848 Bronsted acid Substances 0.000 description 2
- 208000000094 Chronic Pain Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 229910021590 Copper(II) bromide Inorganic materials 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- 208000012661 Dyskinesia Diseases 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- UEXCJVNBTNXOEH-UHFFFAOYSA-N Ethynylbenzene Chemical group C#CC1=CC=CC=C1 UEXCJVNBTNXOEH-UHFFFAOYSA-N 0.000 description 2
- 208000020564 Eye injury Diseases 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 206010019196 Head injury Diseases 0.000 description 2
- 208000010496 Heart Arrest Diseases 0.000 description 2
- 208000023105 Huntington disease Diseases 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- AMIMRNSIRUDHCM-UHFFFAOYSA-N Isopropylaldehyde Chemical compound CC(C)C=O AMIMRNSIRUDHCM-UHFFFAOYSA-N 0.000 description 2
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 2
- 208000019695 Migraine disease Diseases 0.000 description 2
- 208000007101 Muscle Cramp Diseases 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- 206010057852 Nicotine dependence Diseases 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- 208000026251 Opioid-Related disease Diseases 0.000 description 2
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000007868 Raney catalyst Substances 0.000 description 2
- 229910000564 Raney nickel Inorganic materials 0.000 description 2
- 208000017442 Retinal disease Diseases 0.000 description 2
- 206010038923 Retinopathy Diseases 0.000 description 2
- 238000003477 Sonogashira cross-coupling reaction Methods 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 238000006069 Suzuki reaction reaction Methods 0.000 description 2
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- 208000025569 Tobacco Use disease Diseases 0.000 description 2
- RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical compound OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 description 2
- 206010046543 Urinary incontinence Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- OJVLOZUJNFVXHM-UHFFFAOYSA-N [4-iodo-2-nitro-5-(2,2,2-trifluoroethoxy)phenyl]carbamic acid Chemical compound OC(=O)NC1=CC(OCC(F)(F)F)=C(I)C=C1[N+]([O-])=O OJVLOZUJNFVXHM-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 208000005298 acute pain Diseases 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- 150000001543 aryl boronic acids Chemical class 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 239000012148 binding buffer Substances 0.000 description 2
- IPWKHHSGDUIRAH-UHFFFAOYSA-N bis(pinacolato)diboron Chemical compound O1C(C)(C)C(C)(C)OB1B1OC(C)(C)C(C)(C)O1 IPWKHHSGDUIRAH-UHFFFAOYSA-N 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 230000003925 brain function Effects 0.000 description 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 2
- 229910000024 caesium carbonate Inorganic materials 0.000 description 2
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 238000013375 chromatographic separation Methods 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000013058 crude material Substances 0.000 description 2
- 238000005828 desilylation reaction Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- ODCCJTMPMUFERV-UHFFFAOYSA-N ditert-butyl carbonate Chemical compound CC(C)(C)OC(=O)OC(C)(C)C ODCCJTMPMUFERV-UHFFFAOYSA-N 0.000 description 2
- 239000008298 dragée Substances 0.000 description 2
- BGWMHFKCAUBYJJ-UHFFFAOYSA-N ethyl 2-chloroethanimidate;hydrochloride Chemical compound Cl.CCOC(=N)CCl BGWMHFKCAUBYJJ-UHFFFAOYSA-N 0.000 description 2
- HZIKYLAZZZSYKF-UHFFFAOYSA-N ethyl 2-cyanopyridine-4-carboxylate Chemical compound CCOC(=O)C1=CC=NC(C#N)=C1 HZIKYLAZZZSYKF-UHFFFAOYSA-N 0.000 description 2
- ICNWJQOZRDWOMK-UHFFFAOYSA-N ethyl 3-hydroxypropanimidate;hydrochloride Chemical compound Cl.CCOC(=N)CCO ICNWJQOZRDWOMK-UHFFFAOYSA-N 0.000 description 2
- KEHJWELPDWMNRB-UHFFFAOYSA-N ethyl 4-(3-bromophenyl)-2,4-dioxobutanoate Chemical compound CCOC(=O)C(=O)CC(=O)C1=CC=CC(Br)=C1 KEHJWELPDWMNRB-UHFFFAOYSA-N 0.000 description 2
- LIWAQLJGPBVORC-UHFFFAOYSA-N ethylmethylamine Chemical compound CCNC LIWAQLJGPBVORC-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 150000002240 furans Chemical class 0.000 description 2
- 229930195712 glutamate Natural products 0.000 description 2
- 229940049906 glutamate Drugs 0.000 description 2
- 239000003825 glutamate receptor antagonist Substances 0.000 description 2
- 239000008241 heterogeneous mixture Substances 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- 230000007954 hypoxia Effects 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- LRDFRRGEGBBSRN-UHFFFAOYSA-N isobutyronitrile Chemical compound CC(C)C#N LRDFRRGEGBBSRN-UHFFFAOYSA-N 0.000 description 2
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
- CYEBJEDOHLIWNP-UHFFFAOYSA-N methanethioamide Chemical compound NC=S CYEBJEDOHLIWNP-UHFFFAOYSA-N 0.000 description 2
- FXRDQWHOMXLBQD-UHFFFAOYSA-N methyl 3-(1,3-oxazol-4-yl)benzoate Chemical compound COC(=O)C1=CC=CC(C=2N=COC=2)=C1 FXRDQWHOMXLBQD-UHFFFAOYSA-N 0.000 description 2
- KZGRSYGDDBGHOO-POHAHGRESA-N methyl 3-[(z)-hydroxyiminomethyl]benzoate Chemical compound COC(=O)C1=CC=CC(\C=N/O)=C1 KZGRSYGDDBGHOO-POHAHGRESA-N 0.000 description 2
- TZFTWLWSTINBGP-UHFFFAOYSA-N methyl 3-[4-(oxan-2-yloxymethyl)-1,3-oxazol-2-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C=2OC=C(COC3OCCCC3)N=2)=C1 TZFTWLWSTINBGP-UHFFFAOYSA-N 0.000 description 2
- MNDFXDXRMYURMC-UHFFFAOYSA-N methyl 3-carbamoylbenzoate Chemical compound COC(=O)C1=CC=CC(C(N)=O)=C1 MNDFXDXRMYURMC-UHFFFAOYSA-N 0.000 description 2
- XPBHWSMZTSSEJE-UHFFFAOYSA-N methyl 3-cyanobenzoate Chemical compound COC(=O)C1=CC=CC(C#N)=C1 XPBHWSMZTSSEJE-UHFFFAOYSA-N 0.000 description 2
- OBALLCFRLYMDPH-UHFFFAOYSA-N methyl 3-hydrazinylbenzoate;hydrochloride Chemical compound Cl.COC(=O)C1=CC=CC(NN)=C1 OBALLCFRLYMDPH-UHFFFAOYSA-N 0.000 description 2
- FNFWFAVDUMMRJN-UHFFFAOYSA-N methyl 3-pyrazol-1-ylbenzoate Chemical compound COC(=O)C1=CC=CC(N2N=CC=C2)=C1 FNFWFAVDUMMRJN-UHFFFAOYSA-N 0.000 description 2
- 206010027599 migraine Diseases 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- PFFDKLGOPDBQQD-UHFFFAOYSA-N n-(5-chloro-4-fluoro-2-nitrophenyl)acetamide Chemical compound CC(=O)NC1=CC(Cl)=C(F)C=C1[N+]([O-])=O PFFDKLGOPDBQQD-UHFFFAOYSA-N 0.000 description 2
- YCWKZLXTHMGYAO-UHFFFAOYSA-N n-methylcyclopropanamine;hydrochloride Chemical compound Cl.CNC1CC1 YCWKZLXTHMGYAO-UHFFFAOYSA-N 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 201000005040 opiate dependence Diseases 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- WVUCPRGADMCTBN-UHFFFAOYSA-M potassium;3-ethoxy-3-oxopropanoate Chemical compound [K+].CCOC(=O)CC([O-])=O WVUCPRGADMCTBN-UHFFFAOYSA-M 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 239000000651 prodrug Substances 0.000 description 2
- 229940002612 prodrug Drugs 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000013014 purified material Substances 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- XIIOFHFUYBLOLW-UHFFFAOYSA-N selpercatinib Chemical compound OC(COC=1C=C(C=2N(C=1)N=CC=2C#N)C=1C=NC(=CC=1)N1CC2N(C(C1)C2)CC=1C=NC(=CC=1)OC)(C)C XIIOFHFUYBLOLW-UHFFFAOYSA-N 0.000 description 2
- ZNJHFNUEQDVFCJ-UHFFFAOYSA-M sodium;2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid;hydroxide Chemical compound [OH-].[Na+].OCCN1CCN(CCS(O)(=O)=O)CC1 ZNJHFNUEQDVFCJ-UHFFFAOYSA-M 0.000 description 2
- 208000020431 spinal cord injury Diseases 0.000 description 2
- 235000011149 sulphuric acid Nutrition 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- BSZJCTWLDVBMEI-UHFFFAOYSA-N tert-butyl 3-[3-[5-methyl-4-(oxan-2-yloxymethyl)-5h-1,3-thiazol-4-yl]phenyl]-3-oxopropanoate Chemical compound CC1SC=NC1(C=1C=C(C=CC=1)C(=O)CC(=O)OC(C)(C)C)COC1OCCCC1 BSZJCTWLDVBMEI-UHFFFAOYSA-N 0.000 description 2
- GNXLCHRFEUHWGZ-UHFFFAOYSA-N tert-butyl n-[2-[[3-(2-cyanopyridin-4-yl)-3-oxopropanoyl]amino]-5-[methyl(propan-2-yl)amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)C(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=NC(C#N)=C1 GNXLCHRFEUHWGZ-UHFFFAOYSA-N 0.000 description 2
- WDMWPMOTZDRKAQ-UHFFFAOYSA-N tert-butyl n-[2-[[3-(3-imidazol-1-ylphenyl)-3-oxopropanoyl]amino]-5-(2-methylpropylamino)-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(NCC(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C=NC=C2)=C1 WDMWPMOTZDRKAQ-UHFFFAOYSA-N 0.000 description 2
- XBHJRLIRLVINJD-UHFFFAOYSA-N tert-butyl n-[2-[[3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoyl]amino]-5-[methyl(propan-2-yl)amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)C(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C=2ON=C(C)C=2)=C1 XBHJRLIRLVINJD-UHFFFAOYSA-N 0.000 description 2
- JSIDXGFHOPUHRL-UHFFFAOYSA-N tert-butyl n-[2-[[3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoyl]amino]-5-[methyl(propyl)amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)CCC)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C=2ON=C(C)C=2)=C1 JSIDXGFHOPUHRL-UHFFFAOYSA-N 0.000 description 2
- LIGRSHKMROLQTD-UHFFFAOYSA-N tert-butyl n-[4-chloro-2-[[3-(3-imidazol-1-ylphenyl)-3-oxopropanoyl]amino]-5-(2-methylpropylamino)phenyl]carbamate Chemical compound C1=C(Cl)C(NCC(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C=NC=C2)=C1 LIGRSHKMROLQTD-UHFFFAOYSA-N 0.000 description 2
- RFHSVKCCLOQCMN-UHFFFAOYSA-N tert-butyl n-[4-chloro-2-[[3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoyl]amino]-5-(2-methylpropylamino)phenyl]carbamate Chemical compound C1=C(Cl)C(NCC(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C=2ON=C(C)C=2)=C1 RFHSVKCCLOQCMN-UHFFFAOYSA-N 0.000 description 2
- XLSGVHSPOZMAAB-UHFFFAOYSA-N tert-butyl n-[4-chloro-2-[[3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoyl]amino]-5-(propan-2-ylamino)phenyl]carbamate Chemical compound C1=C(Cl)C(NC(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C=2ON=C(C)C=2)=C1 XLSGVHSPOZMAAB-UHFFFAOYSA-N 0.000 description 2
- GWVGGXOYNYVCPS-UHFFFAOYSA-N tert-butyl n-[4-chloro-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]-5-(propan-2-ylamino)phenyl]carbamate Chemical compound C1=C(Cl)C(NC(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C(=CN=N2)COC2OCCCC2)=C1 GWVGGXOYNYVCPS-UHFFFAOYSA-N 0.000 description 2
- USQGVVPGGOGZLX-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-(2-methylpropylamino)-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(NCC(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C(=CN=N2)COC2OCCCC2)=C1 USQGVVPGGOGZLX-UHFFFAOYSA-N 0.000 description 2
- JWMQQUOOCVYRKV-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-(2-methylpropylamino)-2-[[3-oxo-3-[3-(1,2,4-triazol-1-yl)phenyl]propanoyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(NCC(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2N=CN=C2)=C1 JWMQQUOOCVYRKV-UHFFFAOYSA-N 0.000 description 2
- LPBYMROUDRBTBG-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-(2-methylpropylamino)-2-[[3-oxo-3-[3-(triazol-1-yl)phenyl]propanoyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(NCC(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2N=NC=C2)=C1 LPBYMROUDRBTBG-UHFFFAOYSA-N 0.000 description 2
- INOBXZAULHVZGT-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-(dimethylamino)-2-[[3-[3-[4-(oxan-2-yloxymethyl)pyrazol-1-yl]phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2N=CC(COC3OCCCC3)=C2)=C1 INOBXZAULHVZGT-UHFFFAOYSA-N 0.000 description 2
- NPAJKRLCFGBHDO-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-[methyl(2-methylpropyl)amino]-2-[[3-[3-[5-(oxan-2-yloxymethyl)-1,2,4-triazol-1-yl]phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(N(C)CC(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C(=NC=N2)COC2OCCCC2)=C1 NPAJKRLCFGBHDO-UHFFFAOYSA-N 0.000 description 2
- ZDRKMIITUCRCMW-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-[methyl(2-methylpropyl)amino]-2-[[3-oxo-3-[3-(1,2,4-triazol-1-yl)phenyl]propanoyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(N(C)CC(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2N=CN=C2)=C1 ZDRKMIITUCRCMW-UHFFFAOYSA-N 0.000 description 2
- AVUYQXLUAIVSIW-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-[methyl(2-methylpropyl)amino]-2-[[3-oxo-3-[3-(triazol-1-yl)phenyl]propanoyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(N(C)CC(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2N=NC=C2)=C1 AVUYQXLUAIVSIW-UHFFFAOYSA-N 0.000 description 2
- QYHJAKGJAMWCML-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-[methyl(propyl)amino]-2-[[3-[3-[5-(oxan-2-yloxymethyl)-1,2,4-triazol-1-yl]phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(N(C)CCC)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C(=NC=N2)COC2OCCCC2)=C1 QYHJAKGJAMWCML-UHFFFAOYSA-N 0.000 description 2
- BNGOOHCXFRHPSX-UHFFFAOYSA-N tert-butyl n-[4-methyl-2-[[3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoyl]amino]-5-pyrrolidin-1-ylphenyl]carbamate Chemical compound O1N=C(C)C=C1C1=CC=CC(C(=O)CC(=O)NC=2C(=CC(=C(C)C=2)N2CCCC2)NC(=O)OC(C)(C)C)=C1 BNGOOHCXFRHPSX-UHFFFAOYSA-N 0.000 description 2
- FAVKGTRIMRKOFB-UHFFFAOYSA-N tert-butyl n-[4-methyl-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]-5-pyrrolidin-1-ylphenyl]carbamate Chemical compound CC(C)(C)OC(=O)NC=1C=C(N2CCCC2)C(C)=CC=1NC(=O)CC(=O)C(C=1)=CC=CC=1N1N=NC=C1COC1CCCCO1 FAVKGTRIMRKOFB-UHFFFAOYSA-N 0.000 description 2
- RZLUKUKKQKDPPT-UHFFFAOYSA-N tert-butyl n-[4-methyl-5-[methyl(2-methylpropyl)amino]-2-[[3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(C)C(N(C)CC(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C=2ON=C(C)C=2)=C1 RZLUKUKKQKDPPT-UHFFFAOYSA-N 0.000 description 2
- CPEAHVFDCWZIAA-UHFFFAOYSA-N tert-butyl n-[4-methyl-5-[methyl(2-methylpropyl)amino]-2-[[3-[3-[5-(oxan-2-yloxymethyl)-1,2,4-triazol-1-yl]phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(C)C(N(C)CC(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C(=NC=N2)COC2OCCCC2)=C1 CPEAHVFDCWZIAA-UHFFFAOYSA-N 0.000 description 2
- GRHLGOOYJBMHFC-UHFFFAOYSA-N tert-butyl n-[4-methyl-5-[methyl(2-methylpropyl)amino]-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(C)C(N(C)CC(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C(=CN=N2)COC2OCCCC2)=C1 GRHLGOOYJBMHFC-UHFFFAOYSA-N 0.000 description 2
- AETHUAXRRRBRHZ-UHFFFAOYSA-N tert-butyl n-[5-(2-methylpropylamino)-2-[[3-oxo-3-[3-(1,2,4-triazol-1-yl)phenyl]propanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(NCC(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2N=CN=C2)=C1 AETHUAXRRRBRHZ-UHFFFAOYSA-N 0.000 description 2
- LCKRVRMZHMPLEV-UHFFFAOYSA-N tert-butyl n-[5-(2-methylpropylamino)-2-[[3-oxo-3-[3-(triazol-1-yl)phenyl]propanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(NCC(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2N=NC=C2)=C1 LCKRVRMZHMPLEV-UHFFFAOYSA-N 0.000 description 2
- JJISKGCZYORTMV-UHFFFAOYSA-N tert-butyl n-[5-[methyl(2-methylpropyl)amino]-2-[[3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)CC(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C=2ON=C(C)C=2)=C1 JJISKGCZYORTMV-UHFFFAOYSA-N 0.000 description 2
- ZOKAMEQOGGCDGR-UHFFFAOYSA-N tert-butyl n-[5-[methyl(2-methylpropyl)amino]-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)CC(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C(=CN=N2)COC2OCCCC2)=C1 ZOKAMEQOGGCDGR-UHFFFAOYSA-N 0.000 description 2
- KIDWTMNUVFMTQE-UHFFFAOYSA-N tert-butyl n-[5-[methyl(2-methylpropyl)amino]-2-[[3-oxo-3-(3-pyrazol-1-ylphenyl)propanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)CC(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2N=CC=C2)=C1 KIDWTMNUVFMTQE-UHFFFAOYSA-N 0.000 description 2
- GQDXOEKCUSYZSZ-UHFFFAOYSA-N tert-butyl n-[5-[methyl(2-methylpropyl)amino]-2-[[3-oxo-3-[3-(1,2,4-triazol-1-yl)phenyl]propanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)CC(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2N=CN=C2)=C1 GQDXOEKCUSYZSZ-UHFFFAOYSA-N 0.000 description 2
- AMUSXOZSIRDJQN-UHFFFAOYSA-N tert-butyl n-[5-[methyl(2-methylpropyl)amino]-2-[[3-oxo-3-[3-(triazol-1-yl)phenyl]propanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)CC(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2N=NC=C2)=C1 AMUSXOZSIRDJQN-UHFFFAOYSA-N 0.000 description 2
- JXNOGNKAHFIOGV-UHFFFAOYSA-N tert-butyl n-[5-[methyl(propan-2-yl)amino]-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)C(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C(=CN=N2)COC2OCCCC2)=C1 JXNOGNKAHFIOGV-UHFFFAOYSA-N 0.000 description 2
- WVVFAIFCMRFCFA-UHFFFAOYSA-N tert-butyl n-[5-[methyl(propyl)amino]-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)CCC)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C(=CN=N2)COC2OCCCC2)=C1 WVVFAIFCMRFCFA-UHFFFAOYSA-N 0.000 description 2
- ORLXKBASFWRZMF-UHFFFAOYSA-N tert-butyl n-[5-[methyl(propyl)amino]-2-[[3-oxo-3-[3-(1,2,4-triazol-1-yl)phenyl]propanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)CCC)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2N=CN=C2)=C1 ORLXKBASFWRZMF-UHFFFAOYSA-N 0.000 description 2
- HSYXSBMHCRRXDS-UHFFFAOYSA-N tert-butyl n-[5-[methyl(propyl)amino]-2-[[3-oxo-3-[3-(triazol-1-yl)phenyl]propanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)CCC)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2N=NC=C2)=C1 HSYXSBMHCRRXDS-UHFFFAOYSA-N 0.000 description 2
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 229910052720 vanadium Inorganic materials 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- SZYXKFKWFYUOGZ-UHFFFAOYSA-N (2,3-difluorophenyl)boronic acid Chemical compound OB(O)C1=CC=CC(F)=C1F SZYXKFKWFYUOGZ-UHFFFAOYSA-N 0.000 description 1
- JNUZADQZHYFJGW-JOCHJYFZSA-N (2R)-N-[3-[5-fluoro-2-(2-fluoro-3-methylsulfonylanilino)pyrimidin-4-yl]-1H-indol-7-yl]-3-methoxy-2-(4-methylpiperazin-1-yl)propanamide Chemical compound FC=1C(=NC(=NC=1)NC1=C(C(=CC=C1)S(=O)(=O)C)F)C1=CNC2=C(C=CC=C12)NC([C@@H](COC)N1CCN(CC1)C)=O JNUZADQZHYFJGW-JOCHJYFZSA-N 0.000 description 1
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 1
- CULDWLXLZYYWLF-UHFFFAOYSA-N (4-ethynyl-2-nitrophenyl)carbamic acid Chemical compound OC(=O)NC1=CC=C(C#C)C=C1[N+]([O-])=O CULDWLXLZYYWLF-UHFFFAOYSA-N 0.000 description 1
- ZXRMGQGMKJBWTD-UHFFFAOYSA-N (4-fluoro-2-nitro-5-pyrrolidin-1-ylphenyl)carbamic acid Chemical compound C1=C([N+]([O-])=O)C(NC(=O)O)=CC(N2CCCC2)=C1F ZXRMGQGMKJBWTD-UHFFFAOYSA-N 0.000 description 1
- DNQXWCKDUGHASL-ZZXKWVIFSA-N (e)-3-pyrrolidin-1-ylprop-2-enoic acid Chemical compound OC(=O)\C=C\N1CCCC1 DNQXWCKDUGHASL-ZZXKWVIFSA-N 0.000 description 1
- ZGYIXVSQHOKQRZ-COIATFDQSA-N (e)-n-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-[(3s)-oxolan-3-yl]oxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound N#CC1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 ZGYIXVSQHOKQRZ-COIATFDQSA-N 0.000 description 1
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 1
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 1
- KYVBNYUBXIEUFW-UHFFFAOYSA-N 1,1,3,3-tetramethylguanidine Chemical compound CN(C)C(=N)N(C)C KYVBNYUBXIEUFW-UHFFFAOYSA-N 0.000 description 1
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- FKASFBLJDCHBNZ-UHFFFAOYSA-N 1,3,4-oxadiazole Chemical compound C1=NN=CO1 FKASFBLJDCHBNZ-UHFFFAOYSA-N 0.000 description 1
- ODRZAZBEQWAOGU-UHFFFAOYSA-N 1,4-dioxin-2-one Chemical compound O=C1COC=CO1 ODRZAZBEQWAOGU-UHFFFAOYSA-N 0.000 description 1
- APWRZPQBPCAXFP-UHFFFAOYSA-N 1-(1-oxo-2H-isoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]pyrazole-4-carboxamide Chemical compound O=C1NC=CC2=C(C=CC=C12)N1N=CC(=C1C(F)(F)F)C(=O)NC1=CC(=NC=C1)C(F)(F)F APWRZPQBPCAXFP-UHFFFAOYSA-N 0.000 description 1
- ZQHLGLKZCYAHOQ-UHFFFAOYSA-N 1-(3-methoxycarbonylphenyl)pyrazole-4-carboxylic acid Chemical compound COC(=O)C1=CC=CC(N2N=CC(=C2)C(O)=O)=C1 ZQHLGLKZCYAHOQ-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- ORQVLOOOUXHZEJ-UHFFFAOYSA-N 1-cyclopropyl-n-methylmethanamine;hydrochloride Chemical compound Cl.CNCC1CC1 ORQVLOOOUXHZEJ-UHFFFAOYSA-N 0.000 description 1
- QWENRTYMTSOGBR-UHFFFAOYSA-N 1H-1,2,3-Triazole Chemical compound C=1C=NNN=1 QWENRTYMTSOGBR-UHFFFAOYSA-N 0.000 description 1
- JYOCYCDSXDFBGV-UHFFFAOYSA-N 1h-1,4-diazepine-7-carbonitrile Chemical compound N#CC1=CC=NC=CN1 JYOCYCDSXDFBGV-UHFFFAOYSA-N 0.000 description 1
- ZCNFWVGKVHRKCD-UHFFFAOYSA-N 2,2,2-trichloro-n-(3-chlorophenyl)acetamide Chemical compound ClC1=CC=CC(NC(=O)C(Cl)(Cl)Cl)=C1 ZCNFWVGKVHRKCD-UHFFFAOYSA-N 0.000 description 1
- KIPSRYDSZQRPEA-UHFFFAOYSA-N 2,2,2-trifluoroethanamine Chemical compound NCC(F)(F)F KIPSRYDSZQRPEA-UHFFFAOYSA-N 0.000 description 1
- NOFAEQLDLCVPQU-UHFFFAOYSA-N 2-[4-[3-[8-chloro-7-(dimethylamino)-2-oxo-1,3-dihydro-1,5-benzodiazepin-4-yl]phenyl]-1,3-thiazol-2-yl]guanidine Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=CSC(NC(N)=N)=N1 NOFAEQLDLCVPQU-UHFFFAOYSA-N 0.000 description 1
- GBHCABUWWQUMAJ-UHFFFAOYSA-N 2-hydrazinoethanol Chemical compound NNCCO GBHCABUWWQUMAJ-UHFFFAOYSA-N 0.000 description 1
- HQAXHIGPGBPPFU-UHFFFAOYSA-N 2-prop-2-ynoxyoxane Chemical compound C#CCOC1CCCCO1 HQAXHIGPGBPPFU-UHFFFAOYSA-N 0.000 description 1
- ZBWZEFLYRWANSY-UHFFFAOYSA-N 2-quinoxalin-2-ylsulfanylacetic acid Chemical compound C1=CC=CC2=NC(SCC(=O)O)=CN=C21 ZBWZEFLYRWANSY-UHFFFAOYSA-N 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- DGOUQLKTECEPIS-UHFFFAOYSA-N 3-(2-cyanopyridin-4-yl)-3-oxopropanoic acid Chemical compound OC(=O)CC(=O)C1=CC=NC(C#N)=C1 DGOUQLKTECEPIS-UHFFFAOYSA-N 0.000 description 1
- XFODIAHSXPAKCW-UHFFFAOYSA-N 3-(3-cyanophenyl)-3-oxopropanoic acid Chemical compound OC(=O)CC(=O)C1=CC=CC(C#N)=C1 XFODIAHSXPAKCW-UHFFFAOYSA-N 0.000 description 1
- QSIJJFJVURXYMN-UHFFFAOYSA-N 3-(3-imidazol-1-ylphenyl)-3-oxopropanoic acid Chemical compound OC(=O)CC(=O)C1=CC=CC(N2C=NC=C2)=C1 QSIJJFJVURXYMN-UHFFFAOYSA-N 0.000 description 1
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 1
- UYIDTQOITQDPRC-UHFFFAOYSA-N 3-(5-ethoxycarbonylpyrazol-1-yl)benzoic acid Chemical compound CCOC(=O)C1=CC=NN1C1=CC=CC(C(O)=O)=C1 UYIDTQOITQDPRC-UHFFFAOYSA-N 0.000 description 1
- CPNVDNGBZCRCFH-UHFFFAOYSA-N 3-[2-[2-(oxan-2-yloxy)ethyl]pyrazol-3-yl]benzoic acid Chemical compound OC(=O)C1=CC=CC(C=2N(N=CC=2)CCOC2OCCCC2)=C1 CPNVDNGBZCRCFH-UHFFFAOYSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- SRVXSISGYBMIHR-UHFFFAOYSA-N 3-[3-[3-(2-amino-2-oxoethyl)phenyl]-5-chlorophenyl]-3-(5-methyl-1,3-thiazol-2-yl)propanoic acid Chemical compound S1C(C)=CN=C1C(CC(O)=O)C1=CC(Cl)=CC(C=2C=C(CC(N)=O)C=CC=2)=C1 SRVXSISGYBMIHR-UHFFFAOYSA-N 0.000 description 1
- LBCKLXGVOHYRHJ-UHFFFAOYSA-N 3-[5-(2-hydroxyethyl)triazol-1-yl]benzoic acid Chemical compound OCCC1=CN=NN1C1=CC=CC(C(O)=O)=C1 LBCKLXGVOHYRHJ-UHFFFAOYSA-N 0.000 description 1
- QAWYTFVOJUPNQF-UHFFFAOYSA-N 3-[5-(oxan-2-yloxymethyl)pyrazol-1-yl]benzoic acid Chemical compound OC(=O)C1=CC=CC(N2C(=CC=N2)COC2OCCCC2)=C1 QAWYTFVOJUPNQF-UHFFFAOYSA-N 0.000 description 1
- PDSFTMPFQBNXNU-UHFFFAOYSA-N 3-[7-(dimethylamino)-2-oxo-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-4-yl]benzonitrile Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C1=CC=CC(C#N)=C1 PDSFTMPFQBNXNU-UHFFFAOYSA-N 0.000 description 1
- XIFDAGZIOZVZSG-UHFFFAOYSA-N 3-[7-(dimethylamino)-8-methyl-2-oxo-1,3-dihydro-1,5-benzodiazepin-4-yl]benzonitrile Chemical compound C1C(=O)NC=2C=C(C)C(N(C)C)=CC=2N=C1C1=CC=CC(C#N)=C1 XIFDAGZIOZVZSG-UHFFFAOYSA-N 0.000 description 1
- HYTPAQFQBNLBMH-UHFFFAOYSA-N 3-[8-(2,3-difluorophenyl)-7-(dimethylamino)-2-oxo-1,3-dihydro-1,5-benzodiazepin-4-yl]benzonitrile Chemical compound CN(C)C1=CC=2N=C(C=3C=C(C=CC=3)C#N)CC(=O)NC=2C=C1C1=CC=CC(F)=C1F HYTPAQFQBNLBMH-UHFFFAOYSA-N 0.000 description 1
- MTJGVAJYTOXFJH-UHFFFAOYSA-N 3-aminonaphthalene-1,5-disulfonic acid Chemical compound C1=CC=C(S(O)(=O)=O)C2=CC(N)=CC(S(O)(=O)=O)=C21 MTJGVAJYTOXFJH-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- PBOOZQFGWNZNQE-UHFFFAOYSA-N 3-bromobenzoyl chloride Chemical compound ClC(=O)C1=CC=CC(Br)=C1 PBOOZQFGWNZNQE-UHFFFAOYSA-N 0.000 description 1
- RPESZQVUWMFBEO-UHFFFAOYSA-N 3-cyanobenzoyl chloride Chemical compound ClC(=O)C1=CC=CC(C#N)=C1 RPESZQVUWMFBEO-UHFFFAOYSA-N 0.000 description 1
- CRRVZRDISHOQQL-UHFFFAOYSA-N 3-fluoro-4-(trifluoromethyl)aniline Chemical compound NC1=CC=C(C(F)(F)F)C(F)=C1 CRRVZRDISHOQQL-UHFFFAOYSA-N 0.000 description 1
- VKJZLGSUMISODO-UHFFFAOYSA-N 3-imidazol-1-ylbenzoyl chloride;hydrochloride Chemical compound Cl.ClC(=O)C1=CC=CC(N2C=NC=C2)=C1 VKJZLGSUMISODO-UHFFFAOYSA-N 0.000 description 1
- FSGTULQLEVAYRS-UHFFFAOYSA-N 4,5-dichloro-2-nitroaniline Chemical compound NC1=CC(Cl)=C(Cl)C=C1[N+]([O-])=O FSGTULQLEVAYRS-UHFFFAOYSA-N 0.000 description 1
- ZVKOWQCEVFTISF-UHFFFAOYSA-N 4-(2,2-dimethyl-6-oxo-1,3-dioxin-4-yl)pyridine-2-carbonitrile Chemical compound O1C(C)(C)OC(=O)C=C1C1=CC=NC(C#N)=C1 ZVKOWQCEVFTISF-UHFFFAOYSA-N 0.000 description 1
- BQHYNVDPNYBBKW-UHFFFAOYSA-N 4-(3-cyanophenyl)-7-(dimethylamino)-2-oxo-1,3-dihydro-1,5-benzodiazepine-8-carbonitrile Chemical compound C1C(=O)NC=2C=C(C#N)C(N(C)C)=CC=2N=C1C1=CC=CC(C#N)=C1 BQHYNVDPNYBBKW-UHFFFAOYSA-N 0.000 description 1
- SEEBKBVIKDBFAA-UHFFFAOYSA-N 4-(8-fluoro-2-oxo-7-pyrrolidin-1-yl-1,3-dihydro-1,5-benzodiazepin-4-yl)pyridine-2-carbonitrile Chemical compound FC1=CC=2NC(=O)CC(C=3C=C(N=CC=3)C#N)=NC=2C=C1N1CCCC1 SEEBKBVIKDBFAA-UHFFFAOYSA-N 0.000 description 1
- CODGUXADHQPODF-UHFFFAOYSA-N 4-[3-(2-amino-1,3-thiazol-4-yl)phenyl]-8-chloro-7-(dimethylamino)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=CSC(N)=N1 CODGUXADHQPODF-UHFFFAOYSA-N 0.000 description 1
- XVCPMSYQEOOLGK-UHFFFAOYSA-N 4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-2-oxo-7-pyrrolidin-1-yl-1,3-dihydro-1,5-benzodiazepine-8-carbonitrile Chemical compound O1N=C(C)C=C1C1=CC=CC(C=2CC(=O)NC3=CC(=C(N4CCCC4)C=C3N=2)C#N)=C1 XVCPMSYQEOOLGK-UHFFFAOYSA-N 0.000 description 1
- SYNYBOYCEKHBET-UHFFFAOYSA-N 4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-7-[methyl(propan-2-yl)amino]-2-oxo-1,3-dihydro-1,5-benzodiazepine-8-carbonitrile Chemical compound C1C(=O)NC=2C=C(C#N)C(N(C)C(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=CC(C)=NO1 SYNYBOYCEKHBET-UHFFFAOYSA-N 0.000 description 1
- HWIGVDRRBOYZGK-UHFFFAOYSA-N 4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-7-[methyl(propyl)amino]-2-oxo-1,3-dihydro-1,5-benzodiazepine-8-carbonitrile Chemical compound C1C(=O)NC=2C=C(C#N)C(N(C)CCC)=CC=2N=C1C(C=1)=CC=CC=1C1=CC(C)=NO1 HWIGVDRRBOYZGK-UHFFFAOYSA-N 0.000 description 1
- DZEILNWYDVQHPM-UHFFFAOYSA-N 4-[3-[4-(hydroxymethyl)-1,3-oxazol-2-yl]phenyl]-8-methyl-7-[methyl(propyl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C)C(N(C)CCC)=CC=2N=C1C(C=1)=CC=CC=1C1=NC(CO)=CO1 DZEILNWYDVQHPM-UHFFFAOYSA-N 0.000 description 1
- GOWISTOYQREELU-UHFFFAOYSA-N 4-[3-[4-(hydroxymethyl)-1,3-thiazol-2-yl]phenyl]-8-methyl-7-[methyl(propyl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C)C(N(C)CCC)=CC=2N=C1C(C=1)=CC=CC=1C1=NC(CO)=CS1 GOWISTOYQREELU-UHFFFAOYSA-N 0.000 description 1
- GIMKHDIDNDBBTF-UHFFFAOYSA-N 4-[3-[4-[(cyclopropylamino)methyl]pyrazol-1-yl]phenyl]-7-(dimethylamino)-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1N(N=C1)C=C1CNC1CC1 GIMKHDIDNDBBTF-UHFFFAOYSA-N 0.000 description 1
- FMZPYZBBGSLHPR-UHFFFAOYSA-N 4-[3-[5-(azetidin-1-ylmethyl)triazol-1-yl]phenyl]-8-chloro-7-(dimethylamino)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CN1CCC1 FMZPYZBBGSLHPR-UHFFFAOYSA-N 0.000 description 1
- QHWRCSBRSZXIPC-UHFFFAOYSA-N 4-[3-[5-(hydroxymethyl)-1,2,4-triazol-1-yl]phenyl]-8-methyl-7-[methyl(2-methylpropyl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=CN=C1CO QHWRCSBRSZXIPC-UHFFFAOYSA-N 0.000 description 1
- AILZVLZOXJQVNO-UHFFFAOYSA-N 4-[3-[5-(hydroxymethyl)-1,2-oxazol-3-yl]phenyl]-7-pyrrolidin-1-yl-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound O1C(CO)=CC(C=2C=C(C=CC=2)C=2CC(=O)NC3=CC(=C(N4CCCC4)C=C3N=2)C(F)(F)F)=N1 AILZVLZOXJQVNO-UHFFFAOYSA-N 0.000 description 1
- LVLWNASSFOKEBX-UHFFFAOYSA-N 4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-2-oxo-7-pyrrolidin-1-yl-1,3-dihydro-1,5-benzodiazepine-8-carbonitrile Chemical compound OCC1=CN=NN1C1=CC=CC(C=2CC(=O)NC3=CC(=C(N4CCCC4)C=C3N=2)C#N)=C1 LVLWNASSFOKEBX-UHFFFAOYSA-N 0.000 description 1
- ABPLMISEVZCZHA-UHFFFAOYSA-N 4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-7-[methyl(propan-2-yl)amino]-2-oxo-1,3-dihydro-1,5-benzodiazepine-8-carbonitrile Chemical compound C1C(=O)NC=2C=C(C#N)C(N(C)C(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CO ABPLMISEVZCZHA-UHFFFAOYSA-N 0.000 description 1
- DAKIGNUMCUOMEZ-UHFFFAOYSA-N 4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-7-[methyl(propyl)amino]-2-oxo-1,3-dihydro-1,5-benzodiazepine-8-carbonitrile Chemical compound C1C(=O)NC=2C=C(C#N)C(N(C)CCC)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CO DAKIGNUMCUOMEZ-UHFFFAOYSA-N 0.000 description 1
- QQXLJOVKIJCPGQ-UHFFFAOYSA-N 4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-7-[methyl(propyl)amino]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)CCC)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CO QQXLJOVKIJCPGQ-UHFFFAOYSA-N 0.000 description 1
- OMVMQBMBXYZIHE-UHFFFAOYSA-N 4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-7-pyrrolidin-1-yl-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound OCC1=CN=NN1C1=CC=CC(C=2CC(=O)NC3=CC(=C(N4CCCC4)C=C3N=2)C(F)(F)F)=C1 OMVMQBMBXYZIHE-UHFFFAOYSA-N 0.000 description 1
- UUZYOQGNLRBJBX-UHFFFAOYSA-N 4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-8-methyl-7-[methyl(propyl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C)C(N(C)CCC)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CO UUZYOQGNLRBJBX-UHFFFAOYSA-N 0.000 description 1
- DGDZRNZNOCKRLV-UHFFFAOYSA-N 4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-8-methyl-7-pyrrolidin-1-yl-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound CC1=CC=2NC(=O)CC(C=3C=C(C=CC=3)N3C(=CN=N3)CO)=NC=2C=C1N1CCCC1 DGDZRNZNOCKRLV-UHFFFAOYSA-N 0.000 description 1
- ZYGTYKBRRGVVAV-UHFFFAOYSA-N 4-[3-[5-[(cyclopropylamino)methyl]-1,2,4-triazol-1-yl]phenyl]-8-methyl-7-[methyl(2-methylpropyl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=CN=C1CNC1CC1 ZYGTYKBRRGVVAV-UHFFFAOYSA-N 0.000 description 1
- OVIVBMHMNZBFAH-UHFFFAOYSA-N 4-[3-[5-[(cyclopropylamino)methyl]triazol-1-yl]phenyl]-7-[cyclopropylmethyl(methyl)amino]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C=1C=2N=C(C=3C=C(C=CC=3)N3C(=CN=N3)CNC3CC3)CC(=O)NC=2C=C(C(F)(F)F)C=1N(C)CC1CC1 OVIVBMHMNZBFAH-UHFFFAOYSA-N 0.000 description 1
- YZLHISBJGFXNLP-UHFFFAOYSA-N 4-[3-[5-[(cyclopropylamino)methyl]triazol-1-yl]phenyl]-7-[methyl(propan-2-yl)amino]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CNC1CC1 YZLHISBJGFXNLP-UHFFFAOYSA-N 0.000 description 1
- YLYZQRNPGRXGJS-UHFFFAOYSA-N 4-[3-[5-[(cyclopropylmethylamino)methyl]-1,3-thiazol-4-yl]phenyl]-7-(dimethylamino)-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C=1N=CSC=1CNCC1CC1 YLYZQRNPGRXGJS-UHFFFAOYSA-N 0.000 description 1
- FXOVKXSQYWLBRW-UHFFFAOYSA-N 4-[3-[5-[(cyclopropylmethylamino)methyl]triazol-1-yl]phenyl]-7-[methyl(propan-2-yl)amino]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CNCC1CC1 FXOVKXSQYWLBRW-UHFFFAOYSA-N 0.000 description 1
- AIZAUKGBIYZEOH-UHFFFAOYSA-N 4-[3-[5-[(dimethylamino)methyl]triazol-1-yl]phenyl]-7-[methyl(2-methylpropyl)amino]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CN(C)C AIZAUKGBIYZEOH-UHFFFAOYSA-N 0.000 description 1
- XOCCYASOIGNTKW-UHFFFAOYSA-N 4-[3-[5-[(dimethylamino)methyl]triazol-1-yl]phenyl]-7-[methyl(propan-2-yl)amino]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CN(C)C XOCCYASOIGNTKW-UHFFFAOYSA-N 0.000 description 1
- YFCIFWOJYYFDQP-PTWZRHHISA-N 4-[3-amino-6-[(1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl]pyrazin-2-yl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl]-2-fluorobenzamide Chemical compound CNC[C@@H](NC(=O)c1ccc(cc1F)-c1nc(cnc1N)[C@H]1CC[C@H](O)[C@@H](F)C1)c1cc(F)cc(Br)c1 YFCIFWOJYYFDQP-PTWZRHHISA-N 0.000 description 1
- LSBPDSDYJOIHLG-UHFFFAOYSA-N 4-[7-(azetidin-1-yl)-2-oxo-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-4-yl]pyridine-2-carbonitrile Chemical compound FC(F)(F)C1=CC=2NC(=O)CC(C=3C=C(N=CC=3)C#N)=NC=2C=C1N1CCC1 LSBPDSDYJOIHLG-UHFFFAOYSA-N 0.000 description 1
- WALIFVMKFPBEDN-UHFFFAOYSA-N 4-[7-(azetidin-1-yl)-8-chloro-2-oxo-1,3-dihydro-1,5-benzodiazepin-4-yl]pyridine-2-carbonitrile Chemical compound ClC1=CC=2NC(=O)CC(C=3C=C(N=CC=3)C#N)=NC=2C=C1N1CCC1 WALIFVMKFPBEDN-UHFFFAOYSA-N 0.000 description 1
- LERGFJBGZVFWGF-UHFFFAOYSA-N 4-[7-(dimethylamino)-2-oxo-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-4-yl]pyridine-2-carbonitrile Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C1=CC=NC(C#N)=C1 LERGFJBGZVFWGF-UHFFFAOYSA-N 0.000 description 1
- YQMYTNJZZFFHNL-UHFFFAOYSA-N 4-[8-chloro-7-(dimethylamino)-2-oxo-1,3-dihydro-1,5-benzodiazepin-4-yl]pyridine-2-carbonitrile Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C)=CC=2N=C1C1=CC=NC(C#N)=C1 YQMYTNJZZFFHNL-UHFFFAOYSA-N 0.000 description 1
- GVLYYXURXBTTOQ-UHFFFAOYSA-N 4-[8-chloro-7-[cyclopropyl(methyl)amino]-2-oxo-1,3-dihydro-1,5-benzodiazepin-4-yl]pyridine-2-carbonitrile Chemical compound C=1C=2N=C(C=3C=C(N=CC=3)C#N)CC(=O)NC=2C=C(Cl)C=1N(C)C1CC1 GVLYYXURXBTTOQ-UHFFFAOYSA-N 0.000 description 1
- XAHREBHCCFVAHU-UHFFFAOYSA-N 4-amino-2-fluoro-5-nitrobenzonitrile Chemical compound NC1=CC(F)=C(C#N)C=C1[N+]([O-])=O XAHREBHCCFVAHU-UHFFFAOYSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- QVCRSYXVWPPBFJ-UHFFFAOYSA-N 4-iodo-2-nitroaniline Chemical class NC1=CC=C(I)C=C1[N+]([O-])=O QVCRSYXVWPPBFJ-UHFFFAOYSA-N 0.000 description 1
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 description 1
- VYFQYPUJWURCOH-UHFFFAOYSA-N 5-(3-bromophenyl)-1-methyl-4-(oxan-2-yloxymethyl)pyrazole Chemical compound C=1C=CC(Br)=CC=1C=1N(C)N=CC=1COC1CCCCO1 VYFQYPUJWURCOH-UHFFFAOYSA-N 0.000 description 1
- IRPVABHDSJVBNZ-RTHVDDQRSA-N 5-[1-(cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C(F)(F)F)C(N)=NC=C1C1=NN(CC2CC2)C(C2[C@@H]3CN(C[C@@H]32)C2COC2)=C1 IRPVABHDSJVBNZ-RTHVDDQRSA-N 0.000 description 1
- CVICEEPAFUYBJG-UHFFFAOYSA-N 5-chloro-2,2-difluoro-1,3-benzodioxole Chemical group C1=C(Cl)C=C2OC(F)(F)OC2=C1 CVICEEPAFUYBJG-UHFFFAOYSA-N 0.000 description 1
- OQZSZUKPUHEUBM-UHFFFAOYSA-N 5-chloro-2-nitro-4-pyrrol-1-ylaniline Chemical class C1=C([N+]([O-])=O)C(N)=CC(Cl)=C1N1C=CC=C1 OQZSZUKPUHEUBM-UHFFFAOYSA-N 0.000 description 1
- BBWHBSDZHSQECL-UHFFFAOYSA-N 5-chloro-4-methyl-2-nitroaniline Chemical compound CC1=CC([N+]([O-])=O)=C(N)C=C1Cl BBWHBSDZHSQECL-UHFFFAOYSA-N 0.000 description 1
- UTRVMCDXCUQEEJ-UHFFFAOYSA-N 5-fluoro-2-nitro-4-(trifluoromethyl)aniline Chemical compound NC1=CC(F)=C(C(F)(F)F)C=C1[N+]([O-])=O UTRVMCDXCUQEEJ-UHFFFAOYSA-N 0.000 description 1
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 1
- LHXMTKNDTAKAGL-UHFFFAOYSA-N 7-(2-methylpropylamino)-4-[3-(1,2,4-triazol-1-yl)phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(NCC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1C=NC=N1 LHXMTKNDTAKAGL-UHFFFAOYSA-N 0.000 description 1
- DWJWAFNTGHMGGS-UHFFFAOYSA-N 7-(2-methylpropylamino)-4-[3-(triazol-1-yl)phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(NCC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1C=CN=N1 DWJWAFNTGHMGGS-UHFFFAOYSA-N 0.000 description 1
- KREKNXXMELMUOX-UHFFFAOYSA-N 7-(azetidin-1-yl)-4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound O1N=C(C)C=C1C1=CC=CC(C=2CC(=O)NC3=CC(=C(N4CCC4)C=C3N=2)C(F)(F)F)=C1 KREKNXXMELMUOX-UHFFFAOYSA-N 0.000 description 1
- SUNMMHTZSFGTOF-UHFFFAOYSA-N 7-(azetidin-1-yl)-4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound OCC1=CN=NN1C1=CC=CC(C=2CC(=O)NC3=CC(=C(N4CCC4)C=C3N=2)C(F)(F)F)=C1 SUNMMHTZSFGTOF-UHFFFAOYSA-N 0.000 description 1
- ZTSWTPAHEGIJFI-UHFFFAOYSA-N 7-(dimethylamino)-4-(3-pyrazol-1-ylphenyl)-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1C=CC=N1 ZTSWTPAHEGIJFI-UHFFFAOYSA-N 0.000 description 1
- UPFKBXBKDKWIIP-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-(1,2,4-triazol-1-yl)phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1C=NC=N1 UPFKBXBKDKWIIP-UHFFFAOYSA-N 0.000 description 1
- ZEPGJDIJDUJBQU-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-(1,2,4-triazol-4-yl)phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1C=NN=C1 ZEPGJDIJDUJBQU-UHFFFAOYSA-N 0.000 description 1
- RCVBCSUEBNEJHX-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-(1,3-oxazol-4-yl)phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=COC=N1 RCVBCSUEBNEJHX-UHFFFAOYSA-N 0.000 description 1
- MKQSBXLOBFBYJB-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-(1,3-thiazol-4-yl)phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=CSC=N1 MKQSBXLOBFBYJB-UHFFFAOYSA-N 0.000 description 1
- OSDCWVNXAOLLRV-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-(2,5-dimethyl-1,3-thiazol-4-yl)phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C=1N=C(C)SC=1C OSDCWVNXAOLLRV-UHFFFAOYSA-N 0.000 description 1
- SIJJDDYTLXWZAV-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-(2-methyl-1,3-oxazol-4-yl)phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=COC(C)=N1 SIJJDDYTLXWZAV-UHFFFAOYSA-N 0.000 description 1
- UKAWGSFAYUUAOI-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-(2-propan-2-yl-1h-imidazol-5-yl)phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound N1C(C(C)C)=NC(C=2C=C(C=CC=2)C=2CC(=O)NC3=CC(=C(N(C)C)C=C3N=2)C(F)(F)F)=C1 UKAWGSFAYUUAOI-UHFFFAOYSA-N 0.000 description 1
- YHLPMDDUHZBMGP-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-2-oxo-1,3-dihydro-1,5-benzodiazepine-8-carbonitrile Chemical compound C1C(=O)NC=2C=C(C#N)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=CC(C)=NO1 YHLPMDDUHZBMGP-UHFFFAOYSA-N 0.000 description 1
- GVXMXLUMRLAZSE-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-(5-methyl-1,3-oxazol-4-yl)phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C=1N=COC=1C GVXMXLUMRLAZSE-UHFFFAOYSA-N 0.000 description 1
- MNXLDUFFLGXIGJ-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-(5-methyl-1,3-thiazol-4-yl)phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C=1N=CSC=1C MNXLDUFFLGXIGJ-UHFFFAOYSA-N 0.000 description 1
- RLLJZZRODXMVCW-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-(triazol-1-yl)phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1C=CN=N1 RLLJZZRODXMVCW-UHFFFAOYSA-N 0.000 description 1
- STEJVLVUESOIMW-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-[2-(2-hydroxyethyl)pyrazol-3-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=CC=NN1CCO STEJVLVUESOIMW-UHFFFAOYSA-N 0.000 description 1
- CKKYPUYNUGLFNT-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-[2-(hydroxymethyl)-5-methyl-1,3-thiazol-4-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C=1N=C(CO)SC=1C CKKYPUYNUGLFNT-UHFFFAOYSA-N 0.000 description 1
- ZRGKGBSNVPNGKJ-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-[2-(hydroxymethyl)-5-propyl-1,3-thiazol-4-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound S1C(CO)=NC(C=2C=C(C=CC=2)C=2CC(=O)NC3=CC(=C(N(C)C)C=C3N=2)C(F)(F)F)=C1CCC ZRGKGBSNVPNGKJ-UHFFFAOYSA-N 0.000 description 1
- YWLNHBTXNZVZKN-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-[3-(pyrrolidin-1-ylmethyl)-1,2-oxazol-5-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C(ON=1)=CC=1CN1CCCC1 YWLNHBTXNZVZKN-UHFFFAOYSA-N 0.000 description 1
- CNZPINTULZHMNH-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-[3-[(dimethylamino)methyl]-1,2-oxazol-5-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound O1N=C(CN(C)C)C=C1C1=CC=CC(C=2CC(=O)NC3=CC(=C(N(C)C)C=C3N=2)C(F)(F)F)=C1 CNZPINTULZHMNH-UHFFFAOYSA-N 0.000 description 1
- XPGNDPLHGBOEKZ-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-[4-(hydroxymethyl)-1,2-oxazol-3-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=NOC=C1CO XPGNDPLHGBOEKZ-UHFFFAOYSA-N 0.000 description 1
- SDAOODKHWZMYFW-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-[4-(hydroxymethyl)-2-methylpyrazol-3-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=C(CO)C=NN1C SDAOODKHWZMYFW-UHFFFAOYSA-N 0.000 description 1
- UQGJPUBPGOJANX-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-[4-(hydroxymethyl)-3-methyl-1,2-oxazol-5-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C=1ON=C(C)C=1CO UQGJPUBPGOJANX-UHFFFAOYSA-N 0.000 description 1
- QIUBFTYQGWANLK-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-[5-(2-hydroxyethyl)-1,3,4-oxadiazol-2-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=NN=C(CCO)O1 QIUBFTYQGWANLK-UHFFFAOYSA-N 0.000 description 1
- KOQICBOZFABQGM-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-[5-(2-hydroxyethyl)-1,3,4-thiadiazol-2-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=NN=C(CCO)S1 KOQICBOZFABQGM-UHFFFAOYSA-N 0.000 description 1
- LSVFBRGKFKCGMC-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-[5-(2-hydroxyethyl)triazol-1-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CCO LSVFBRGKFKCGMC-UHFFFAOYSA-N 0.000 description 1
- ZMCDXMJTBHCFNR-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-[5-(hydroxymethyl)-1,2-oxazol-3-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C=1C=C(CO)ON=1 ZMCDXMJTBHCFNR-UHFFFAOYSA-N 0.000 description 1
- XRMZMXKASPTRJY-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-[5-(hydroxymethyl)-1,3,4-oxadiazol-2-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=NN=C(CO)O1 XRMZMXKASPTRJY-UHFFFAOYSA-N 0.000 description 1
- VRJXKJRQGGOMBG-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-[5-(hydroxymethyl)-2-methyl-1,3-thiazol-4-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C=1N=C(C)SC=1CO VRJXKJRQGGOMBG-UHFFFAOYSA-N 0.000 description 1
- XLEPXURUIQRBLZ-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-[5-(hydroxymethyl)pyrazol-1-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=CC=C1CO XLEPXURUIQRBLZ-UHFFFAOYSA-N 0.000 description 1
- WTUXKMCLKJNWKX-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-8-methyl-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CO WTUXKMCLKJNWKX-UHFFFAOYSA-N 0.000 description 1
- QOMKTRWWFOHYDC-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-[5-[(2,2,2-trifluoroethylamino)methyl]triazol-1-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CNCC(F)(F)F QOMKTRWWFOHYDC-UHFFFAOYSA-N 0.000 description 1
- HPHLAXSQXBMGAF-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-[5-[(dimethylamino)methyl]triazol-1-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound CN(C)CC1=CN=NN1C1=CC=CC(C=2CC(=O)NC3=CC(=C(N(C)C)C=C3N=2)C(F)(F)F)=C1 HPHLAXSQXBMGAF-UHFFFAOYSA-N 0.000 description 1
- OVVVBOUOJRHUOL-UHFFFAOYSA-N 7-(dimethylamino)-4-[3-[5-[(dimethylamino)methyl]triazol-1-yl]phenyl]-8-fluoro-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound CN(C)CC1=CN=NN1C1=CC=CC(C=2CC(=O)NC3=CC(F)=C(N(C)C)C=C3N=2)=C1 OVVVBOUOJRHUOL-UHFFFAOYSA-N 0.000 description 1
- GJAUABFUPDQOFL-UHFFFAOYSA-N 7-(dimethylamino)-8-(2-fluorophenyl)-4-[3-(triazol-1-yl)phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound CN(C)C1=CC=2N=C(C=3C=C(C=CC=3)N3N=NC=C3)CC(=O)NC=2C=C1C1=CC=CC=C1F GJAUABFUPDQOFL-UHFFFAOYSA-N 0.000 description 1
- MJXACAKMGHENPL-UHFFFAOYSA-N 7-(dimethylamino)-8-fluoro-4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=CC(C)=NO1 MJXACAKMGHENPL-UHFFFAOYSA-N 0.000 description 1
- ICCNPLJSTFTKDH-UHFFFAOYSA-N 7-(dimethylamino)-8-fluoro-4-[3-[3-(hydroxymethyl)-1,2-oxazol-5-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=CC(CO)=NO1 ICCNPLJSTFTKDH-UHFFFAOYSA-N 0.000 description 1
- KWPWUKXJTHNZAA-UHFFFAOYSA-N 7-(dimethylamino)-8-fluoro-4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CO KWPWUKXJTHNZAA-UHFFFAOYSA-N 0.000 description 1
- RFWFVAXPEXLSSF-UHFFFAOYSA-N 7-[ethyl(methyl)amino]-4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-8-methyl-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C)C(N(C)CC)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CO RFWFVAXPEXLSSF-UHFFFAOYSA-N 0.000 description 1
- ZCWLHZMOEMKKFB-UHFFFAOYSA-N 7-[methyl(2-methylpropyl)amino]-2-oxo-4-[3-[5-(pyrrolidin-1-ylmethyl)triazol-1-yl]phenyl]-1,3-dihydro-1,5-benzodiazepine-8-carbonitrile Chemical compound C1C(=O)NC=2C=C(C#N)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CN1CCCC1 ZCWLHZMOEMKKFB-UHFFFAOYSA-N 0.000 description 1
- WZCPSKLGMOSDEB-UHFFFAOYSA-N 7-[methyl(2-methylpropyl)amino]-4-(3-pyrazol-1-ylphenyl)-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1C=CC=N1 WZCPSKLGMOSDEB-UHFFFAOYSA-N 0.000 description 1
- OTTUZANBSOAVTP-UHFFFAOYSA-N 7-[methyl(2-methylpropyl)amino]-4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-2-oxo-1,3-dihydro-1,5-benzodiazepine-8-carbonitrile Chemical compound C1C(=O)NC=2C=C(C#N)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=CC(C)=NO1 OTTUZANBSOAVTP-UHFFFAOYSA-N 0.000 description 1
- CUFABNBLNKUDRN-UHFFFAOYSA-N 7-[methyl(2-methylpropyl)amino]-4-[3-[5-(pyrrolidin-1-ylmethyl)triazol-1-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CN1CCCC1 CUFABNBLNKUDRN-UHFFFAOYSA-N 0.000 description 1
- OUPZQDLYWSUOLZ-UHFFFAOYSA-N 7-[methyl(2-methylpropyl)amino]-4-[3-[5-[[methyl(2-methylpropyl)amino]methyl]triazol-1-yl]phenyl]-2-oxo-1,3-dihydro-1,5-benzodiazepine-8-carbonitrile Chemical compound CC(C)CN(C)CC1=CN=NN1C1=CC=CC(C=2CC(=O)NC3=CC(=C(N(C)CC(C)C)C=C3N=2)C#N)=C1 OUPZQDLYWSUOLZ-UHFFFAOYSA-N 0.000 description 1
- ORRZRVJTBOZGNG-UHFFFAOYSA-N 7-[methyl(propan-2-yl)amino]-4-[3-[5-[(propan-2-ylamino)methyl]triazol-1-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound CC(C)NCC1=CN=NN1C1=CC=CC(C=2CC(=O)NC3=CC(=C(N(C)C(C)C)C=C3N=2)C(F)(F)F)=C1 ORRZRVJTBOZGNG-UHFFFAOYSA-N 0.000 description 1
- ZACXGJUDDYRSFP-UHFFFAOYSA-N 7-[methyl(propan-2-yl)amino]-4-[3-[5-[[methyl(propan-2-yl)amino]methyl]triazol-1-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound CC(C)N(C)CC1=CN=NN1C1=CC=CC(C=2CC(=O)NC3=CC(=C(N(C)C(C)C)C=C3N=2)C(F)(F)F)=C1 ZACXGJUDDYRSFP-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- KNRVFEQLSYJSOV-UHFFFAOYSA-N 8-(2,3-difluorophenyl)-7-(dimethylamino)-4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound CN(C)C1=CC=2N=C(C=3C=C(C=CC=3)N3C(=CN=N3)CO)CC(=O)NC=2C=C1C1=CC=CC(F)=C1F KNRVFEQLSYJSOV-UHFFFAOYSA-N 0.000 description 1
- NWIYLCHBJCUSCI-UHFFFAOYSA-N 8-(2-fluorophenyl)-4-(3-imidazol-1-ylphenyl)-7-(2,2,2-trifluoroethoxy)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound FC1=CC=CC=C1C(C(=C1)OCC(F)(F)F)=CC2=C1N=C(C=1C=C(C=CC=1)N1C=NC=C1)CC(=O)N2 NWIYLCHBJCUSCI-UHFFFAOYSA-N 0.000 description 1
- RXCXQRRNCKUOTK-UHFFFAOYSA-N 8-(2-fluorophenyl)-4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-7-(2,2,2-trifluoroethoxy)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound OCC1=CN=NN1C1=CC=CC(C=2CC(=O)NC3=CC(=C(OCC(F)(F)F)C=C3N=2)C=2C(=CC=CC=2)F)=C1 RXCXQRRNCKUOTK-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- GRIBLMMLNFPFAX-UHFFFAOYSA-N 8-chloro-4-[3-(2-methyl-1,3-oxazol-4-yl)phenyl]-7-[methyl(propyl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CCC)=CC=2N=C1C(C=1)=CC=CC=1C1=COC(C)=N1 GRIBLMMLNFPFAX-UHFFFAOYSA-N 0.000 description 1
- CZIHQKXTHNTSPR-UHFFFAOYSA-N 8-chloro-4-[3-[5-(diethylaminomethyl)triazol-1-yl]phenyl]-7-[methyl(propyl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CCC)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CN(CC)CC CZIHQKXTHNTSPR-UHFFFAOYSA-N 0.000 description 1
- GOBRBTVFFBNZMY-UHFFFAOYSA-N 8-chloro-4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-7-(propan-2-ylamino)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(NC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CO GOBRBTVFFBNZMY-UHFFFAOYSA-N 0.000 description 1
- SMBPDAGZHSMKQB-UHFFFAOYSA-N 8-chloro-4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-7-[2-methoxyethyl(methyl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CCOC)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CO SMBPDAGZHSMKQB-UHFFFAOYSA-N 0.000 description 1
- SSVXNKOACSAHAK-UHFFFAOYSA-N 8-chloro-4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-7-piperidin-1-yl-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound OCC1=CN=NN1C1=CC=CC(C=2CC(=O)NC3=CC(Cl)=C(N4CCCCC4)C=C3N=2)=C1 SSVXNKOACSAHAK-UHFFFAOYSA-N 0.000 description 1
- FBFLRNUYFLAWIA-UHFFFAOYSA-N 8-chloro-4-[3-[5-(methylaminomethyl)triazol-1-yl]phenyl]-7-[methyl(propyl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CCC)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CNC FBFLRNUYFLAWIA-UHFFFAOYSA-N 0.000 description 1
- LIUKHGRJOMYEFO-UHFFFAOYSA-N 8-chloro-4-[3-[5-[(cyclopentylamino)methyl]triazol-1-yl]phenyl]-7-[methyl(propan-2-yl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CNC1CCCC1 LIUKHGRJOMYEFO-UHFFFAOYSA-N 0.000 description 1
- BCXPYFAYSBWNMF-UHFFFAOYSA-N 8-chloro-4-[3-[5-[(cyclopropylamino)methyl]-1,2,4-triazol-1-yl]phenyl]-7-[methyl(propyl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CCC)=CC=2N=C1C(C=1)=CC=CC=1N1N=CN=C1CNC1CC1 BCXPYFAYSBWNMF-UHFFFAOYSA-N 0.000 description 1
- OYFIEEWFOLWIRM-UHFFFAOYSA-N 8-chloro-4-[3-[5-[(cyclopropylamino)methyl]triazol-1-yl]phenyl]-7-[methyl(propan-2-yl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CNC1CC1 OYFIEEWFOLWIRM-UHFFFAOYSA-N 0.000 description 1
- VAUKAERSBWYPID-UHFFFAOYSA-N 8-chloro-4-[3-[5-[(cyclopropylmethylamino)methyl]triazol-1-yl]phenyl]-7-[methyl(propan-2-yl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CNCC1CC1 VAUKAERSBWYPID-UHFFFAOYSA-N 0.000 description 1
- NFWXOZTVMYYPPZ-UHFFFAOYSA-N 8-chloro-4-[3-[5-[(dimethylamino)methyl]-1,2,4-triazol-1-yl]phenyl]-7-[methyl(propyl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CCC)=CC=2N=C1C(C=1)=CC=CC=1N1N=CN=C1CN(C)C NFWXOZTVMYYPPZ-UHFFFAOYSA-N 0.000 description 1
- WLYQPLFEGZHVEG-UHFFFAOYSA-N 8-chloro-4-[3-[5-[(dimethylamino)methyl]triazol-1-yl]phenyl]-7-[methyl(propan-2-yl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CN(C)C WLYQPLFEGZHVEG-UHFFFAOYSA-N 0.000 description 1
- URGZKSOUCWRELE-UHFFFAOYSA-N 8-chloro-4-[3-[5-[[2-methoxyethyl(methyl)amino]methyl]triazol-1-yl]phenyl]-7-[methyl(propan-2-yl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound COCCN(C)CC1=CN=NN1C1=CC=CC(C=2CC(=O)NC3=CC(Cl)=C(N(C)C(C)C)C=C3N=2)=C1 URGZKSOUCWRELE-UHFFFAOYSA-N 0.000 description 1
- BLFGVJJQRHRAQL-UHFFFAOYSA-N 8-chloro-4-[3-[5-[[methyl(propan-2-yl)amino]methyl]triazol-1-yl]phenyl]-7-[methyl(propyl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CCC)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CN(C)C(C)C BLFGVJJQRHRAQL-UHFFFAOYSA-N 0.000 description 1
- SGULSKLAVAWUDW-UHFFFAOYSA-N 8-chloro-7-(2-methylpropylamino)-4-[3-(1,2,4-triazol-1-yl)phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(NCC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1C=NC=N1 SGULSKLAVAWUDW-UHFFFAOYSA-N 0.000 description 1
- CVJIDKLNUBXNGG-UHFFFAOYSA-N 8-chloro-7-(2-methylpropylamino)-4-[3-(triazol-1-yl)phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(NCC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1C=CN=N1 CVJIDKLNUBXNGG-UHFFFAOYSA-N 0.000 description 1
- HKVBUGAKZFRAJA-UHFFFAOYSA-N 8-chloro-7-(dimethylamino)-4-[2-(3-methyl-1,2-oxazol-5-yl)pyridin-4-yl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C)=CC=2N=C1C(C=1)=CC=NC=1C1=CC(C)=NO1 HKVBUGAKZFRAJA-UHFFFAOYSA-N 0.000 description 1
- WQIBNPORXAFYDY-UHFFFAOYSA-N 8-chloro-7-(dimethylamino)-4-[3-(1,2,4-triazol-1-yl)phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1C=NC=N1 WQIBNPORXAFYDY-UHFFFAOYSA-N 0.000 description 1
- QCULZRCIUIOFTB-UHFFFAOYSA-N 8-chloro-7-(dimethylamino)-4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=CC(C)=NO1 QCULZRCIUIOFTB-UHFFFAOYSA-N 0.000 description 1
- AIPADPRVJVAPBZ-UHFFFAOYSA-N 8-chloro-7-(dimethylamino)-4-[3-(triazol-1-yl)phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1C=CN=N1 AIPADPRVJVAPBZ-UHFFFAOYSA-N 0.000 description 1
- PNZBHAPZESDRIM-UHFFFAOYSA-N 8-chloro-7-(dimethylamino)-4-[3-[2-(pyridin-4-ylamino)-1,3-thiazol-4-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C(N=1)=CSC=1NC1=CC=NC=C1 PNZBHAPZESDRIM-UHFFFAOYSA-N 0.000 description 1
- MQIXLHPJAGPVFF-UHFFFAOYSA-N 8-chloro-7-(dimethylamino)-4-[3-[3-(hydroxymethyl)-1,2-oxazol-5-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=CC(CO)=NO1 MQIXLHPJAGPVFF-UHFFFAOYSA-N 0.000 description 1
- DPUOIPGBHVCPNO-UHFFFAOYSA-N 8-chloro-7-(dimethylamino)-4-[3-[3-(methoxymethyl)-1,2-oxazol-5-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound O1N=C(COC)C=C1C1=CC=CC(C=2CC(=O)NC3=CC(Cl)=C(N(C)C)C=C3N=2)=C1 DPUOIPGBHVCPNO-UHFFFAOYSA-N 0.000 description 1
- KEBJPACGJHQCCT-UHFFFAOYSA-N 8-chloro-7-(dimethylamino)-4-[3-[4-(hydroxymethyl)-3-methyl-1,2-oxazol-5-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C=1ON=C(C)C=1CO KEBJPACGJHQCCT-UHFFFAOYSA-N 0.000 description 1
- FAVDNBQWGDZXHU-UHFFFAOYSA-N 8-chloro-7-(dimethylamino)-4-[3-[4-(hydroxymethyl)pyrazol-1-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1C=C(CO)C=N1 FAVDNBQWGDZXHU-UHFFFAOYSA-N 0.000 description 1
- CQZAWXZEVZGHAX-UHFFFAOYSA-N 8-chloro-7-(dimethylamino)-4-[3-[4-(morpholin-4-ylmethyl)-1,3-thiazol-2-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C(SC=1)=NC=1CN1CCOCC1 CQZAWXZEVZGHAX-UHFFFAOYSA-N 0.000 description 1
- HQNDWERZSRHMKZ-UHFFFAOYSA-N 8-chloro-7-(dimethylamino)-4-[3-[5-(hydroxymethyl)-1,2-oxazol-3-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C=1C=C(CO)ON=1 HQNDWERZSRHMKZ-UHFFFAOYSA-N 0.000 description 1
- OZYHZFRVGGLBCN-UHFFFAOYSA-N 8-chloro-7-(dimethylamino)-4-[3-[5-(pyrrolidin-1-ylmethyl)triazol-1-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CN1CCCC1 OZYHZFRVGGLBCN-UHFFFAOYSA-N 0.000 description 1
- ZKKVYNGICIBSAL-UHFFFAOYSA-N 8-chloro-7-(dimethylamino)-4-[3-[5-[(dimethylamino)methyl]triazol-1-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound CN(C)CC1=CN=NN1C1=CC=CC(C=2CC(=O)NC3=CC(Cl)=C(N(C)C)C=C3N=2)=C1 ZKKVYNGICIBSAL-UHFFFAOYSA-N 0.000 description 1
- LLQYGIZZGGPYTM-UHFFFAOYSA-N 8-chloro-7-[2-methoxyethyl(methyl)amino]-4-[2-(3-methyl-1,2-oxazol-5-yl)pyridin-4-yl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CCOC)=CC=2N=C1C(C=1)=CC=NC=1C1=CC(C)=NO1 LLQYGIZZGGPYTM-UHFFFAOYSA-N 0.000 description 1
- HPJRHDDRXCOEQI-UHFFFAOYSA-N 8-chloro-7-[2-methoxyethyl(methyl)amino]-4-[3-(triazol-1-yl)phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CCOC)=CC=2N=C1C(C=1)=CC=CC=1N1C=CN=N1 HPJRHDDRXCOEQI-UHFFFAOYSA-N 0.000 description 1
- VWCLHQHJQPBFNV-UHFFFAOYSA-N 8-chloro-7-[cyclopropyl(methyl)amino]-4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C=1C=2N=C(C=3C=C(C=CC=3)C=3ON=C(C)C=3)CC(=O)NC=2C=C(Cl)C=1N(C)C1CC1 VWCLHQHJQPBFNV-UHFFFAOYSA-N 0.000 description 1
- VGLCHUFGYYXNJO-UHFFFAOYSA-N 8-chloro-7-[ethyl(methyl)amino]-4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CC)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CO VGLCHUFGYYXNJO-UHFFFAOYSA-N 0.000 description 1
- MHHCLDMNPVUBAW-UHFFFAOYSA-N 8-chloro-7-[methyl(2-methylpropyl)amino]-4-[3-(1,2,4-triazol-1-yl)phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1C=NC=N1 MHHCLDMNPVUBAW-UHFFFAOYSA-N 0.000 description 1
- XGVLRWUNONNGAT-UHFFFAOYSA-N 8-chloro-7-[methyl(2-methylpropyl)amino]-4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=CC(C)=NO1 XGVLRWUNONNGAT-UHFFFAOYSA-N 0.000 description 1
- DEPSEOHYKUJAEW-UHFFFAOYSA-N 8-chloro-7-[methyl(2-methylpropyl)amino]-4-[3-[5-(pyrrolidin-1-ylmethyl)-1,2,4-triazol-1-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=CN=C1CN1CCCC1 DEPSEOHYKUJAEW-UHFFFAOYSA-N 0.000 description 1
- FAPPMMYIBQTHPI-UHFFFAOYSA-N 8-chloro-7-[methyl(propan-2-yl)amino]-4-[3-[5-[(2-methylpropylamino)methyl]triazol-1-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound CC(C)CNCC1=CN=NN1C1=CC=CC(C=2CC(=O)NC3=CC(Cl)=C(N(C)C(C)C)C=C3N=2)=C1 FAPPMMYIBQTHPI-UHFFFAOYSA-N 0.000 description 1
- STUPZNSOKMMPGN-UHFFFAOYSA-N 8-chloro-7-[methyl(propan-2-yl)amino]-4-[3-[5-[(propan-2-ylamino)methyl]triazol-1-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound CC(C)NCC1=CN=NN1C1=CC=CC(C=2CC(=O)NC3=CC(Cl)=C(N(C)C(C)C)C=C3N=2)=C1 STUPZNSOKMMPGN-UHFFFAOYSA-N 0.000 description 1
- WLXUGFHWQBDCDU-UHFFFAOYSA-N 8-chloro-7-[methyl(propyl)amino]-4-[3-[5-(pyrrolidin-1-ylmethyl)-1,2,4-triazol-1-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CCC)=CC=2N=C1C(C=1)=CC=CC=1N1N=CN=C1CN1CCCC1 WLXUGFHWQBDCDU-UHFFFAOYSA-N 0.000 description 1
- DTUNAMNFMAKCJB-UHFFFAOYSA-N 8-fluoro-4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-7-pyrrolidin-1-yl-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound O1N=C(C)C=C1C1=CC=CC(C=2CC(=O)NC3=CC(F)=C(N4CCCC4)C=C3N=2)=C1 DTUNAMNFMAKCJB-UHFFFAOYSA-N 0.000 description 1
- VBHZONMHXNOQNT-UHFFFAOYSA-N 8-fluoro-4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-7-pyrrolidin-1-yl-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound OCC1=CN=NN1C1=CC=CC(C=2CC(=O)NC3=CC(F)=C(N4CCCC4)C=C3N=2)=C1 VBHZONMHXNOQNT-UHFFFAOYSA-N 0.000 description 1
- CTBWYVQBVFWWTN-UHFFFAOYSA-N 8-methyl-4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-7-[methyl(propyl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C)C(N(C)CCC)=CC=2N=C1C(C=1)=CC=CC=1C1=CC(C)=NO1 CTBWYVQBVFWWTN-UHFFFAOYSA-N 0.000 description 1
- JGBUUMCATKRZKE-UHFFFAOYSA-N 8-methyl-4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-7-pyrrolidin-1-yl-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound O1N=C(C)C=C1C1=CC=CC(C=2CC(=O)NC3=CC(C)=C(N4CCCC4)C=C3N=2)=C1 JGBUUMCATKRZKE-UHFFFAOYSA-N 0.000 description 1
- KNAQVUZYXPNAFY-UHFFFAOYSA-N 8-methyl-7-[methyl(2-methylpropyl)amino]-4-[3-[5-(pyrrolidin-1-ylmethyl)-1,2,4-triazol-1-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=CN=C1CN1CCCC1 KNAQVUZYXPNAFY-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 125000006847 BOC protecting group Chemical group 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 244000166102 Eucalyptus leucoxylon Species 0.000 description 1
- 235000004694 Eucalyptus leucoxylon Nutrition 0.000 description 1
- GISRWBROCYNDME-PELMWDNLSA-N F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C Chemical compound F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C GISRWBROCYNDME-PELMWDNLSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 108010065028 Metabotropic Glutamate 5 Receptor Proteins 0.000 description 1
- 102100036834 Metabotropic glutamate receptor 1 Human genes 0.000 description 1
- 102100038352 Metabotropic glutamate receptor 3 Human genes 0.000 description 1
- 102100038354 Metabotropic glutamate receptor 4 Human genes 0.000 description 1
- 102100038357 Metabotropic glutamate receptor 5 Human genes 0.000 description 1
- 102100038300 Metabotropic glutamate receptor 6 Human genes 0.000 description 1
- 102100038294 Metabotropic glutamate receptor 7 Human genes 0.000 description 1
- 102100037636 Metabotropic glutamate receptor 8 Human genes 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 1
- GMEHFXXZSWDEDB-UHFFFAOYSA-N N-ethylthiourea Chemical compound CCNC(N)=S GMEHFXXZSWDEDB-UHFFFAOYSA-N 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 101100030361 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pph-3 gene Proteins 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- IDRGFNPZDVBSSE-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F IDRGFNPZDVBSSE-UHFFFAOYSA-N 0.000 description 1
- 229910019213 POCl3 Inorganic materials 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- BDYVWDMHYNGVGE-UHFFFAOYSA-N [2-(aminomethyl)cyclohexyl]methanamine Chemical compound NCC1CCCCC1CN BDYVWDMHYNGVGE-UHFFFAOYSA-N 0.000 description 1
- NCVAPUHBJWNGCZ-UHFFFAOYSA-N [4-chloro-5-(diethylamino)-2-nitrophenyl]carbamic acid Chemical compound CCN(CC)C1=CC(NC(O)=O)=C([N+]([O-])=O)C=C1Cl NCVAPUHBJWNGCZ-UHFFFAOYSA-N 0.000 description 1
- LDEKDGNPINTCMC-UHFFFAOYSA-N [4-cyano-5-(dimethylamino)-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]phenyl]carbamic acid Chemical compound C1=C(C#N)C(N(C)C)=CC(NC(O)=O)=C1NC(=O)CC(=O)C1=CC=CC(N2C(=CN=N2)COC2OCCCC2)=C1 LDEKDGNPINTCMC-UHFFFAOYSA-N 0.000 description 1
- BICWJZLKUDDQCS-UHFFFAOYSA-N [5-(3-bromophenyl)-1-methylpyrazol-3-yl]methanol Chemical compound CN1N=C(CO)C=C1C1=CC=CC(Br)=C1 BICWJZLKUDDQCS-UHFFFAOYSA-N 0.000 description 1
- GZJOJIIWQFNEAY-UHFFFAOYSA-N [5-(3-bromophenyl)-1-methylpyrazol-4-yl]methanol Chemical compound CN1N=CC(CO)=C1C1=CC=CC(Br)=C1 GZJOJIIWQFNEAY-UHFFFAOYSA-N 0.000 description 1
- WMOHZRASAUMJIO-UHFFFAOYSA-N [5-(3-bromophenyl)-3-methyl-1,2-oxazol-4-yl]methanol Chemical compound CC1=NOC(C=2C=C(Br)C=CC=2)=C1CO WMOHZRASAUMJIO-UHFFFAOYSA-N 0.000 description 1
- POHFZUJHTAZVKK-UHFFFAOYSA-N [5-(dimethylamino)-4-(2-fluorophenyl)-2-[[3-oxo-3-[3-(triazol-1-yl)phenyl]propanoyl]amino]phenyl]carbamic acid Chemical compound C1=C(C=2C(=CC=CC=2)F)C(N(C)C)=CC(NC(O)=O)=C1NC(=O)CC(=O)C(C=1)=CC=CC=1N1C=CN=N1 POHFZUJHTAZVKK-UHFFFAOYSA-N 0.000 description 1
- CXSMKNYHOKLNPC-UHFFFAOYSA-N [5-(hydroxymethyl)-2-nitro-4-(2-phenylethynyl)phenyl]carbamic acid Chemical compound OCC1=CC(NC(O)=O)=C([N+]([O-])=O)C=C1C#CC1=CC=CC=C1 CXSMKNYHOKLNPC-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- UFADUBOVLLHKJZ-UHFFFAOYSA-N benzyl 1-(3-methoxycarbonylphenyl)pyrazole-4-carboxylate Chemical compound COC(=O)C1=CC=CC(N2N=CC(=C2)C(=O)OCC=2C=CC=CC=2)=C1 UFADUBOVLLHKJZ-UHFFFAOYSA-N 0.000 description 1
- YKDQCFXTQZGXPJ-UHFFFAOYSA-N benzyl 2-cyano-3-ethoxyprop-2-enoate Chemical compound CCOC=C(C#N)C(=O)OCC1=CC=CC=C1 YKDQCFXTQZGXPJ-UHFFFAOYSA-N 0.000 description 1
- BOSGOOPKQKGEMD-UHFFFAOYSA-N benzyl 5-amino-1-(3-methoxycarbonylphenyl)pyrazole-4-carboxylate Chemical compound COC(=O)C1=CC=CC(N2C(=C(C(=O)OCC=3C=CC=CC=3)C=N2)N)=C1 BOSGOOPKQKGEMD-UHFFFAOYSA-N 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- RLECCBFNWDXKPK-UHFFFAOYSA-N bis(trimethylsilyl)sulfide Chemical compound C[Si](C)(C)S[Si](C)(C)C RLECCBFNWDXKPK-UHFFFAOYSA-N 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- NISGSNTVMOOSJQ-UHFFFAOYSA-N cyclopentanamine Chemical compound NC1CCCC1 NISGSNTVMOOSJQ-UHFFFAOYSA-N 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- MATPZHBYOVDBLI-JJYYJPOSSA-N dcg-iv Chemical compound OC(=O)[C@@H](N)C1[C@@H](C(O)=O)[C@@H]1C(O)=O MATPZHBYOVDBLI-JJYYJPOSSA-N 0.000 description 1
- 230000006196 deacetylation Effects 0.000 description 1
- 238000003381 deacetylation reaction Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- OKGXJRGLYVRVNE-UHFFFAOYSA-N diaminomethylidenethiourea Chemical compound NC(N)=NC(N)=S OKGXJRGLYVRVNE-UHFFFAOYSA-N 0.000 description 1
- VNGOYPQMJFJDLV-UHFFFAOYSA-N dimethyl benzene-1,3-dicarboxylate Chemical compound COC(=O)C1=CC=CC(C(=O)OC)=C1 VNGOYPQMJFJDLV-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- GTCBVGDJIQFBFF-AATRIKPKSA-N ethyl (e)-4-(dimethylamino)-2-oxobut-3-enoate Chemical compound CCOC(=O)C(=O)\C=C\N(C)C GTCBVGDJIQFBFF-AATRIKPKSA-N 0.000 description 1
- BNYXCUYTAHGECY-UHFFFAOYSA-N ethyl 2-(3-bromophenyl)-3-oxopropanoate Chemical compound CCOC(=O)C(C=O)C1=CC=CC(Br)=C1 BNYXCUYTAHGECY-UHFFFAOYSA-N 0.000 description 1
- HFKBJCIXEIHVKK-UHFFFAOYSA-N ethyl 3-(3-bromophenyl)-3-pyrrolidin-1-ylprop-2-enoate Chemical compound C=1C=CC(Br)=CC=1C(=CC(=O)OCC)N1CCCC1 HFKBJCIXEIHVKK-UHFFFAOYSA-N 0.000 description 1
- BKFPVHXPYUFQHT-UHFFFAOYSA-N ethyl 3-(3-cyanophenyl)-3-oxopropanoate Chemical compound CCOC(=O)CC(=O)C1=CC=CC(C#N)=C1 BKFPVHXPYUFQHT-UHFFFAOYSA-N 0.000 description 1
- RDYVOLQRIFEJAZ-UHFFFAOYSA-N ethyl 3-(3-methyl-1,2-oxazol-5-yl)benzoate Chemical compound CCOC(=O)C1=CC=CC(C=2ON=C(C)C=2)=C1 RDYVOLQRIFEJAZ-UHFFFAOYSA-N 0.000 description 1
- PGNHYEASYXBVHG-UHFFFAOYSA-N ethyl 3-oxo-3-[3-(1,2,4-triazol-4-yl)phenyl]propanoate Chemical compound CCOC(=O)CC(=O)C1=CC=CC(N2C=NN=C2)=C1 PGNHYEASYXBVHG-UHFFFAOYSA-N 0.000 description 1
- GTCBVGDJIQFBFF-UHFFFAOYSA-N ethyl 4-(dimethylamino)-2-oxobut-3-enoate Chemical compound CCOC(=O)C(=O)C=CN(C)C GTCBVGDJIQFBFF-UHFFFAOYSA-N 0.000 description 1
- WJQBCAKQPSSFLF-UHFFFAOYSA-N ethyl 5-(3-bromophenyl)-1-methylpyrazole-3-carboxylate Chemical compound CN1N=C(C(=O)OCC)C=C1C1=CC=CC(Br)=C1 WJQBCAKQPSSFLF-UHFFFAOYSA-N 0.000 description 1
- PKRZEHHASBGPPG-UHFFFAOYSA-N ethyl 5-(3-bromophenyl)-3-methyl-1,2-oxazole-4-carboxylate Chemical compound CC1=NOC(C=2C=C(Br)C=CC=2)=C1C(=O)OCC PKRZEHHASBGPPG-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- PQVSTLUFSYVLTO-UHFFFAOYSA-N ethyl n-ethoxycarbonylcarbamate Chemical compound CCOC(=O)NC(=O)OCC PQVSTLUFSYVLTO-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- MGJURKDLIJVDEO-UHFFFAOYSA-N formaldehyde;hydrate Chemical compound O.O=C MGJURKDLIJVDEO-UHFFFAOYSA-N 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229960004903 invert sugar Drugs 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- OWFXIOWLTKNBAP-UHFFFAOYSA-N isoamyl nitrite Chemical compound CC(C)CCON=O OWFXIOWLTKNBAP-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- CFHGBZLNZZVTAY-UHFFFAOYSA-N lawesson's reagent Chemical compound C1=CC(OC)=CC=C1P1(=S)SP(=S)(C=2C=CC(OC)=CC=2)S1 CFHGBZLNZZVTAY-UHFFFAOYSA-N 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium hydroxide monohydrate Substances [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 1
- 229940040692 lithium hydroxide monohydrate Drugs 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 150000002690 malonic acid derivatives Chemical class 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 108010038421 metabotropic glutamate receptor 2 Proteins 0.000 description 1
- 108010038445 metabotropic glutamate receptor 3 Proteins 0.000 description 1
- 108010038422 metabotropic glutamate receptor 4 Proteins 0.000 description 1
- 108010038450 metabotropic glutamate receptor 6 Proteins 0.000 description 1
- 108010038449 metabotropic glutamate receptor 7 Proteins 0.000 description 1
- 108010038448 metabotropic glutamate receptor 8 Proteins 0.000 description 1
- 108010014719 metabotropic glutamate receptor type 1 Proteins 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- VYXBNKUFCQQDDQ-UHFFFAOYSA-N methyl 2-(3-bromobenzoyl)-3-(propan-2-ylamino)prop-2-enoate Chemical compound CC(C)NC=C(C(=O)OC)C(=O)C1=CC=CC(Br)=C1 VYXBNKUFCQQDDQ-UHFFFAOYSA-N 0.000 description 1
- OIQHKKSYHZIDLX-UHFFFAOYSA-N methyl 2-(3-methyl-1,2-oxazol-5-yl)pyridine-4-carboxylate Chemical compound COC(=O)C1=CC=NC(C=2ON=C(C)C=2)=C1 OIQHKKSYHZIDLX-UHFFFAOYSA-N 0.000 description 1
- XXOKMYMXDALOEN-UHFFFAOYSA-N methyl 2-iodopyridine-4-carboxylate Chemical compound COC(=O)C1=CC=NC(I)=C1 XXOKMYMXDALOEN-UHFFFAOYSA-N 0.000 description 1
- LEIJXXQQGMEHKW-UHFFFAOYSA-N methyl 3-(2-methylpyrazol-3-yl)benzoate Chemical compound COC(=O)C1=CC=CC(C=2N(N=CC=2)C)=C1 LEIJXXQQGMEHKW-UHFFFAOYSA-N 0.000 description 1
- PSSQBUQWZUHXSD-UHFFFAOYSA-N methyl 3-(propan-2-ylamino)prop-2-enoate Chemical compound COC(=O)C=CNC(C)C PSSQBUQWZUHXSD-UHFFFAOYSA-N 0.000 description 1
- AYLPJSUBPOVONU-UHFFFAOYSA-N methyl 3-[2-[2-(oxan-2-yloxy)ethyl]pyrazol-3-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C=2N(N=CC=2)CCOC2OCCCC2)=C1 AYLPJSUBPOVONU-UHFFFAOYSA-N 0.000 description 1
- FSNMMQOYIMVURW-UHFFFAOYSA-N methyl 3-[2-methyl-4-(oxan-2-yloxymethyl)pyrazol-3-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C=2N(N=CC=2COC2OCCCC2)C)=C1 FSNMMQOYIMVURW-UHFFFAOYSA-N 0.000 description 1
- KUGUVCXSMYNPIW-UHFFFAOYSA-N methyl 3-[2-methyl-5-(oxan-2-yloxymethyl)pyrazol-3-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C=2N(N=C(COC3OCCCC3)C=2)C)=C1 KUGUVCXSMYNPIW-UHFFFAOYSA-N 0.000 description 1
- FXIPLAQQNNBNPC-UHFFFAOYSA-N methyl 3-[3-(methoxymethyl)-1,2-oxazol-5-yl]benzoate Chemical compound O1N=C(COC)C=C1C1=CC=CC(C(=O)OC)=C1 FXIPLAQQNNBNPC-UHFFFAOYSA-N 0.000 description 1
- OUEQQZHRRCUGRX-UHFFFAOYSA-N methyl 3-[3-(oxan-2-yloxymethyl)-1,2-oxazol-5-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C=2ON=C(COC3OCCCC3)C=2)=C1 OUEQQZHRRCUGRX-UHFFFAOYSA-N 0.000 description 1
- MNGVEOFABSEVKT-UHFFFAOYSA-N methyl 3-[3-methyl-4-(oxan-2-yloxymethyl)-1,2-oxazol-5-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C2=C(C(C)=NO2)COC2OCCCC2)=C1 MNGVEOFABSEVKT-UHFFFAOYSA-N 0.000 description 1
- RJMQKNVGFXRGTN-UHFFFAOYSA-N methyl 3-[4-(chloromethyl)-1,3-oxazol-2-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C=2OC=C(CCl)N=2)=C1 RJMQKNVGFXRGTN-UHFFFAOYSA-N 0.000 description 1
- ADPGNRIPFOFTRX-UHFFFAOYSA-N methyl 3-[4-(hydroxymethyl)-1,2-oxazol-3-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C=2C(=CON=2)CO)=C1 ADPGNRIPFOFTRX-UHFFFAOYSA-N 0.000 description 1
- QGRNIDIZWMQJOP-UHFFFAOYSA-N methyl 3-[4-(hydroxymethyl)-1,3-oxazol-2-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C=2OC=C(CO)N=2)=C1 QGRNIDIZWMQJOP-UHFFFAOYSA-N 0.000 description 1
- LWDMCPHCJUZZGW-UHFFFAOYSA-N methyl 3-[4-(hydroxymethyl)-2-methylpyrazol-3-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C=2N(N=CC=2CO)C)=C1 LWDMCPHCJUZZGW-UHFFFAOYSA-N 0.000 description 1
- LCXIEMPOGIQGOT-UHFFFAOYSA-N methyl 3-[4-(hydroxymethyl)-3-methyl-1,2-oxazol-5-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C2=C(C(C)=NO2)CO)=C1 LCXIEMPOGIQGOT-UHFFFAOYSA-N 0.000 description 1
- DTEDTUIKLPLDAD-UHFFFAOYSA-N methyl 3-[4-(hydroxymethyl)pyrazol-1-yl]benzoate Chemical compound COC(=O)C1=CC=CC(N2N=CC(CO)=C2)=C1 DTEDTUIKLPLDAD-UHFFFAOYSA-N 0.000 description 1
- GGHQUXYWSROBLW-UHFFFAOYSA-N methyl 3-[4-(methoxymethyl)-2-methylpyrazol-3-yl]benzoate Chemical compound C1=NN(C)C(C=2C=C(C=CC=2)C(=O)OC)=C1COC GGHQUXYWSROBLW-UHFFFAOYSA-N 0.000 description 1
- LNKVHYDELJTSTA-UHFFFAOYSA-N methyl 3-[4-(oxan-2-yloxymethyl)-1,2-oxazol-3-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C=2C(=CON=2)COC2OCCCC2)=C1 LNKVHYDELJTSTA-UHFFFAOYSA-N 0.000 description 1
- QROVVEMWFSEHAU-UHFFFAOYSA-N methyl 3-[4-(oxan-2-yloxymethyl)pyrazol-1-yl]benzoate Chemical compound COC(=O)C1=CC=CC(N2N=CC(COC3OCCCC3)=C2)=C1 QROVVEMWFSEHAU-UHFFFAOYSA-N 0.000 description 1
- HQJZIGGTSGNDTL-UHFFFAOYSA-N methyl 3-[5-(2-hydroxyethyl)triazol-1-yl]benzoate Chemical compound COC(=O)C1=CC=CC(N2C(=CN=N2)CCO)=C1 HQJZIGGTSGNDTL-UHFFFAOYSA-N 0.000 description 1
- KYJZYWYCNUDCAL-UHFFFAOYSA-N methyl 3-[5-(hydroxymethyl)-2-methylpyrazol-3-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C=2N(N=C(CO)C=2)C)=C1 KYJZYWYCNUDCAL-UHFFFAOYSA-N 0.000 description 1
- DQCJSZVIXSKROW-UHFFFAOYSA-N methyl 3-[5-(hydroxymethyl)pyrazol-1-yl]benzoate Chemical compound COC(=O)C1=CC=CC(N2C(=CC=N2)CO)=C1 DQCJSZVIXSKROW-UHFFFAOYSA-N 0.000 description 1
- BDTPDPQMEHZDSZ-UHFFFAOYSA-N methyl 3-[5-(oxan-2-yloxymethyl)-1,2,4-triazol-1-yl]benzoate Chemical compound COC(=O)C1=CC=CC(N2C(=NC=N2)COC2OCCCC2)=C1 BDTPDPQMEHZDSZ-UHFFFAOYSA-N 0.000 description 1
- YKRNIIORQBLEDF-UHFFFAOYSA-N methyl 3-[5-(oxan-2-yloxymethyl)-1,2-oxazol-3-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C2=NOC(COC3OCCCC3)=C2)=C1 YKRNIIORQBLEDF-UHFFFAOYSA-N 0.000 description 1
- SSUXEQLGCRQMKU-UHFFFAOYSA-N methyl 3-[5-(oxan-2-yloxymethyl)pyrazol-1-yl]benzoate Chemical compound COC(=O)C1=CC=CC(N2C(=CC=N2)COC2OCCCC2)=C1 SSUXEQLGCRQMKU-UHFFFAOYSA-N 0.000 description 1
- MLCIBDZPKBPFBY-UHFFFAOYSA-N methyl 3-[5-(oxan-2-yloxymethyl)triazol-1-yl]benzoate Chemical compound COC(=O)C1=CC=CC(N2C(=CN=N2)COC2OCCCC2)=C1 MLCIBDZPKBPFBY-UHFFFAOYSA-N 0.000 description 1
- DGMIWLZFGRRVIS-UHFFFAOYSA-N methyl 3-[5-[(dimethylamino)methyl]triazol-1-yl]benzoate Chemical compound COC(=O)C1=CC=CC(N2C(=CN=N2)CN(C)C)=C1 DGMIWLZFGRRVIS-UHFFFAOYSA-N 0.000 description 1
- IYFILPNCUBNJQP-UHFFFAOYSA-N methyl 3-[5-[2-(oxan-2-yloxy)ethyl]triazol-1-yl]benzoate Chemical compound COC(=O)C1=CC=CC(N2C(=CN=N2)CCOC2OCCCC2)=C1 IYFILPNCUBNJQP-UHFFFAOYSA-N 0.000 description 1
- KWQLFXZPEFEFIB-UHFFFAOYSA-N methyl 3-[[(2-methylpropan-2-yl)oxycarbonylamino]carbamoyl]benzoate Chemical compound COC(=O)C1=CC=CC(C(=O)NNC(=O)OC(C)(C)C)=C1 KWQLFXZPEFEFIB-UHFFFAOYSA-N 0.000 description 1
- CWINGXPWIXWOBS-UHFFFAOYSA-N methyl 3-imidazol-1-ylbenzoate Chemical compound COC(=O)C1=CC=CC(N2C=NC=C2)=C1 CWINGXPWIXWOBS-UHFFFAOYSA-N 0.000 description 1
- MHMSOJGMEYRQQN-UHFFFAOYSA-N methyl 5-(3-bromophenyl)-1-methylpyrazole-4-carboxylate Chemical compound C1=NN(C)C(C=2C=C(Br)C=CC=2)=C1C(=O)OC MHMSOJGMEYRQQN-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- MVCQUSKTBSVSRY-UHFFFAOYSA-N n-(2-methoxyethylidene)hydroxylamine Chemical compound COCC=NO MVCQUSKTBSVSRY-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- MCSAJNNLRCFZED-UHFFFAOYSA-N nitroethane Chemical compound CC[N+]([O-])=O MCSAJNNLRCFZED-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 1
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000003880 polar aprotic solvent Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000003586 protic polar solvent Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003217 pyrazoles Chemical class 0.000 description 1
- HLOFIQOOOSRNFY-UHFFFAOYSA-N pyridin-4-ylthiourea Chemical compound NC(=S)NC1=CC=NC=C1 HLOFIQOOOSRNFY-UHFFFAOYSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 210000002265 sensory receptor cell Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- IBAOZGUIXMWLRA-UHFFFAOYSA-N tert-butyl 3-[3-(2-methylsulfanylimidazol-1-yl)phenyl]-3-oxopropanoate Chemical compound CSC1=NC=CN1C1=CC=CC(C(=O)CC(=O)OC(C)(C)C)=C1 IBAOZGUIXMWLRA-UHFFFAOYSA-N 0.000 description 1
- YJGSSDSWQCZGOH-UHFFFAOYSA-N tert-butyl 3-[3-[2-(oxan-2-yloxymethyl)-5-propyl-1,3-thiazol-4-yl]phenyl]-3-oxopropanoate Chemical compound N=1C(C=2C=C(C=CC=2)C(=O)CC(=O)OC(C)(C)C)=C(CCC)SC=1COC1CCCCO1 YJGSSDSWQCZGOH-UHFFFAOYSA-N 0.000 description 1
- AXHICXOCVDBIIU-UHFFFAOYSA-N tert-butyl 3-[3-[5-methyl-2-(oxan-2-yloxymethyl)-1,3-thiazol-4-yl]phenyl]-3-oxopropanoate Chemical compound N=1C(C=2C=C(C=CC=2)C(=O)CC(=O)OC(C)(C)C)=C(C)SC=1COC1CCCCO1 AXHICXOCVDBIIU-UHFFFAOYSA-N 0.000 description 1
- DRGMVJSFMPQXOP-UHFFFAOYSA-N tert-butyl 3-[5-(hydroxymethyl)pyrazol-1-yl]benzoate Chemical compound CC(C)(C)OC(=O)C1=CC=CC(N2C(=CC=N2)CO)=C1 DRGMVJSFMPQXOP-UHFFFAOYSA-N 0.000 description 1
- WMOVHXAZOJBABW-UHFFFAOYSA-N tert-butyl acetate Chemical compound CC(=O)OC(C)(C)C WMOVHXAZOJBABW-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- XOCFGBHXKGLLNA-UHFFFAOYSA-N tert-butyl n-[2-[[3-(3-cyanophenyl)-3-oxopropanoyl]amino]-5-methyl-4-[methyl(propyl)amino]phenyl]carbamate Chemical compound C1=C(C)C(N(C)CCC)=CC(NC(=O)CC(=O)C=2C=C(C=CC=2)C#N)=C1NC(=O)OC(C)(C)C XOCFGBHXKGLLNA-UHFFFAOYSA-N 0.000 description 1
- YMPLUGHBUAMPKM-UHFFFAOYSA-N tert-butyl n-[2-amino-5-(dimethylamino)-4-(2-phenylethynyl)phenyl]carbamate Chemical compound CN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C#CC1=CC=CC=C1 YMPLUGHBUAMPKM-UHFFFAOYSA-N 0.000 description 1
- FQFILJKFZCVHNH-UHFFFAOYSA-N tert-butyl n-[3-[(5-bromo-2-chloropyrimidin-4-yl)amino]propyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCCNC1=NC(Cl)=NC=C1Br FQFILJKFZCVHNH-UHFFFAOYSA-N 0.000 description 1
- PUEZFVQDVZKFKJ-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-(dimethylamino)-2-[[3-oxo-3-[3-(1,2,4-triazol-1-yl)phenyl]propanoyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2N=CN=C2)=C1 PUEZFVQDVZKFKJ-UHFFFAOYSA-N 0.000 description 1
- HWMZPHNADLQYPF-UHFFFAOYSA-N tert-butyl n-[4-cyano-5-(dimethylamino)-2-[[3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoyl]amino]phenyl]carbamate Chemical compound C1=C(C#N)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2C(=CN=N2)COC2OCCCC2)=C1 HWMZPHNADLQYPF-UHFFFAOYSA-N 0.000 description 1
- NRJGOMGAWXWVIE-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-2-[[3-[3-(2-methylpyrazol-3-yl)phenyl]-3-oxopropanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C=2N(N=CC=2)C)=C1 NRJGOMGAWXWVIE-UHFFFAOYSA-N 0.000 description 1
- VIPMNJYBYAUTAH-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-2-[[3-[3-[5-(oxan-2-yloxymethyl)-1,2-oxazol-3-yl]phenyl]-3-oxopropanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C2=NOC(COC3OCCCC3)=C2)=C1 VIPMNJYBYAUTAH-UHFFFAOYSA-N 0.000 description 1
- NZMHIVZLEGVWOV-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-4-(2-fluorophenyl)-2-[[3-oxo-3-[3-(triazol-1-yl)phenyl]propanoyl]amino]phenyl]carbamate Chemical compound C1=C(C=2C(=CC=CC=2)F)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C(C=1)=CC=CC=1N1C=CN=N1 NZMHIVZLEGVWOV-UHFFFAOYSA-N 0.000 description 1
- CRAJFVNFDNRPAS-UHFFFAOYSA-N tert-butyl-dimethyl-[3-(oxan-2-yloxy)prop-1-ynyl]silane Chemical compound CC(C)(C)[Si](C)(C)C#CCOC1CCCCO1 CRAJFVNFDNRPAS-UHFFFAOYSA-N 0.000 description 1
- 150000003536 tetrazoles Chemical class 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- VLLMWSRANPNYQX-UHFFFAOYSA-N thiadiazole Chemical compound C1=CSN=N1.C1=CSN=N1 VLLMWSRANPNYQX-UHFFFAOYSA-N 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- YUKQRDCYNOVPGJ-UHFFFAOYSA-N thioacetamide Chemical compound CC(N)=S YUKQRDCYNOVPGJ-UHFFFAOYSA-N 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- FTVLMFQEYACZNP-UHFFFAOYSA-N trimethylsilyl trifluoromethanesulfonate Chemical compound C[Si](C)(C)OS(=O)(=O)C(F)(F)F FTVLMFQEYACZNP-UHFFFAOYSA-N 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Definitions
- the present invention relates to compounds of general formula I wherein
- the transmission of stimuli takes place by the interaction of a neurotransmitter, which is sent out by a neuron, with a neuroreceptor.
- L-glutamic acid the most commonly occurring neurotransmitter in the CNS, plays a critical role in a large number of physiological processes.
- the glutamate-dependent stimulus receptors are divided into two main groups.
- the first main group forms ligand-controlled ion channels.
- the metabotropic glutamate receptors (mGluR) form the second main group and, furthermore, belong to the family of G-protein-coupled receptors.
- these eight receptors can be sub-divided into three sub-groups: mGluR1 and mGluR5 belong to group I, mGluR2 and mGluR3 belong to group II and mGluR4, mGluR6, mGluR7 and mGluR8 belong to group III.
- Ligands of metabotropic glutamate receptors belonging to the group II can be used for the treatment or prevention of acute and/or chronic neurological disorders such as psychosis, schizophrenia, Alzheimer's disease, cognitive disorders and memory deficits.
- treatable indications in this connection are restricted brain function caused by bypass operations or transplants, poor blood supply to the brain, spinal cord injuries, head injuries, hypoxia caused by pregnancy, cardiac arrest and hypoglycaemia.
- Further treatable indications are chronic and acute pain, Huntington's chorea, amyotrophic lateral sclerosis (ALS), dementia caused by AIDS, eye injuries, retinopathy, idiopathic parkinsonism or parkinsonism caused by medicaments as well as conditions which lead to glutamate-deficiency functions, such as e.g. muscle spasms, convulsions, migraine, urinary incontinence, nicotine addiction, opiate addiction, anxiety, vomiting, dyskinesia and depressions.
- ALS amyotrophic lateral sclerosis
- Objects of the present invention are compounds of formula I and their pharmaceutically acceptable salts per se and as pharmaceutically active substances, their manufacture, medicaments based on a compound in accordance with the invention and their production, as well as the use of the compounds in accordance with the invention in the control or prevention of illnesses of the aforementioned kind, and, respectively, for the production of corresponding medicaments.
- the compounds of formula I can also be used in form of their prodrugs.
- examples are esters, N-oxides, phosphate esters, glycoamide esters, glyceride conjugates and the like.
- the prodrugs may add to the value of the present compounds advantages in absorption, pharmacokinetics in distribution and transport to the brain.
- R 3 is an optionally substituted five-membered aromatic heterocycle, which may be substituted by halogen, fluoro-lower alkyl, fluoro-lower alkoxy,
- R 3 is an optionally substituted five-membered aromatic heterocycle selected from the group consisting of thiazolyl, oxazolyl, isoxazolyl, imidazolyl, 2H-pyrazolyl, [1,2,3]triazolyl, [1,2,4]triazolyl, [1,3,4]thiadiazolyl and [1,3,4]oxadiazolyl.
- R 3 is an optionally substituted five-membered aromatic heterocycle selected from the group consisting of thiazolyl, oxazolyl, isoxazolyl, imidazolyl, 2H-pyrazolyl, [1,2,3]triazolyl, [1,2,4]triazolyl, [1,3,4]thiadiazolyl and [1,3,4]oxadiazolyl. Examples of such compounds are the following:
- R 2 is -N(CH 3 ) 2 or pyrrolidine. Also preferred are compounds, wherein R 2 is isopropyl-amino, isopropyl-methyl-amino, isobutyl-amino or isobutyl-methyl-amino.
- Preferred compounds of formula I in the scope of the present invention are further those, wherein R 3 is cyano or an optionally substituted five-membered aromatic heterocycle, which may be substituted by -CH 2 OH or -CH 2 N(CH 3 ) 2 .
- lower alkyl used in the present description denotes straight-chain or branched saturated hydrocarbon residues with 1-7 carbon atoms, preferably with 1-4 carbon atoms, such as methyl, ethyl, n-propyl, i-propyl and the like.
- lower alkoxy denotes a lower alkyl residue in the sense of the foregoing definition bound via an oxygen atom.
- lower alkoxy residues indude methoxy, ethoxy, isopropoxy and the like.
- halogen embraces fluorine, chlorine, bromine and iodine.
- fluoro-lower alkyl means a lower alkyl residue, wherein one or more hydrogen-atoms may be replaced by fluoro.
- fluoro-lower alkoxy denotes a lower alkoxy residue in the sense of the definition herein before, wherein one or more hydrogen-atoms may be replaced by fluoro.
- C 3 -C 6 -cycloalkyl means a cycloalkyl group containing 3 to 6 carbon atoms, such as cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl.
- lower alkylthio denotes a lower alkyl residue in the sense of the foregoing definition bound via an sulfur atom, for example methylsulfanyl.
- five-membered aromatic heterocycle embraces furane, thiophene, thiazole, pyrrole, imidazole, pyrazole, oxazole, isoxazole, triazole, oxadiazole, thiadiazole and tetrazole.
- Preferred heterocycles are 1,2,3-triazole, 1,2,4-triazole, isoxazole, 1,3-oxazole, 1,3-thiazole, 1,3,4-oxadiazole or imidazole.
- Optionally substituted means that a group may or may not be substituted with one or more, preferably one or two substituents independently selected from the specified group.
- pharmaceutically acceptable addition salt refers to any salt derived from an inorganic or organic acid or base.
- the compounds of general formula I and their pharmaceutically acceptable salts can be manufactured according to methods, which process comprises
- compounds of general formula III can also be prepared by for example reaction of a compound of general formula II with a ⁇ -ketoester (general formula IVa), in which Y and R 3 are as described above using the same conditions as described for the reaction with the dioxinones.
- the deprotection-cyclization step can be carried out by treating the compounds of general formula III with for example a Bronsted acid such as trifluoroacetic acid in an inert solvent such as dichloromethane (DCM).
- a Bronsted acid such as trifluoroacetic acid
- an inert solvent such as dichloromethane (DCM).
- DCM dichloromethane
- the reaction is preferably carried out at temperatures between 0 °C and 50 °C. It may be advantageous to use also anisole or 1,3-dimethoxybenzene as a carbocation scavenger in the reaction mixture.
- compound B1 can be prepared from the commercially available 5-chloro-2-nitroaniline by iodination to give the synthetic intermediate A1, which in turn can be protected to yield the compound B1.
- the iodination step can be carried out by for example using iodine monochloride in acetic acid in the presence of sodium acetate.
- the reaction can be for example carried out at temperatures between 20 °C and 80 °C.
- the protection of the amino function can be applied to a number of commercially available starting materials or compounds synthesized by anyone skilled in the art to produce the corresponding 2-nitroanilines with the general formula VII, in which X is a single bond and R 1 is as described above.
- This transformation leads to the key intermediates of the general formula VIb, and the exact conditions for the respective compounds used in this invention can be found in the experimental part.
- One possibility for the protection of the amino function is for example reacting compounds of general formula VII with di-tert.-butyl-carbonate in the presence of a base such as cesium carbonate.
- the reaction can be carried out in polar solvents such as acetone or butanone and the like at temperatures between 20 °C and 60 °C.
- the protection of the amino group can be achieved by preparing the intermediate isocyanate by treatment of compounds of the general formula VII with diphosgene, preferably in aprotic solvents such as ethyl acetate or 1,4-dioxane at temperatures from 0 °C to 100 °C, and subsequent treatment of the isocyanate with tert. butanol in solvents such as dichloromethane or 1,2-dichloroethane and the like at temperatures between 20 °C and 85 °C to give the desired compounds of general formula VIb.
- diphosgene preferably in aprotic solvents such as ethyl acetate or 1,4-dioxane at temperatures from 0 °C to 100 °C
- solvents such as dichloromethane or 1,2-dichloroethane and the like at temperatures between 20 °C and 85 °C to give the desired compounds of general formula VIb.
- Another suitable method to achieve this protection step is the intermediate formation of a di-BOC compound by treatment of compounds of the general formula VII with di-tert.-butyl-carbonate in the presence of DMAP in an aprotic solvent such as tetrahydrofuran and the like, followed by selective removal of a single BOC-group by treatment with a Bronsted-acid, like e.g. TFA, in aprotic solvents such as dichloromethane, chloroform or 1,2-dichloroethane at temperatures between 0 °C and 20 °C to give the desired compounds of general formula VIb.
- aprotic solvent such as e.g. TFA
- the reaction is preferably carried out in acidic media, like for example acetic acid or propionic acid and the like, at temperatures between 40 °C to 100 °C.
- acidic media like for example acetic acid or propionic acid and the like.
- the exact conditions for the respective compounds can be found in the experimental part.
- the corresponding substituted 2,5-dimethoxytetrahydrofurans with the general formula VIII, in which R a , R b and R c are as described above in the general claim for the pyrrol-1-yl compounds, are either commercially available, or synthesized from the suitable substituted furan, as shown in scheme E.
- the corresponding substituents can optionally be protected with suitable protecting groups, known to someone skilled in the art, or alternatively can be introduced after the pyrrol ring synthesis.
- the two-step sequence consists of reacting the furan with bromine in MeOH at low temperature, like for example -35 °C, followed by treatment with base, like for example triethylamine and the like or potassium carbonate or sodium hydrogen carbonate and the like.
- the resulting 2,5-dimethoxydihydrofuran with the general formula VIII in which R a , R b and R c are as described above, can be reduced by catalytic hydrogenation, preferably in MeOH with catalysts like for example Palladium on carbon or Raney-Nickel and the like, to produce the desired 2,5-dimethoxytetrahydrofurans with the general formula VIII.
- catalytic hydrogenation preferably in MeOH with catalysts like for example Palladium on carbon or Raney-Nickel and the like.
- An example for this sequence can be found in Tetrahedron 1971 , 27,1973-1996.
- the exact conditions for the individual compounds to be synthesized can be found in the experimental part.
- compounds of general formula VIc in which R 2 is attached via a nitrogen-atom and is as described above, can be prepared from the intermediate compounds with the general formula VIb - which individual synthesis can be found in the experimental part - by a nucleophilic substitution reaction with the respective amines in the presence of a suitable base.
- the reaction is preferably carried out in a polar, aprotic solvent such as dimethyl formamide, N-methyl-pyrrolidone or dimethyl sulfoxide and the like.
- the base can be selected from the sterically hindered amines such as triethylamine or Hünig's base, alkoxides such as sodium methoxide and tert.-butoxide, or hydrides such as sodium hydride.
- the reaction can be performed at temperatures between 20 °C and 110 °C, depending on the individual compounds to be synthesized.
- the dioxinones and ⁇ -keto esters building blocks with the general formula IV and IVa can be prepared by methods known to someone skilled in the art from the corresponding carboxylic acid derivatives R 3 -COR, i.e. free acids, methyl or ethyl esters and acid chlorides. The exact conditions for the corresponding compounds can be found in the experimental part.
- the pharmaceutically acceptable salts can be manufactured readily according to methods known per se and taking into consideration the nature of the compound to be converted into a salt.
- Inorganic or organic acids such as, for example, hydrochloric acid, hydrobromic acid, sulphuric acid, nitric acid, phosphoric acid or citric acid, formic acid, fumaric acid, maleic acid, acetic acid, succinic acid, tartaric acid, methanesulphonic acid, p-toluenesulphonic acid and the like are suitable for the formation of pharmaceutically acceptable salts of basic compounds of formula I.
- the compounds of formula I and their pharmaceutically acceptable salts are metabotropic glutamate receptor antagonists and can be used for the treatment or prevention of acute and/or chronic neurological disorders, such as psychosis, schizophrenia, Alzheimer's disease, cognitive disorders and memory deficits.
- Other treatable indications are restricted brain function caused by bypass operations or transplants, poor blood supply to the brain, spinal cord injuries, head injuries, hypoxia caused by pregnancy, cardiac arrest and hypoglycaemia.
- Further treatable indications are acute and chronic pain, Huntington's chorea, ALS, dementia caused by AIDS, eye injuries, retinopathy, idiopathic parkinsonism or parkinsonism caused by medicaments as well as conditions which lead to glutamate-deficient functions, such as e.g. muscle spasms, convulsions, migraine, urinary incontinence, nicotine addiction, psychoses, opiate addiction, anxiety, vomiting, dyskinesia and depression.
- the compounds of formula I and pharmaceutically acceptable salts thereof can be used as medicaments, e.g. in the form of pharmaceutical preparations.
- the pharmaceutical preparations can be administered orally, e.g. in the form of tablets, coated tablets, dragées, hard and soft gelatine capsules, solutions, emulsions or suspensions.
- the administration can also be effected rectally, e.g. in the form of suppositories, or parenterally, e.g. in the form of injection solutions.
- the compounds of formula I and pharmaceutically acceptable salts thereof can be processed with pharmaceutically inert, inorganic or organic carriers for the production of pharmaceutical preparations.
- Lactose, corn starch or derivatives thereof, talc, stearic acid or its salts and the like can be used, for example, as such carriers for tablets, coated tablets, dragées and hard gelatine capsules.
- Suitable carriers for soft gelatine capsules are, for example, vegetable oils, waxes, fats, semi-solid and liquid polyols and the like; depending on the nature of the active substance no carriers are, however, usually required in the case of soft gelatine capsules.
- Suitable carriers for the production of solutions and syrups are, for example, water, polyols, sucrose, invert sugar, glucose and the like.
- Adjuvants such as alcohols, polyols, glycerol, vegetable oils and the like, can be used for aqueous injection solutions of water-soluble salts of compounds of formula I, but as a rule are not necessary.
- Suitable carriers for suppositories are, for example, natural or hardened oils, waxes, fats, semi-liquid or liquid polyols and the like.
- the pharmaceutical preparations can contain preservatives, solubilizers, stabilizers, wetting agents, emulsifiers, sweeteners, colorants, flavorants, salts for varying the osmotic pressure, buffers, masking agents or antioxidants. They can also contain still other therapeutically valuable substances.
- medicaments containing a compound of formula I or a pharmaceutically acceptable salt thereof and a therapeutically inert excipient are also an object of the present invention, as is a process for the production of such medicaments which comprises bringing one or more compounds of formula I or pharmaceutically acceptable salts thereof and, if desired, one or more other therapeutically valuable substances into a galenical dosage form together with one or more therapeutically inert carriers.
- the dosage can vary within wide limits and will, of course, be fitted to the individual requirements in each particular case.
- the effective dosage for oral or parenteral administration is between 0.01-20 mg/kg/day, with a dosage of 0.1-10 mg/ kg/day being preferred for all of the indications described.
- the present invention relates also to the use of compounds of formula I and of pharmaceutically acceptable salts thereof for the production of medicaments, especially for the control or prevention of acute and/or chronic neurological disorders of the aforementioned kind.
- the compounds of the present invention are group II mGlu receptor antagonists.
- the compounds show activities, as measured in the assay described below, of 10 ⁇ M or less, typically 1 ⁇ M or less, and ideally of 0.3 ⁇ M or less.
- cDNA encoding the rat mGlu2 receptor protein in pBluescript II was obtained from Prof. S. Nakanishi (Kyoto, Japan), and subcloned into the eukaryotic expression vector pcDNA I-amp from Invitrogen (NV Leek, The Netherlands).
- This vector construct (pcD1mGR2) was co-transfected with a psvNeo plasmid encoding the gene for neomycin resistance, into CHO cells by a modified calcium phosphate method described by Chen & Okayama (1988).
- the cells were maintained in Dulbecco's Modified Eagle medium with reduced L-glutamine (2 mM final concentration) and 10 % dialysed foetal calf serum from Gibco BRL (Basel, Switzerland). Selection was made in the presence of G-418 (1000 ug/ml final).
- Clones were identified by reverse transcription of 5 ⁇ g total RNA, followed by PCR using mGlu2 receptor specific primers 5'-atcactgcttgggtttctggcactg-3' and 5'-agcatcactgtgggtggcataggagc-3' in 60 mM Tris HCl (pH 10), 15 mM (NH4) 2 SO 4 , 2 mM MgCl 2 , 25 units/ml Taq Polymerase with 30 cycles annealing at 60 °C for 1 min., extention at 72 °C for 30 s, and 1 min. 95 °C denaturation.
- the membranes were resuspended in cold 50mM Tris-HCl buffer containing 2 mM MgCl 2 and 2 mM CaCl 2 , (pH 7) (binding buffer). The final concentration of the membranes in the assays was 25 ⁇ g protein/ml. Inhibition experiments were performed with membranes incubated with 10 nM [ 3 H]-LY354740 at room temperature, for 1 hour, in presence of various concentrations of the compound to be tested. Following the incubations, membranes were filtered onto Whatmann GF/C glass fiber filters and washed 5 times with cold binding buffer. Non specific binding was measured in the presence of 10 ⁇ M DCG IV.
- the inhibition curves were fitted with a four parameter logistic equation giving K i values, and Hill coefficients.
- the title compound was prepared via the di-Boc-compound from 5-fluoro-2-nitro-4-trifluoromethyl-phenylamine; prepared from commercially available 4-amino-2-fluorobenzotrifluoride by acetylation withAc 2 O in toluene at 23 °C, nitration with 100 % nitric acid from 10-23 °C and deacetylation with 2N NaOH in THF at 50 °C] (5.21 g, 23.2 mmol) and Boc 2 O (10.63 g, 48.7 mmol), followed by treatment with 2 eq. TFA in CH 2 Cl 2 according to the general procedure B (method c). Obtained as a light yellow solid (6.33 g, 84 %). MS (ISN) 323 [(M-H)-]; mp 104 °C.
- the title compound was prepared via the di-Boc-compound from 4-iodo-2-nitro-5-(2,2,2-trifluoro-ethoxy)-phenylamine [prepared by stirring 5-chloro-4-iodo-2-nitro-phenylamine (Example A1) (8.95 g, 30 mmol), 2,2,2-trifluoroethanol (30 mL) and KOH (4.36 g, 66 mmol) in DMSO (60 mL) at 23 °C for 35 days.] (10.41 g, 29 mmol) and Boc 2 O (12.87 g, 59 mmol), followed by treatment with 2 eq. TFA in CH 2 Cl 2 according to the general procedure B (method c). Obtained as a yellow solid (13.34 g, 100 %). MS (ISN) 461 [(M-H) - ].
- the title compound was prepared via the di-Boc-compound from commercially available 5-chloro-2-nitro-4-trifluoromethyl-phenylamine [CAS-No. 35375-74-7] (22.61 g, 94 mmol) and Boc 2 O (42.06 g, 193 mmol), followed by treatment with 2 eq. TFA in CH 2 Cl 2 according to the general procedure B (method c). Obtained as a yellow solid (31.82 g, 99 %). MS (ISN) 339.1 [(M-H) - ] and 341 ((M+2-H) - ]; mp 113-115 °C.
- the title compound was prepared via the di-Boc-compound from commercially available 3'-chloro-4'-fluoro-6'-nitroacetanilide [CAS-No. 81962-58-5] (59 g, 254 mmol), and Boc 2 O (58.13 g, 266 mmol), followed by treatment with NH 4 OH (25%, 77.5 mL, 507 mmol) according to the general procedure B (method d). Obtained as a yellow solid (73.53 g, 100 %). MS (ISN) 289 [(M-H) - ] and 291 [(M+2-H) - ]; mp 73-74 °C.
- the title compound was prepared via the di-Boc-compound from 4-iodo-2-nitro-5-(2,2,2-trifluoro-ethoxy)-phenylamine [prepared by stirring 5-chloro-4-iodo-2-nitro-phenylamine (Example A1), 2,2,2-trifluoroethanol and KOH in DMSO at 23 °C for 32.5 days.] and Boc 2 O, followed by treatment with 2 eq. TFA in CH 2 Cl 2 according to the general procedure B (method c). Obtained as a yellow solid (18.955 g). MS (ISN) 403 [(M-H) - ].
- the title compound was prepared via the di-Boc compound from commercially available 5-chloro-4-methyl-2-nitroaniline (10.0 g, 53.6 mmol) and Boc 2 O (23.9 g, 109 mmol), followed by treatment with 2 eq. TFA in CH 2 Cl 2 according to the general procedure B (method c). Obtained by column chromatography (toluene/ethylacetate 19:1) as a yellow solid (14.6 g, 95%). MS (ISN) 285.1 [(M-H) - ].
- the ethyl or tert.-butyl 3-aryl-3-oxo-propionates were prepared from the aryl acid chlorides and ethyl or tert.-butyl malonate potassium salt [CAS-no. 6148-64-7 and 75486-33-8] with Et 3 N and MgCl 2 in CH 3 CN at 0 °C to 23 °C according to Synthesis 1993 , 290. If the free aryl carboxylic acid was employed in this reaction, it was activated by treatment with ethyl chloroformate and Et 3 N in THF/CH 3 CN at 0 °C prior to reaction with the malonate salt.
- the tert.-butyl 3-aryl-3-oxo-propionates were alternatively prepared from the methyl or ethyl aryl esters by treatment with lithium tert.-butyl acetate [prepared by treatment of tert.-butyl acetate with lithium diisopropylamide in THF at -78 °C] in the presence of lithium tert.-butoxide according to Synthesis 1985 , 45. If the product contained residual starting material after workup, thus could be removed by selective saponification with LiOH in THF/MeOH/H 2 O at 23 °C.
- the 3-aryl-3-oxo-propionic acids were prepared from the aryl acid chlorides and bis(trimethylsilyl)malonate with Et 3 N and LiBr in CH 3 CN at 0 °C according to Synth. Commun . 1985 , 15 , 1039 (method c1) or with n-BuLi in ether at -60 °C to 0 °C according to Synthesis 1979, 787 (method c2).
- the title compound was prepared from 3-[1,2,3]triazol-1-yl-benzoic acid, prepared by refluxing of methyl 3-azidobenzoate [CAS-No. 93066-93-4] in trimethylsilylacetylene, followed by saponification with aqueous NaOH in refluxing EtOH] by activation with ethyl chloroformate/Et 3 N and reaction with ethyl malonate potassium salt with Et 3 N and MgCl 2 in CH 3 CN according to general procedure K (method a). Obtained as a light yellow solid (2.22 g). MS (EI) 259 (M + ); mp 72-74 °C.
- the title compound was prepared from ethyl 3-(3-methyl-isoxazol-5-yl)-benzoate [prepared by reaction of ethyl 3-ethynylbenzoate [CAS-No. 178742-95-5] with a mixture ofNCS, acetaldoxime, Et 3 N and cat. amount of pyridine in CHCl 3 at 50 °C according to Tetrahedron 1984 , 40 , 2985-2988] by treatment with lithium tert.-butyl acetate according to general procedure K (method b). Obtained as a yellow solid (2.54 g). MS (ISP) 302 [(M+H) + ]; mp 50-56 °C.
- the title compound was prepared from (RS)-3-[5-(tetrahydro-pyran-2-yloxymethyl)-[1,2,3]triazol-1-yl]-benzoic acid methyl ester [prepared by the following sequence: i.) methyl 3-azidobenzoate [CAS-No. 93066-93-4] (15.55 g, 88 mmol) and (RS)-tert.-butyl-dimethyl-[3-(tetrahydro-pyran-2-yloxy)-prop-1-ynyl]-silane [CAS-No.
- the title compound was prepared from 2-(3-methyl-isoxazol-5-yl)-isonicotinic acid methyl ester [prepared by i.) reaction of 2-iodo-isonicotinic acid methyl ester [CAS-No. 134579-47-8] with trimethylsilylacetylene according to general procedure H; ii.) desilylation by reaction with cat. K 2 CO 3 in MeOH at 0 °C for 4 h; iii.) cycloadditon with a mixture of NCS, acetaldoxime, Et 3 N and cat.
- the title compound was prepared from 3-(2-methyl-2H-pyrazol-3-yl)-benzoic acid methyl ester [prepared by i.) reaction of 1-(3-bromo-phenyl)-3-dimethylamino-propenone [CAS-No. 163852-04-8] with methylhydrazine in EtOH at 23 °C for 2.5 days; ii.) chromatographic separation of the obtained isomers; iii.) treatment of the clean isomer with n-BuLi in THF at -78 °C for 1 h, followed by quenching with a stream of CO 2 and subsequent esterification with MeOH and conc.
- the title compound was prepared from 3-(5-dimethylaminomethyl-[1,2,3]triazol-1-yl)-benzoic acid methyl ester [prepared from methyl 3-azidobenzoate following the synthetic steps i.) to iii.) as described in the preparation of Example K5 and reacting the obtained product with SOCl 2 in THF at 0 to 23 °C for 1 h, followed by addition of dimethylamine (7.9 M in H 2 O) and stirring at 23 to 70 °C for 1 h.] (2.14 g, 8.22 mmol) by treatment with lithium tert.-butyl acetate according to general procedure K (method b). Obtained as a yellow oil (2.90 g). MS (ISP) 345 [(M+H) + ].
- the title compound was prepared from methyl 3-(3-methoxymethyl-isoxazol-5-yl)-benzoate [prepared by reaction of ethyl 3-ethynylbenzoate [CAS-No. 178742-95-5] with a mixture of NCS, 2-methoxyacetaldoxime [CAS-No. 71494-93-4], Et 3 N and cat. amount of pyridine in CHCl 3 at 50 °C according to Tetrahedron 1984 , 40 , 2985-2988] by treatment with lithium tert.-butyl acetate according to general procedure K (method b). Obtained as a light yellow liquid (1.548 g). MS (EI) 331 (M + ).
- the title compound was prepared from (RS)-3-[4-(tetrahydro-pyran-2-yloxymethyl)-thiazol-2-yl]-benzoic acid methyl ester [prepared by the following sequence: i.) A mixture of 3-thiocarbamoyl-benzoic acid methyl ester [CAS-No. 106748-27-0] (7.8 g), 1,3-dichloro-2-propanone (8.4 g) and sodium bicarbonate (8.4 g) in 1,4-dioxane (180 mL) was heated to 60 °C for 24 h.
- the title compound was prepared from (RS)-3-[4-(tetrahydro-pyran-2-yloxymethyl)-oxazol-2-yl]-benzoic acid methyl ester [prepared by the following sequence: i.) A mixture of 3-carbamoyl-benzoic acid methyl ester [CAS-No. 106748-24-7] (17.9 g) and 1,3-dichloro-2-propanone (14.0 g) was heated to 140 °C for 1.5 h. The mixture was cooled to 20 °C and conc. sulfuric acid (12 mL) was carefully added. The mixture was stirred for 10 min. and then poured into ice-water.
- the cooled reaction mixture was poured into ice-water and the mixture was extracted with diethyl ether.
- the aqueous layer was acidified to pH 1 by the addition of 6N HCl and the precipitate formed was collected by filtration and crystallized from dichloromethane/hexane.
- the pale-yellow crystals (5.5 g) were dissolved in DMSO (25 mL), and after the addition of N,N,N',N'-tetramethyl-guanidine (4.4 mL) and methyl iodide (2.2 mL), the mixture was stirred at 20 °C for 1 h. Ethyl acetate was added and the mixture was washed successively with water, 1N HCl and brine.
- the title compound was prepared from (RS)-3-[3-methyl-4-(tetrahydro-pyran-2-yloxymethyl)-isoxazol-5-yl]-benzoic acid methyl ester [prepared by the following sequence: i.) (3-bromo-phenyl)-3-oxo-propionic acid ethyl ester [CAS-No. 21575-91-7], pyrrolidine and TMSOTf in benzene were refluxed for 16 h (Org. Synth.
- the title compound was prepared from (RS)-3-[5-(tetrahydro-pyran-2-yloxymethyl)-isoxazol-3-yl]-benzoic acid methyl ester [prepared from (Z)-3-(hydroxyiminomethyl)-benzoic acid methyl ester [CAS-No. 91186-80-0] by treatment with NCS, cat. amount pyridine in CHCl 3 followed by addition of (RS)-tetrahydro-2-(2-propynyloxy)-2H-pyran and slow addition of Et 3 N in CHCl 3 at 23 °C.] by treatment with lithium tert.-butyl acetate according to general procedure K (method b). Obtained as a yellow oil (3.00 g). MS (ISN) 400.5 [(M-H) - ].
- the title compound was prepared from (RS)-3-[4-(tetrahydro-pyran-2-yloxymethyl)-pyrazol-1-yl]-benzoic acid methyl ester [prepared by the following sequence: i.) A mixture of 3-hydrazino-benzoic acid methyl ester hydrochloride [CAS-No. 167626-26-8] (15.14 g, 75 mmol), 2-cyano-3-ethoxy-acrylic acid benzyl ester [CAS-No. 32016-27-6] (17.36 g, 75 mmol) and Et 3 N (10.5 mL, 75 mmol) in isopropanol (115 mL) was refluxed for 1.5 h.
- the title compound was prepared from (RS)-3-[4-(tetrahydro-pyran-2-yloxymethyl)-isoxazol-3-yl]-benzoic acid methyl ester [prepared by the following sequence: i.) (Z)-3-(hydroxyimino-methyl)-benzoic acid methyl ester [CAS-No. 91186-80-0] was treated with NCS, cat. amount pyridine in CHCl 3 followed by addition of (E)-3-pyrrolidin-1-yl-acrylic acid tert.-butyl ester [CAS-No. 340257-76-3] and slow addition of Et 3 N in CHCl 3 at 23 °C.
- the title compound was prepared from (RS)-3-[2-methyl-4-(tetrahydro-pyran-2-yloxymethyl)-2H-pyrazol-3-yl]-benzoic acid methyl ester [prepared by the following sequence: i.) 3-bromobenzoyl chloride and 3-isopropylamino-acrylic acid methyl ester [CAS-No. 89895-40-9] were reacted in toluene and Et 3 N according to Synthesis 1982, 318. ii.) The obtained 2-(3-bromo-benzoyl)-3-isopropylamino-acrylic acid methyl ester was reacted with methylhydrazine in ether at 23 °C according to Synthesis 1982, 318.
- the title compound was prepared from (RS)-3- ⁇ 2-[2-(tetrahydro-pyran-2-yloxy)-ethyl]-2H-pyrazol-3-yl ⁇ -benzoic acid methyl ester [prepared by i.) reaction of 1-(3-bromo-phenyl)-3-dimethylamino-propenone [CAS-No. 163852-04-8] with 2-hydroxy-ethylhydrazine in EtOH at 23 °C for 2.5 days. ii.) The obtained mixture of pyrazoles (12.36 g, 35.19 mmol) was reacted with 3,4-dihydro-2H-pyran (4.79 mL, 52.8 mmol) and cat.
- the title compound was prepared from (RS)-3- ⁇ 5-[2-(tetrahydro-pyran-2-yloxy)-ethyl]-[1,2,3]triazol-1-yl ⁇ -benzoic acid methyl ester [prepared by the following sequence: i.) methyl 3-azidobenzoate [CAS-No. 93066-93-4] and (RS)-tert.-butyldimethyl-[4-(tetrahydro-pyran-2-yloxy)-but-1-ynyl]-silane [CAS-No.
- the title compound was prepared from (RS)-3-[5-(tetrahydro-pyran-2-yloxymethyl)-pyrazol-1-yl]-benzoic acid [prepared by the following sequence: i.) A mixture of 3-hydrazino-benzoic acid [CAS-No. 38235-71-1], 4-dimethylamino-2-oxo-but-3-enoic acid ethyl ester [CAS-No. 67751-14-8] in acetic acid was refluxed for 15.5 h.
- the title compound was prepared from 3-[1,2,3]triazol-1-yl-benzoic acid [prepared by refluxing of methyl 3-azidobenzoate [CAS-No. 93066-93-4] in trimethylsilylacetylene, followed by saponification with aqueous NaOH in refluxing EtOH] (10.0 g, 52.86 mmol) by activation with ethyl chloroformate/Et 3 N and reaction with mono tert.-butyl malonate potassium salt with Et 3 N and MgCl 2 in CH 3 CN according to general procedure K (method a). Obtained as an orange oil (11.55 g). MS (ISP) 288 [(M+H) + ].
- the title compound was prepared from (RS)-3-[5-(tetrahydro-pyran-2-yloxymethyl)-[1,2,4]triazol-1-yl]-benzoic acid methyl ester [prepared by the following sequence: i.) methyl 3-(1H-1,2,4-triazol-1-yl)-benzoate, [CAS-No. 167626-27-9] (39.4 g, 194 mmol) was heated in 36% formaldehyde-water (250 ml) in an autoclave for 41 h at 150°C.
- the title compound was prepared from methyl 3-(1H-imidazol-1-yl)benzoate [prepared from 3-(1H-imidazol-1-yl)benzoic acid ( J. Med. Chem . 1987 , 30 , 1342; CAS-No. [108035-47-8] by refluxing in conc. H 2 SO 4 /MeOH] by treatment with lithium tert.-butyl acetate according to general procedure K (method b). Obtained as an orange-brown oil. MS (ISP) 287 [(M+H) + ].
- 3-Oxazol-4-yl-benzoic acid methyl ester (0.85 g) was treated with lithium tert.-butyl acetate according to the general procedure K (method b) to give crude 3-(3-oxazol-4-yl-phenyl)-3-oxo-propionic acid tert-butyl ester (1.46 g) as a pale-yellow oil.
- 3-Thiazol-4-yl-benzoic acid methyl ester (0.91 g) was treated with lithium tert.-butyl acetate according to the general procedure K (method b) to give crude 3-oxo-3-(3-thiazol-4-yl-phenyl)-propionic acid tert-butyl ester (1.54 g) as a pale-yellow oil.
- 6-aryl-2,2-dimethyl-[1,3]dioxin-4-ones were prepared from 3-aryl-3-oxo-propionic acids and catalytic amount of conc. H 2 SO 4 or trifluoroacetic acid (TFA) in isopropenyl acetate at 23 °C according to Chem. Pharm. Bull. 1983 , 31 , 1896.
- the final products were purified by silica gel column chromatography with hexane/EtOAc.
- 6-aryl-2,2-dimethyl-[1,3]dioxin-4-ones were prepared from the tert.-butyl 3-aryl-3-oxo-propionates by treatment with trifluoroacetic anhydride (TFAA) in a mixture of TFA and acetone at 23 °C according to Tetrahedron Lett . 1998 , 39 , 2253.
- TFAA trifluoroacetic anhydride
- the final products were if necessary purified by silica gel column chromatography with hexane/EtOAc.
- the 3-(3-cyano-phenyl)-3-oxo-propionic acid was prepared from 3-cyanobenzoyl chloride (828 mg, 5 mmol) and bis(trimethylsilyl)malonate (2.56 mL, 10 mmol) with n-BuLi (1.6M in hexane, 6.25 mL) in ether at -60 °C to 0 °C according to general procedure M (method c2).
- the crude material (1.04 g) was transformed into the title compound by stirring in isopropenyl acetate and TFA according to general procedure L (method a). Obtained as a light yellow solid (0.8 g).
- the 3-(3-imidazol-1-yl-phenyl)-3-oxo-propionic acid was prepared from 3-(1H-imidazol-1-yl)benzoyl chloride hydrochloride [prepared by treatment of 3-(1H-imidazol-1-yl)-benzoic acid ( J. Med. Chem. 1987 , 30 , 1342; CAS-No. [108035-47-8] with SOCl 2 ) and bis(trimethylsilyl)malonate with Et 3 N and LiBr in CH 3 CN at 0 °C according to general procedure K (method c1).
- the crude material was transformed into the title compound by stirring in isopropenyl acetate and conc. H 2 SO 4 according to general procedure L (method a). Obtained as an orange semisolid (617 mg). MS (EI) 270 (M + ).
- the title compound was prepared from (2-amino-4-chloro-5-dimethylaminophenyl)-carbamic acid tert.-butyl ester (Example J1) (0.5 mmol) and 3-(3-cyanophenyl)-3-oxo-propionic acid ethyl ester [CAS-No. 62088-13-5; prepared from 3-cyanobenzoyi chloride according to general procedure K, method a] (0.55 mmol) according to the general procedure M. Obtained as a white solid (160 mg). MS (ISP) 457 [(M+H) + ]; mp 159-163 °C.
- Example J1 (2-amino-4-chloro-5-dimethylaminophenyl)-carbamic acid tert.-butyl ester (Example J1) (143 mg, 0.5 mmol) and 3-oxo-3-(3-[1,2,3]triazol-1-yl-phenyl)-propionic acid ethyl ester (Example K1) (150 mg, 0.58 mmol) according to the general procedure M. Obtained as a beige solid (160 mg). MS (ISP) 499 [(M+H) + ] and 501 [(M+2+H) + ]; mp 136-137 °C.
- Example J1 (2-amino-4-chloro-5-dimethylaminophenyl)-carbamic acid tert.-butyl ester (Example J1) (143 mg, 0.5 mmol) and 3-[3-(3-methyl-isoxazol-5-yl)-phenyl]-3-oxo-propionic acid tert.-butyl ester (Example K4) (450 mg, 0.75 mmol) according to the general procedure M. Obtained as a white solid (136 mg). MS (ISP) 513 [(M+H) + ] and 515 [(M+2+H) + ]; mp 109-114 °C.
- Example J4 The title compound was prepared from ⁇ 2-amino-4-chloro-5-[(2-methoxy-ethyl)-methyl-amino]-phenyl ⁇ -carbamic acid tert.-butyl ester (Example J4) (165 mg, 0.5 mmol) and 3-[3-(3-methyl-isoxazol-5-yl)-phenyl]-3-oxo-propionic acid tert.-butyl ester (Example K4) (165 mg, 0.55 mmol) according to the general procedure M. Obtained as an amorphous yellow substance (207 mg). MS (ISP) 557 [(M+H) + ] and 559 [(M+2+H) + ].
- Example J4 The title compound was prepared from ⁇ 2-amino-4-chloro-5-[(2-methoxy-ethyl)-methyl-amino]-phenyl ⁇ -carbamic acid tert.-butyl ester (Example J4) (165 mg, 0.5 mmol) and 3-oxo-3-(3-[1,2,3]triazol-1-yl-phenyl)-propionic acid ethyl ester (Example K1) (165 mg, 0.5 mmol) according to the general procedure M. Obtained as an amorphous yellow substance (167 mg). MS (ISP) 543 [(M+H) + ] and 545 [(M+2+H) + ].
- the title compound was prepared from (2-amino-5-dimethylamino-4-trifluoromethyl-phenyl)-carbamic acid tert.-butyl ester (Example J6) (160 mg, 0.5 mmol) and 3-[3-(3-methyl-isoxazol-5-yl)-phenyl]-3-oxo-propionic acid tert.-butyl ester (Example K4) (151 mg, 0.5 mmol) according to the general procedure M. Obtained as an amorphous yellow substance (94 mg). MS (ISP) 547 [(M+H) + ].
- Example J1 The title compound was prepared from (2-amino-4-chloro-5-dimethylaminophenyl)-carbamic acid tert.-butyl ester (Example J1) and 3-[3-(3-methoxymethyl-isoxazol-5-yl)-phenyl]-3-oxo-propionic acid tert.-butyl ester (Example K9) according to the general procedure M. Obtained as a yellow solid (205 mg). MS (ISP) 543 [(M+H) + ] and 545 [(M+2+H) + ].
- Example J5 [5-amino-2'-fluoro-2-(2,2,2-trifluoro-ethoxy)-biphenyl-4-yl]-carbamic acid tert.-butyl ester (Example J5) (200 mg, 0.5 mmol) and (RS)-3-oxo-3- ⁇ 3-[5-(tetrahydro-pyran-2-yloxymethyl)-[1,2,3]triazol-1-yl]-phenyl ⁇ -propionic acid tert-butyl ester (Example K5) (220 mg, 0.55 mmol) according to the general procedure M. Obtained as a yellow oil(100 mg).
- Example J7 [2-amino-4-chloro-5-(ethyl-methyl-amino)-phenyl]-carbamic acid tert-butyl ester (Example J7) (300 mg, 1.0 mmol) and (RS)-3-oxo-3- ⁇ 3-[5-(tetrahydro-pyran-2-yloxymethyl)-[1,2,3]triazol-1-yl]-phenyl ⁇ -propionic acid tert-butyl ester (Example K5) (402 mg, 1.0 mmol) according to the general procedure M. Obtained as a yellow foam (500 mg). MS (ISP) 627.1 [(M+H) + ].
- the title compound was prepared from (2-amino-4-fluoro-5-pyrrolidin-1-yl-phenyl)-carbamic acid tert.-butyl ester (Example J15) and 3-[3-(3-methyl-isoxazol-5-yl)-phenyl]-3-oxo-propionic acid tert.-butyl ester (Example K4) according to the general procedure M. Obtained as a light yellow solid (126 mg). MS (ISP) 468 [(M+H) + ]; mp 186 °C.
- the title compound was prepared from (5-amino-2-dimethylamino-2'-fluoro-biphenyl-4-yl)-carbamic acid tert.-butyl ester (Example J20) (691 mg, 2.0 mmol) and 2,2-dimethyl-6-(3-[1,2,3]triazol-1-yl-phenyl)-[1,3]dioxin-4-one (Example L4) (543 mg, 2.0 mmol) according to the general procedure M. Obtained as a yellow solid (820 mg). Mp 125-135 °C.
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI200230163T SI1379511T1 (en) | 2001-04-12 | 2002-04-02 | DIHYDRO-BENZO (b) (1, 4) DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II |
EP02737911A EP1379511B1 (en) | 2001-04-12 | 2002-04-02 | DIHYDRO-BENZO (b) (1, 4) DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01109125 | 2001-04-12 | ||
EP01109125 | 2001-04-12 | ||
PCT/EP2002/003644 WO2002083652A1 (en) | 2001-04-12 | 2002-04-02 | DIHYDRO-BENZO [b] [1, 4] DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II |
EP02737911A EP1379511B1 (en) | 2001-04-12 | 2002-04-02 | DIHYDRO-BENZO (b) (1, 4) DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1379511A1 EP1379511A1 (en) | 2004-01-14 |
EP1379511B1 true EP1379511B1 (en) | 2005-07-20 |
Family
ID=8177126
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02737911A Expired - Lifetime EP1379511B1 (en) | 2001-04-12 | 2002-04-02 | DIHYDRO-BENZO (b) (1, 4) DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II |
Country Status (38)
Country | Link |
---|---|
US (1) | US6544985B2 (sh) |
EP (1) | EP1379511B1 (sh) |
JP (1) | JP4071115B2 (sh) |
KR (1) | KR100566171B1 (sh) |
CN (1) | CN1264825C (sh) |
AR (1) | AR035816A1 (sh) |
AT (1) | ATE299868T1 (sh) |
AU (1) | AU2002312788B2 (sh) |
BG (1) | BG108254A (sh) |
BR (1) | BR0208891A (sh) |
CA (1) | CA2442557C (sh) |
CZ (1) | CZ20033003A3 (sh) |
DE (1) | DE60205100T2 (sh) |
DK (1) | DK1379511T3 (sh) |
EC (1) | ECSP034797A (sh) |
ES (1) | ES2246012T3 (sh) |
GT (1) | GT200200073A (sh) |
HK (1) | HK1068888A1 (sh) |
HR (1) | HRP20030792A2 (sh) |
HU (1) | HUP0400851A3 (sh) |
IL (2) | IL157873A0 (sh) |
JO (1) | JO2285B1 (sh) |
MA (1) | MA27012A1 (sh) |
MX (1) | MXPA03009311A (sh) |
MY (1) | MY140271A (sh) |
NO (1) | NO20034576L (sh) |
NZ (1) | NZ528315A (sh) |
PA (1) | PA8543301A1 (sh) |
PE (1) | PE20021041A1 (sh) |
PL (1) | PL367064A1 (sh) |
PT (1) | PT1379511E (sh) |
RU (1) | RU2263112C2 (sh) |
SI (1) | SI1379511T1 (sh) |
SK (1) | SK13682003A3 (sh) |
UY (1) | UY27258A1 (sh) |
WO (1) | WO2002083652A1 (sh) |
YU (1) | YU79003A (sh) |
ZA (1) | ZA200307243B (sh) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR200201026T2 (tr) * | 1999-10-15 | 2002-08-21 | F.Hoffmann-La Roche Ag | Benzodiazepin türevleri |
WO2003061698A1 (fr) * | 2001-12-27 | 2003-07-31 | Taisho Pharmaceutical Co.,Ltd. | Derives de 6-fluorobicyclo[3.1.0]hexane |
CA2480869A1 (en) | 2002-03-28 | 2003-10-09 | Wisys Technology Foundation, Inc. | Anxiolytic agents with reduced sedative and ataxic effects |
EP1925614A1 (en) * | 2002-03-28 | 2008-05-28 | Wisys Technology Foundation, Inc. | Anxiolytic agents with reduced sedative and ataxic effects |
CA2532347C (en) * | 2003-07-25 | 2012-03-27 | F. Hoffmann-La Roche Ag | Combination of mglur2 antagonist and ache inhibitor for treatment of acute and/or chronic neurological disorders |
US7329662B2 (en) | 2003-10-03 | 2008-02-12 | Hoffmann-La Roche Inc. | Pyrazolo-pyridine |
US20060160823A1 (en) * | 2004-05-28 | 2006-07-20 | Leonore Witchey-Lakshmanan | Particulate-stabilized injectable pharmaceutical compositions of Posaconazole |
JP4708438B2 (ja) * | 2005-02-11 | 2011-06-22 | エフ.ホフマン−ラ ロシュ アーゲー | mGluR2アンタゴニストとしてのピラゾロピリミジン誘導体 |
ATE460417T1 (de) | 2005-03-23 | 2010-03-15 | Hoffmann La Roche | Acetylenylpyrazolopyrimidinderivate als mglur2- antagonsten |
AR054623A1 (es) * | 2005-06-23 | 2007-07-04 | Astrazeneca Ab | PROCESO PARA PREPARAR DERIVADOS DE BENCIMIDAZOL Y COMPUESTOS INTERMEDIARIOS DE SíNTESIS DE LOS MISMOS. |
AU2006298829B2 (en) | 2005-09-27 | 2011-03-03 | F. Hoffmann-La Roche Ag | Oxadiazolyl pyrazolo-pyrimidines as mGluR2 antagonists |
GB0600228D0 (en) * | 2006-01-06 | 2006-02-15 | Fermentas Uab | Inactivation method |
AR059898A1 (es) | 2006-03-15 | 2008-05-07 | Janssen Pharmaceutica Nv | Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2 |
TW200808751A (en) * | 2006-04-13 | 2008-02-16 | Astrazeneca Ab | New compounds |
KR101096476B1 (ko) | 2006-09-20 | 2011-12-20 | 에프. 호프만-라 로슈 아게 | 4-옥소-2,3,4,5-테트라히드로-벤조[b][1,4]디아제핀 유도체 |
TW200900065A (en) | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
TW200845978A (en) | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
WO2008128889A1 (en) | 2007-04-19 | 2008-10-30 | F. Hoffmann-La Roche Ag | Dihydro-benzo[b][1,4]diazepin-2-one sulfonamide derivatives |
JP5433579B2 (ja) * | 2007-09-14 | 2014-03-05 | ジャンセン ファーマシューティカルズ, インコーポレイテッド. | 1,3−二置換−4−フェニル−1h−ピリジン−2−オン |
PT2203439E (pt) | 2007-09-14 | 2011-02-11 | Ortho Mcneil Janssen Pharm | 4-fenil-3,4,5,6-tetra-hidro-2h,1'h-[1,4']bipiridinil-2'- onas 1',3'-dissubstituídas |
NZ584152A (en) | 2007-09-14 | 2011-11-25 | Ortho Mcneil Janssen Pharm | 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones |
MX2010005110A (es) | 2007-11-14 | 2010-09-09 | Ortho Mcneil Janssen Pharm | Derivados de imidazo[1,2-a]piridina y su uso como moduladores alostericos positivos de los receptores de glutamato metabotropico 2. |
BRPI0918055A2 (pt) | 2008-09-02 | 2015-12-01 | Addex Pharmaceuticals Sa | derivados de 3-azabiciclo[3,1,0]hexila como moduladores de receptores metabotrópicos de glutamato. |
CA2738849C (en) | 2008-10-16 | 2016-06-28 | Addex Pharma S.A. | Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors |
JP5690277B2 (ja) | 2008-11-28 | 2015-03-25 | ジャンセン ファーマシューティカルズ, インコーポレイテッド. | 代謝型グルタミン酸受容体の調節因子としてのインドールおよびベンゾオキサジン誘導体 |
NZ596078A (en) | 2009-05-12 | 2013-06-28 | Janssen Pharmaceuticals Inc | 1,2,4-TRIAZOLO [4,3-a] PYRIDINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OR PREVENTION OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS |
MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
CN102439015B (zh) | 2009-05-12 | 2015-05-13 | 杨森制药有限公司 | 1,2,4-三唑并[4,3-a]吡啶衍生物和其作为mGluR2受体的正向变构调节剂的用途 |
CN104086528A (zh) | 2010-07-15 | 2014-10-08 | 拜耳知识产权有限责任公司 | 作为杀虫剂的新杂环化合物 |
WO2012059431A1 (en) | 2010-11-01 | 2012-05-10 | Abbott Gmbh & Co. Kg | Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-ht6 receptor |
WO2012059432A1 (en) | 2010-11-01 | 2012-05-10 | Abbott Gmbh & Co. Kg | N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the 5-ht6 receptor |
CA2814998C (en) | 2010-11-08 | 2019-10-29 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
US9271967B2 (en) | 2010-11-08 | 2016-03-01 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
US8993591B2 (en) | 2010-11-08 | 2015-03-31 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors |
WO2012149540A1 (en) | 2011-04-28 | 2012-11-01 | The Broad Institute Inc | Inhibitors of histone deacetylase |
JP5790195B2 (ja) * | 2011-06-22 | 2015-10-07 | セントラル硝子株式会社 | ピラゾール化合物の製造方法 |
WO2013033246A2 (en) | 2011-08-29 | 2013-03-07 | Braincells, Inc. | Novel benzodiazepinones as modulators of metabotropic glutamate receptor functions and neurological uses thereof |
CA2880117C (en) | 2012-07-27 | 2021-04-06 | The Broad Institute, Inc. | Inhibitors of histone deacetylase |
WO2014064028A1 (en) | 2012-10-23 | 2014-05-01 | F. Hoffmann-La Roche Ag | Mglu2/3 antagonists for the treatment of autistic disorders |
US9914717B2 (en) | 2012-12-20 | 2018-03-13 | The Broad Institute, Inc. | Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors |
ES2696700T3 (es) | 2012-12-28 | 2019-01-17 | Crystalgenomics Inc | Derivado de 2,3-dihidro-isoindol-1-on como supresor de quinasa BTK y composición farmacéutica que incluye el mismo |
JO3368B1 (ar) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2 |
JO3367B1 (ar) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2 |
SI3096790T1 (sl) | 2014-01-21 | 2019-11-29 | Janssen Pharmaceutica Nv | Kombinacije, ki vsebujejo pozitivne aleostrične modulatorje ali ortosterične agoniste metabotropnega glutamatergičnega receptorja podtipa 2 in njihova uporaba |
ME03518B (me) | 2014-01-21 | 2020-04-20 | Janssen Pharmaceutica Nv | Kombinacije koje obuhvataju pozitivne alosterične modulatore ili ortosterične agoniste metabotropnog glutamatergičnog receptora podtipa 2 i njihova primjena |
AU2015226855C1 (en) | 2014-03-07 | 2021-02-11 | Biocryst Pharmaceuticals, Inc. | Human plasma kallikrein inhibitors |
CA2943877A1 (en) * | 2014-04-23 | 2015-10-29 | F. Hoffmann-La Roche Ag | Mglu2/3 antagonists for the treatment of intellectual disabilities |
WO2015191630A1 (en) | 2014-06-10 | 2015-12-17 | Sanford-Burnham Medical Research Institute | Metabotropic glutamate receptor negative allosteric modulators (nams) and uses thereof |
CN108727345B (zh) * | 2017-04-25 | 2023-06-27 | 广东东阳光药业有限公司 | 一种咪唑环中间体的制备方法 |
CN108586447B (zh) * | 2018-01-19 | 2021-01-29 | 中国人民解放军第四军医大学 | 一种苯二氮杂卓化合物及其制备方法和应用 |
MX2021014130A (es) * | 2019-06-06 | 2022-01-04 | Arcus Biosciences Inc | Procesos para preparar compuestos de aminopirimidina. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1210338A2 (en) * | 1999-08-05 | 2002-06-05 | IGT Pharma Inc. | 1,4-diazepine derivatives for the treatment of diseases related to the central nervous system |
IL148816A0 (en) * | 1999-10-15 | 2002-09-12 | Hoffmann La Roche | Benzodiazepine derivatives |
TR200201026T2 (tr) * | 1999-10-15 | 2002-08-21 | F.Hoffmann-La Roche Ag | Benzodiazepin türevleri |
-
2002
- 2002-04-02 NZ NZ528315A patent/NZ528315A/en unknown
- 2002-04-02 CA CA002442557A patent/CA2442557C/en not_active Expired - Fee Related
- 2002-04-02 SK SK1368-2003A patent/SK13682003A3/sk unknown
- 2002-04-02 EP EP02737911A patent/EP1379511B1/en not_active Expired - Lifetime
- 2002-04-02 YU YU79003A patent/YU79003A/sh unknown
- 2002-04-02 ES ES02737911T patent/ES2246012T3/es not_active Expired - Lifetime
- 2002-04-02 CZ CZ20033003A patent/CZ20033003A3/cs unknown
- 2002-04-02 RU RU2003130637/04A patent/RU2263112C2/ru not_active IP Right Cessation
- 2002-04-02 AT AT02737911T patent/ATE299868T1/de not_active IP Right Cessation
- 2002-04-02 SI SI200230163T patent/SI1379511T1/xx unknown
- 2002-04-02 JP JP2002581408A patent/JP4071115B2/ja not_active Expired - Fee Related
- 2002-04-02 HU HU0400851A patent/HUP0400851A3/hu unknown
- 2002-04-02 DK DK02737911T patent/DK1379511T3/da active
- 2002-04-02 DE DE60205100T patent/DE60205100T2/de not_active Expired - Lifetime
- 2002-04-02 PT PT02737911T patent/PT1379511E/pt unknown
- 2002-04-02 KR KR1020037013300A patent/KR100566171B1/ko not_active IP Right Cessation
- 2002-04-02 PL PL02367064A patent/PL367064A1/xx not_active Application Discontinuation
- 2002-04-02 MX MXPA03009311A patent/MXPA03009311A/es active IP Right Grant
- 2002-04-02 AU AU2002312788A patent/AU2002312788B2/en not_active Ceased
- 2002-04-02 BR BR0208891-6A patent/BR0208891A/pt not_active Application Discontinuation
- 2002-04-02 CN CNB028081811A patent/CN1264825C/zh not_active Expired - Fee Related
- 2002-04-02 IL IL15787302A patent/IL157873A0/xx active IP Right Grant
- 2002-04-02 WO PCT/EP2002/003644 patent/WO2002083652A1/en active IP Right Grant
- 2002-04-03 US US10/115,826 patent/US6544985B2/en not_active Expired - Fee Related
- 2002-04-09 PA PA20028543301A patent/PA8543301A1/es unknown
- 2002-04-09 AR ARP020101290A patent/AR035816A1/es not_active Application Discontinuation
- 2002-04-10 JO JO200232A patent/JO2285B1/en active
- 2002-04-10 PE PE2002000291A patent/PE20021041A1/es not_active Application Discontinuation
- 2002-04-11 GT GT200200073A patent/GT200200073A/es unknown
- 2002-04-11 UY UY27258A patent/UY27258A1/es not_active Application Discontinuation
- 2002-04-11 MY MYPI20021345A patent/MY140271A/en unknown
-
2003
- 2003-09-11 IL IL157873A patent/IL157873A/en not_active IP Right Cessation
- 2003-09-16 ZA ZA200307243A patent/ZA200307243B/en unknown
- 2003-10-01 HR HR20030792A patent/HRP20030792A2/hr not_active Application Discontinuation
- 2003-10-08 EC EC2003004797A patent/ECSP034797A/es unknown
- 2003-10-08 MA MA27346A patent/MA27012A1/fr unknown
- 2003-10-10 BG BG108254A patent/BG108254A/bg unknown
- 2003-10-10 NO NO20034576A patent/NO20034576L/no not_active Application Discontinuation
-
2005
- 2005-02-24 HK HK05101555A patent/HK1068888A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1379511B1 (en) | DIHYDRO-BENZO (b) (1, 4) DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II | |
EP1379522B1 (en) | DIHYDRO-BENZO(b)(1,4)DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS I | |
AU2002312788A1 (en) | Dihydro-benzo [b] [1, 4] diazepin-2-one derivatives as mGluR2 antagonists II | |
US6960578B2 (en) | Glutamate receptor antagonists | |
AU2002310912A1 (en) | Dihydro-benzo[b][1,4]diazepin-2-one derivatives as mGluR2 antagonists I | |
NZ534122A (en) | Dihydro-benzo[b][1, 4]diazepin-2-one derivatives for the treatment of neurological disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20031112 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: ADAM, GEO Inventor name: MUTEL, VINCENT Inventor name: WOLTERING, THOMAS, JOHANNES Inventor name: WICHMANN, JUERGEN Inventor name: GOETSCHI, ERWIN |
|
17Q | First examination report despatched |
Effective date: 20040611 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Extension state: LT LV MK RO SI |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REF | Corresponds to: |
Ref document number: 60205100 Country of ref document: DE Date of ref document: 20050825 Kind code of ref document: P |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: SC4A Effective date: 20050831 |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 |
|
REG | Reference to a national code |
Ref country code: GR Ref legal event code: EP Ref document number: 20050403172 Country of ref document: GR |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2246012 Country of ref document: ES Kind code of ref document: T3 |
|
ET | Fr: translation filed | ||
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20060421 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: LU Payment date: 20070323 Year of fee payment: 6 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: MC Payment date: 20070329 Year of fee payment: 6 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DK Payment date: 20080319 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CY Payment date: 20070430 Year of fee payment: 6 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: TR Payment date: 20080326 Year of fee payment: 7 Ref country code: PT Payment date: 20080401 Year of fee payment: 7 |
|
LTIE | Lt: invalidation of european patent or patent extension | ||
LTLA | Lt: lapse of european patent or patent extension |
Effective date: 20080402 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080430 |
|
REG | Reference to a national code |
Ref country code: SI Ref legal event code: KO00 Effective date: 20081210 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080402 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GR Payment date: 20080411 Year of fee payment: 7 |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: MM4A Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20091002 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: EBP |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20091002 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090430 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IE Payment date: 20100319 Year of fee payment: 9 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20091104 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20100312 Year of fee payment: 9 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080402 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20100419 Year of fee payment: 9 Ref country code: FI Payment date: 20100407 Year of fee payment: 9 Ref country code: FR Payment date: 20100420 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20100315 Year of fee payment: 9 Ref country code: DE Payment date: 20100430 Year of fee payment: 9 Ref country code: IT Payment date: 20100422 Year of fee payment: 9 Ref country code: NL Payment date: 20100412 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20100504 Year of fee payment: 9 Ref country code: CH Payment date: 20100430 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20100407 Year of fee payment: 9 |
|
BERE | Be: lapsed |
Owner name: F. *HOFFMANN-LA ROCHE A.G. Effective date: 20110430 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: V1 Effective date: 20111101 |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: EUG |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20110402 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 299868 Country of ref document: AT Kind code of ref document: T Effective date: 20110402 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20111230 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20110430 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20110430 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20110502 Ref country code: FI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20110402 Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20111101 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20111101 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20110430 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20110402 Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20110402 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20110402 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 60205100 Country of ref document: DE Effective date: 20111101 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20110404 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20120524 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20110403 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090402 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20110403 |